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Understanding the mechanisms involved in the viral entry process is key for 
developing effective anti-viral therapies and vaccines. Entry of membrane-enveloped 
viruses typically involves two key processes mediated by a dual-function viral 
glycoprotein. During influenza infection hemagglutinin (HA) binds to sialic acid 
moieties on epithelial cell membranes, triggering engulfment into the cell via 
endocytosis. As the endosome matures and becomes more acidic, HA undergoes a 
conformational change, which induces fusion of the viral and endosomal membranes, 
releasing viral RNA into the cell. Quantitative kinetic studies of binding and fusion are 
often conducted in-vitro to obtain high-resolution measurements. Total internal 
reflection microscopy combined with microfluidics and supported bilayers is a 
powerful, single particle tracking (SPT) platform for host-pathogen membrane fusion 
studies.  
One inadequacy of the aforementioned SPT platform has been capturing the 
complexity of the cell membrane, including membrane proteins. Sialic acid receptors 
are easily integrated into the platform using glycolipids. However, viruses that bind 
proteinaceous receptors for cell entry have been precluded from study. We have 
developed a general method to integrate proteinaceous receptors and cellular 
 membrane components into supported lipid bilayers for SPT fusion studies of feline 
coronavirus (FCoV). Supported lipid bilayers are formed from mammalian cell 
membrane vesicles that express the FCoV receptor, aminopeptidase N (APN), using a 
cell blebbing technique. SPT is then used to identify fusion intermediates and measure 
membrane fusion kinetics of FCoV, which to our knowledge have not been obtained 
before. Overall, the fusion results recapitulate what is observed in-vivo, that 
coronavirus required binding to specific receptors, a low-pH trigger, and that 
membrane fusion is receptor and protease-dependent.  We also observe that small 
populations of FCoV viruses are capable of fusing at neutral pH. This phenomenon 
was previously un-reported in-vivo for this strain of FCoV and may have implications 
for explaining the infection efficiency and cellular tropism of some coronaviruses. 
This platform also provides a new route to study how viruses rapidly adapt to other 
hosts, and to identify the factors that led to the emergence of other zoonotic 
coronaviruses, such as SARS-CoV and the new emerging MERS-CoVe. In this thesis 
I will also present our advances on using the cell blebbing technique to create simple 
virus-like particles (VLPs). VLPs can be used to study the highly pathogenic 
coronaviruses such as SARS-CoV and avian influenzas such as H5N1 in a biosafety 
level 2 laboratory 
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CHAPTER 1 
LITERATURE REVIEW 
 
1.1 Membrane Enveloped Viral Infection 
A membrane-enveloped virus is in essence a collection of viral genes, encapsulated in 
a lipid membrane and decorated with viral proteins that mediate host cell entry and 
egress. Membrane enveloped viruses infect host species by fusing the lipid membrane 
surrounding the viral genome with the membrane of host cells.  Fusion of two 
biological membranes is thermodynamically favorable but the kinetic barrier is 
high(1). This kinetic barrier is overcome by engaging membrane proteins on the 
surface of the virus to mediate membrane fusion(2).  Before this kinetic barrier can be 
overcome, viral proteins undergo activation steps. Most viral fusion proteins require a 
priming event, such as proteolytic cleavage, which prepares the virus for cellular 
uptake(3).  At some point during the entry process, the viral fusion protein undergoes 
a conformational change, frequently triggered by proton binding in a low pH 
environment or binding to a specific membrane protein. The conformational change in 
the fusion protein mediates the merging of the viral and cellular membrane(4), 
resulting in the release of the genome and continuation of the replication cycle. 
Membrane fusion and the cellular cues accompanying this process are thus vital steps 
in the life cycle of many viruses. Membrane-enveloped viruses include influenza A, 
severe acute respiratory syndrome (SARS), human immunodeficiency virus (HIV) and 
 20 
ebola virus. These viruses represent some of the biggest threats to global health and 
thus warrant the development of quantitative methods to discern the steps involved 
cell entry.  
The most well characterized viral fusion protein is influenza hemagglutinin (HA), 
which mediates both cellular binding and membrane fusion. Understanding the 
mechanism of influenza entry has been the subject of much research over the last 
twenty years because of the constant threat of another highly lethal strain emerging 
similar to the 1918 pandemic strain.  
 
 
Figure 1 schematic of influenza replication cycle. Virus enters the cell by receptor mediated endocytosis. As 
the endosome matures and becomes midly acidic, the viral and target membranes fuse and the segmented 
viral genome is released. RNA is replicated in the nucleus and after transcription and translation of viral 
proteins the viru assembles at the plasma membrane. Influenza acquires it’s membrane by budding through 
the plasma membrane and progenies go on to infect neighbouring cells.  
Endocytosis*
Endosome(
Nucleus(
Fusion*
Cell(
Inﬂuenza(Virus(
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RNA**
transfer*
Protein*
synthesis*
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HA binds to sialic acid residues on the cell plasma membrane. This binding event 
triggers uptake via receptor mediated endocytosis(5). As the endosome matures, the 
pH drops from neutral to a mildly acidic pH(6) (between 6 and 5) and it is this change 
in pH which initiates the HA conformational change and provides the energy that 
initiates membrane fusion. HA is a protein comprised of two glycopolypeptides, HA1 
and HA2, linked by a single disulphide bond. HA2 is anchored in the viral membrane 
by its C-terminus.  Structural analysis(7, 8) has revealed that HA2 chains are a large 
component of an alpha-helical stem, which forms the center of the molecule. HA1 
chains form three membrane distal globular domains containing the sialic acid binding 
sites. A key feature of the HA2 domain is the presence of a hydrophobic sequence 
located close to the N-terminus called the fusion peptide(9, 10), shown in figure 2. The 
fusion peptide is located approximately 35 Å from the viral membrane and 100 Å 
from distal tip of the HA. During the low pH-induced conformational change of HA, 
the fusion peptide is exposed and inserts into the endosomal membrane. 
 
Figure 2. Schematic of the hypothesized steps in the membrane fusion process.  Adapted from Harrison et 
al(11). The fusion peptide of HA (small green ends of the red region) is concealed and facing the viral 
pH dependent 
conformational change Hemifusion  
Stalk formation 
Pore 
formation 
Viral RNA 
release 
Endosome 
Virus 
HA 
protein 
pH 
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membrane until the pH drops to 5.5. Proton binding results in the projection of the fusion peptide to the 
target membrane and conformation rearrangement of the protein that leads to the bending of the two 
membranes. The outer leaflets of the membranes are the first to mix (hemifusion) and upon collapse of the 
hemifusion stalk a fusion pore is opened. The viral capsid is then released into the cell where it is transported 
to the nucleus for replication.   
 Viral membrane fusion entails multiple kinetic steps and the activation of multiple 
HA trimers. In recent years it has been shown that number of HAs needed for fusion is 
could be anywhere from one to six (12-14) .  
 Harrison(11) proposed the following mechanism, which is summarized in figure 
2.  
1. The fusion peptide of HA bridges the target membrane forming an extended 
intermediate state of HA and enabling the first steps of membrane fusion.  
2. The extended intermediate then undergoes collapse and the C-terminal 
segment of the protein folds back along the outside of the HA. Segments from 
the three subunits of the C-terminal do not fold back at the same rate so that 
they can extend to different lengths along the HA core, enabling the entire 
protein to bend away from the deformed membrane.  
3. Hemifusion happens next, as the outer monolayers of the membranes are 
brought into contact after the extended intermediate collapses. The outer 
monolayers fuse into a hemifusion stalk.  
4. The hemifusion stalk collapses and a fusion pore opens. Hemifusion is the 
final intermediate state before a fusion pore is fully formed and RNA is 
released. 
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Understanding the entry mechanisms is key not only for influenza viruses, but also for 
other viruses that can utilize the endosomal pathway to enter cells.  In the last 10 
years, coronaviruses have emerged as a serious pandemic threat. Coronaviruses are 
zoonotic viruses that typically cause respiratory and enteric disease in mammals and 
birds. Like influenza, transmission of coronavirus can occur between animal reservoirs 
and a human host. The outbreak of severe acute respiratory syndrome (SARS) in 2003 
and Middle Eastern respiratory syndrome (MERS) in 2012 are two widely known 
examples of such species jumping events. The factors that contribute to coronaviruses 
adapting to new hosts are not well understood and due to the high mortality rates 
associated with SARS and MERS, understanding the critical steps involved in viral 
entry has become increasingly important for developing antiviral therapies.  
 Coronavirus membranes typically contain 3 viral proteins, spike protein (S), the 
membrane protein (M) and the envelope protein (E)(15). The spike protein regulates 
both binding and membrane fusion and thus plays an important role in determining the 
host tropism. Like influenza (HA), spike binds to cellular receptors and triggers uptake 
of the coronavirus via endocytosis and membrane fusion is mediated by 
conformational changes in the spike protein(16). Spike protein must undergo 
proteolytic cleavage to expose the hydrophobic fusion peptide that mediates 
membrane fusion(15, 17). The timing of cleavage can be a key determinant in 
pathogenicity. For example, influenza HA may be cleaved by several proteases, but 
some serotypes can be cleaved with host cell furin during the secretion pathway, 
resulting in a systemic infection(3). Timing is equally important for coronavirus S 
cleavage. The most dramatic example occurs during infection with SARS. In the 
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presence of certain exogenous proteases SARS can bind and fuse at the cell surface, 
which is believed to 100- to 1000-fold more efficient than endosomal entry(18). This 
example demonstrates how the timing of proteolytic activation changed the pathway 
and efficiency. By studying coronavirus entry single particle fusion assays, the 
sequence of trigger e.g. cleavage-binding-fusion or binding-cleavage-fusion can be 
easily controlled and more insight into the entry pathways can be elucidated.  
 
 
 1.2 Methods for Monitoring Viral Fusion 
In vitro systems are typically used to monitor fusion as conditions inside mammalian 
cells are difficult to control and assay. The majority of work to date uses bulk fusion 
techniques(19) to quantify viral fusion kinetics. In these experiments virus was labeled 
with self-quenching fluorescent dye conjugated to a single acyl chain, typically 
octadecylrhodamine B (R18), which inserts into the viral membrane. At high 
concentrations of R18 in the viral membrane the fluorescence is quenched. Upon 
fusion with nearby liposomes, triggered by low pH, the mixing of the viral and 
liposome membrane results in dilution of the R18. As the dye molecules diffuse into 
the target membrane, they become diluted and the overall fluorescence increases. 
From the change in fluorescence intensity in time, kinetic parameters can be obtained. 
Bulk experiments data does not provide enough detail or resolution to be able to 
observe the individual steps involved in viral fusion mechanism, for example, one 
cannot distinguish between binding of the virus to sialic acid receptors and fusion.  
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Single particle tracking techniques can mitigate many of the drawbacks associated 
with bulk fusion assays. The study of single events requires a surface-specific 
technique where individual viruses can be located and observed.  One such optical 
technique is total internal reflection microscopy (TIRF). Recently, TIRF has increased 
in popularity for studying viral fusion(20-23). The use of TIRF with supported lipid 
bilayers to study viral fusion enables tracking of individual binding and fusion events. 
Using supported lipid bilayers facilitates the use of TIRF and its planarity is closer to 
the geometry the virus sees in the late endosome in nature.  Events can be followed 
using the same dequenching strategy as used in the bulk assays, however, individual 
particles can be monitored using TIRF if the concentration of bound virus is low 
enough to distinguish particles from one another. In TIRF(24), a collimated laser beam 
is passed through a prism at a high incidence angle. Total internal reflection occurs 
when the laser beam passes from a medium with a high refractive index (glass 
coverslip) to a medium with a lower refractive index (water), at an angle that is larger 
than the critical angle αc. The critical angle is calculated according to Snell’s Law 
(equation 1) 
 
      Equation 1 
 
In our system, n1 and n2 are the refractive indices of water (1.33) and the glass 
coverslip (1.518), respectively. Using these values, the critical angle (αc) is 61o. When 
€ 
n1 sin(α1) = n2 sin(α2)
€ 
α2 = 90o
αc = sin−1
n2
n1
$ 
% 
& 
'
( 
) 
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the angle incident laser beam is greater than 61o, total internal reflection occurs at the 
interface of the coverslip and water. This results in a standing wave at the interface, 
with an intensity that decreases exponentially with distance away from the interface. 
This is known as an evanescent wave. This surface-specific technique typically 
illuminates a region up to 200 nm away from the interface, thus exciting only 
fluorophores that are located in this region and eliminating any noise from particles in 
the bulk fluid (figure 4). By locating the supported bilayer within the evanescent field, 
viral particles can be bound within the evanescent field to facilitate observation of 
fusion events. 
 
 
Figure 3. Schematic representation of TIRF microscopy. The incident laser beam is totally internally 
reflected at the interface between glass and buffer. The resultant evanescent wave excites fluorophores that 
are no more than 100 nm from the interface, thus eliminating noise from virus in the bulk solution.  
 
Wessels et al(20) demonstrated that TIRF could be used to study the fusion of 
single influenza and Sindbis particles to solid supported lipid bilayers. Wessels(20) 
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used R18 dequenching to detect fusion. This work showed that dequenching of a 
single influenza virus occurred on the order of 100 ms. However, it is impossible to 
known how much R18 partitions into the inner leaflet of the viral membrane, because 
R18 can “flip-flop”(25, 26) across the bilayer. Thus, the typical dequenching spike is 
not a definitive indicator of complete pore formation, but reports only on 
“hemifusion”, which the fusion of the two outer-most leaflets of the viral and host 
membranes. In order to accurately distinguish hemifusion from pore formation, an 
additional dye must be used to label the internal contents of the viral particle to 
indicate its release from the virus.  
Floyd et al(21) developed a two-color fluorescence assay to differentiate influenza 
membrane hemifusion and full pore-formation. Viruses were bound to a supported 
lipid bilayer containing sialic acid receptor, GD1a. Viral particles were labeled with a 
green membrane dye (R110C18) to track hemifusion and sulforhodamine B (SRB), a 
red dye that intercalates into the viral interior. The time at which pore formation 
occurs is reported by a decrease in SRB intensity as the pore opens and the dye is 
released for the virus. Using this technique to study membrane fusion provides 
detailed kinetic information of both the hemifusion and pore formation processes. 
Kinetic analysis revealed a multistep process where the number of steps (N) occurring 
in the hemifusion process was approximately equal to three, confirming earlier 
estimates(21). Their analysis showed that three steps occurred in parallel and N 
represented the number of HAs that must undergo a conformational change at low pH 
to initiate a hemifusion event. In addition, they confirmed that the collapse of the 
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hemifusion stalk to form a pore is the single rate-limiting step in the membrane fusion 
process(27).  
 One of the most compelling reasons to study influenza fusion using single 
particle tracking techniques stems from the process of producing high titers of 
influenza virus for vaccine production and anti-fusogenic drug testing. For 
development of anti-fusogenic drugs, antibody therapies and vaccines, a high titer of 
virus is required for testing. This is achieved by infecting large batches of 
embryonated chicken eggs with the clinical virus strains in a method first developed 
50 years ago(28, 29). Various studies have shown that passaging virus in eggs alters 
the composition of the HA making it significantly different from the wild-type 
virus(30, 31). In chapter 2, we use single virion fusion assays to determine significant 
differences in fusion kinetics between lab adapted and clinical strains of influenza.  
 
1.4 Difficulties associated with the single virion approach 
1.3.1 Method of initiation for pH triggered proteins 
While the use of single virion tracking techniques has improved the resolution at 
which we can probe virus-host interactions, there are still limitations associated with 
this technique. One of the biggest concerns associated with typical TIRF assays is the 
method of buffer exchange used to simulate a low pH environment in microfluidic 
channels. A key aspect of determining the fusion lag times in any assay is a precise 
knowledge of when the pH drop occurs in the system. The timescale for the re-
arrangement of HA and exposure of the fusion peptide is on the order of 
milliseconds(27). Thus in order to study fusion most accurately in an in vitro system, 
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the timescale of acidification is a key parameter to control.  Typically, to mark when 
acidification occurs a pH sensitive fluorescent marker such as fluorescein is typically 
incorporated into the lipid bilayer. Thus when the fluorescein intensity decreases, low 
pH has been reached in the system. However, there are inherent difficulties in using 
hydrodynamic flow to initiate fusion. The binding affinity of HA to sialic acid is weak 
and flowing buffer through the system shears viruses. This shear force can not only 
remove particles from the bilayer and carry them along with the flow, but could also 
induce a deformation in the viral envelope or fusion protein. Simulations have shown 
spherical vesicles tethered to a surface undergo a slight morphological change when 
under the influence of a shear force(32).  
Photo-dissociation of nitrobenzaldehyde has been studied by transient absorption 
and photo acoustic methods(33). Upon UV excitation, the nitronate ion of the cage 
compound is rapidly produced through intramolecular proton transfer reaction and 
protons are released into solution, resulting in a change in pH in the local environment 
(33). Caged compounds have been used in the investigation of the mechanisms of 
organized biological systems such as the active transport of proteins in muscle fibers 
(34) protein folding kinetics(35, 36) and proton transfer in green fluorescent 
protein(37). Proton cages are advantageous because they induce a rapid, localized pH 
change on the order of microseconds that is orders of magnitude faster than the buffer 
exchange, which can take up to five seconds. Also, the reaction occurs in a completely 
quiescent environment, removing any artifacts induced by shearing buffer flow. In 
chapter 2, we describe the integration of proton cages into the individual virion 
tracking assay and the impact on membrane fusion kinetics. 
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1.3.2 Studying viruses that utilize membrane proteins as receptors for entry 
One of the biggest drawbacks when using single virion assays to study virus 
entry is the limited range of enveloped viruses that can be studied. Viruses like 
influenza or vesicular stomatitis virus (VSV) are studied because their cellular 
receptors are easily integrated into supported lipid bilayers. However, the receptors for 
many enveloped viruses are membrane proteins. The receptors for the coronaviruses, 
SARS and MERS were determined to be angiotensin-converting enzyme 2(38) and 
dipeptidyl-peptidase 4(39)  respectively. Coronaviruses have been precluded from 
study in single virion fusion assays because of the difficulty associated with 
embedding functional, membrane proteins in supported lipids bilayers. Usually, 
proteins are incorporated into vesicles by using detergent to solubilize the membrane 
protein of interest, which is then reconstituted into a vesicle called a 
proteoliposome(40). When membrane proteins are solubilized, they are extracted from 
their native environment exposing the hydrophobic transmembrane domains to an 
aqueous environment. To minimize these energetically unfavorable interactions, the 
proteins refold and this can result in incorporation of misfolded proteins into 
proteoliposomes and hence supported bilayers. The conformation of membrane 
proteins involved in viral entry is crucial and it is of utmost importance when 
analyzing the steps in pathogenesis. To overcome this limitation, we have developed a 
method of embedding, functional, enzymatically active membrane proteins in 
supported bilayers by utilizing chemically induced cell blebbing(23). Cell blebs are 
spherical membrane protrusions that are produced by contractions of the actin 
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cytoskeleton. When the plasma membrane locally detaches from the cytoskeleton, the 
hydrostatic pressure in the cytoplasm drives membrane expansion by forcing 
cytoplasmic fluid through the cortex hole (41). This causes the membrane to detach 
further from the actin cortex eventually resulting in vesicles pinching off the cell 
membrane. Blebs are a common marker of apoptosis but blebs are also observed in 
healthy cells during cytokinesis and cell spreading(42). 
 
Figure 4 adapted from Dogterom et al (41) shows bleb initiation after detachment of plasma membrane from 
the actomyosin cortex (a) and expansion due to difference in cytoplasmic pressure (b). A confocal-
microscopy image (c) of  of multiple membrane blebs forming on a single cell . The scale bar in (c) is 5um 
  
Chemical induction of blebs in cell culture was first observed in the 1970s . Blebs are 
induced by incubating cells with buffer containing millimolar concentrations of 
formaldehyde and dithiotreitol (DTT)(43-45). Chemical induction of cell blebs 
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produces vesicles containing transmembrane proteins that have never been subjected 
to solubilization and are ideal for use in biomimetic systems to study virus-host 
interactions. We adsorb membrane blebs, from cells transfected with receptor proteins 
specific for coronaviruses to a glass substrate, and then incubate with liposomes 
devoid of proteins. Rupturing of the liposomes in spaces between adsorbed blebs 
induces the rupture of the cell blebs on the substrate(23). In chapter 3, we describe 
using cell blebs to create, cell membrane-like supports containing coronavirus 
receptors, to demonstrate the first single virion coronavirus fusion studies. This new 
technique could potentially be extended to any membrane-enveloped virus that binds 
proteinaceous cellular receptors.  
 
1.3.3 Investigating fusion kinetics of highly pathogenic viruses 
 In chapters 4 and 5, we will show that the single virion fusion assay can be 
extended to studying systems of highly pathogenic viruses. In biosafety level 2 
laboratories, pathogens such as pandemic influenza viruses cannot be handled. 
Studying native viruses like, H2N2, H5N1 and SARS is confined to biosafety level 3 
containment. However, for studying virus-host entry mechanism, it may be sufficient 
to use a system wherein only the fusion proteins from high path viruses are expressed 
in pseudotyped viruses. A pseudotyped virus has the envelope protein of a 
heterologous virus on the backbone of another virus, usually vesicular stomatitis virus 
(VSV) or murine leukemia virus (MLV). Viral pseudotypes provide a safe method for 
studying highly pathogenic viruses and an effective way of delivering genes for 
therapeutic uses. However, production of the pseudoviruses can still be quite complex. 
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One significant drawback of pseudotyping is the presence of viral RNA in the 
pseudoparticles. Even though pseudotypes have an inherent life span of one infection 
cycle, in the case of retroviral systems, there are still some safety concerns regarding 
human exposure since retroviral DNA is integrated in cellular DNA to complete it’s 
life cycle. A safer and simpler approach would involve the use of RNA free systems.  
In chapter 4, we describe a simple approach to making virus-like proteoliposomes 
(VLP) by using the cell blebbing technique to create liposomes from plasma 
membranes containing viral envelope proteins(46). VLPs are RNA free and we show 
that they are capable of undergoing membrane hemifusion and pore formation 
mediated by fully functional transmembrane HA proteins. Due to the flexibility of the 
system, VLPs could also have a significant impact on delivery techniques for proteins 
and therapeutic agents.  
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Reproduced with permission from ‘ Costello DA, Lee DW, Drewes J, Vasquez KA, 
Kisler K, Wiesner U, et al. Influenza virus-membrane fusion triggered by proton 
uncaging for single particle studies of fusion kinetics. Anal Chem. 2012;84(20):8480-
9. [2012] American Chemical Society. 
 
 
    CHAPTER 2 
INFLUENZA VIRUS-MEMBRANE FUSION TRIGGERED BY RAPID PROTON 
UNCAGING FOR SINGLE PARTICLE STUDIES OF FUSION KINETICS 
 
2.1.Introduction 
Fusion of cell membranes is a ubiquitous biological process involved in vesicle 
fusion to membrane synapses, fertilization between sperm and egg cells, the merging 
of intracellular lysosomes, and membrane-enveloped virus fusion to endosomes(47). 
The fusion step is critical to the delivery of material across membranes. For example, 
in virus infection, membrane-enveloped viruses, such as influenza, infect cells via the 
endocytotic pathway, which necessitates the merging of the viral membrane with the 
endosomal membrane to pass viral genetic material into the cytosol. For many 
enveloped viruses, a drop in endosomal pH triggers conformational changes in the 
viral coat proteins required to initiate fusion between the viral and endosomal 
membranes(48). Characterization of virus fusion kinetics is important for a number of 
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reasons beyond understanding fundamental fusion processes, such as classification of 
viral strain virulence and in the development of anti-fusogenic drugs(49). Yet, directly 
studying fusion in vivo is difficult because it occurs inside intracellular compartments 
that are cumbersome to control and assay. Therefore, much of what is known about 
virus fusion has been determined using bulk or ensemble in vitro fusion assays that 
report on the collective fusion behavior of many viruses to model membranes(5, 50-
58). 
In bulk fusion assays, virus fusion is typically reported by a collective change in 
intensity resulting from fluorescence dequenching upon fusion of an ensemble of 
fluorescently-labeled viruses to model membranes(5, 50, 52-59). Fusion is initiated by 
acidification of the bulk solution. From the resulting temporal change in the 
fluorescence signal, some information about the kinetics of virus fusion can be 
obtained.  Many studies of virus fusion to date have been conducted using this type of 
assay(5, 50, 52-59), but there are significant limitations with this approach. First, 
because individual events cannot be observed in this assay, viral binding and fusion 
cannot be distinguished from each other; this constraint impedes the separation of 
transport limitations from the fusion kinetics. Second, as the output signal is an 
aggregate of fluorescence changes resulting from many stochastic fusion events, only 
averaged information can be obtained from these assays; this drawback can obscure 
processes that occur at shorter timescales. Third, temporal limitations in uniformly 
acidifying the solution can spread initiation times of individual events, impacting 
signal response and its analysis. This limitation can reduce the temporal resolution of 
the measurements and obscure the sensitivity of initiating pH on kinetics(60).  
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Direct observation of individual virus fusion events circumvents many of the 
drawbacks of ensemble methods. Single particle virus fusion methods were first 
developed around the early 1990’s(61-63), and have improved significantly since then 
with modern electronics and optics capable of single molecule fluorescence detection, 
microfluidic approaches for fluid handling, and new strategies for creating robust 
membranes. More recent work has provided information on the kinetics of 
intermediate steps of the fusion mechanism by employing total internal reflection 
fluorescence microscopy (TIRF)(64) to detect individual virus fusion events to solid-
supported lipid bilayers (SLBs) adsorbed to the walls of microfluidic devices(20, 21). 
Although today’s single particle virus fusion studies are easier to implement and can 
provide more insight into virus fusion than previously possible, two significant 
limitations of this approach remain: the rate at which acidification can be achieved in 
the confined space of the microfluidic device via acidic buffer exchange and the 
subsequent shearing that is imposed in the channel due to the flow.  
Here we describe a method to achieve rapid acidification under quiescent 
conditions by integrating a photoisomerizable compound, o-nitrobenzaldehyde (o-
NBA) into our single particle fusion assay. o-NBA donates a proton to the surrounding 
solution when illuminated with a 355 nm long-wave ultraviolet laser(65) with release 
times on the order of microseconds(66). This acidification method will hereafter be 
referred to as “proton uncaging”. The photolysis of o-NBA to create a pH jump has 
been used in the investigation of the mechanisms of biological systems because it 
offers very high time resolution for kinetic measurements. In a review by McCray et 
al.(65), applications for uncaging are highlighted that include the study of active 
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transport of proteins in muscle fibers, mechanistic studies of ion channels, and time-
resolved responses of bacterial flagella motors to rapid changes in extracellular pH. 
Abbruzzetti et al.(35) used it to examine the dissociation kinetics of histidines in Gu 
HCl-unfolded Fe(III) cytochrome C to increase the temporal resolution of data 
acquisition and allow for investigation over a wider temperature range. Saxena et 
al.(37) studied the kinetics of proton transfer in green fluorescent protein (GFP) using 
o-NBA, as a model system for characterizing the correlation between dynamics and 
function of proteins in general. Each of these examples illustrates the advantages of 
using a rapid pH jump to study pH-dependent kinetic processes. To the best of our 
knowledge, however, uncaging has not yet been employed for the study of pH-
dependent fusion kinetics of enveloped viruses to host membranes. 
There are several advantages of an uncaging strategy that are particularly 
beneficial for kinetic studies of viral fusion. First, the rate of release of the effector 
molecule (a proton) is much faster than rapid exchange of solution. Second, the 
effector molecule can be released close to the target, i.e., the fusion protein.  
Increasing the certainty of when the acidification occurs and ensuring the coordinated 
initiation of fusion events improves the resolution of fusion kinetics. Uncaging times 
are much faster than the protein conformational change for influenza hemagglutinin 
(HA) X:31 at the optimum triggering pH of ~ 5.0(27).  A third advantage is that the 
environment in which the dynamics are studied is unperturbed by external forces 
resulting from hydrodynamic flow. The quiescent surroundings more closely mimic 
the endosomal environment and eliminate the possibility of hydrodynamic 
deformation of protein structures, which could (slightly) change the conformation of 
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the protein-receptor complex and impact fusion kinetics. Fourth, the absence of flow 
makes it possible to follow multiple processes (e.g., binding, hemifusion, pore 
formation) within an individual virion without it leaving the field of view.   
By adjusting the concentration of o-NBA, the triggering pH immediately 
following uncaging can be tuned to achieve pH values within the range of 
physiological fusion pH for influenza. The characterization of the pH change in 
nanoliter volumes is a challenge, however, as the UV irradiation triggering proton 
uncaging also typically bleaches pH sensing reporter dyes. In order to be able to 
quantify pH a more UV resistant sensor probe thus had to be developed. 
  In addition to presenting a new method of initiating viral fusion in a quiescent 
environment we also show the utility of using single particle fusion techniques to 
investigate the effect of laboratory adaptations of influenza on fusion kinetics. 
Laboratory adaptations are antigenic and morphological changes, which occur when 
influenza virus is passaged repeatedly in eggs to increase the viral yield. Virus is 
injected into the allantoic cavity of embryonated eggs, harvested, inactivated and 
purified. Some clinical human strains do not grow to a high titer in eggs and have to 
be passaged through eggs over and over until a high yield is achieved, resulting in 
egg-adapted viruses(67-69). Egg adapted viruses exhibit markedly different receptor 
specificities morphology from clinical isolates. Human strains that are forced to 
passage through eggs can change receptor specificity from human type linkages α,2-6 
sialic acid to avian α,2-3 linkages. It has also been shown clinical isolates of influenza 
virus typically contain a filamentous population, but after multiple passages in eggs 
virions become more pleiomorphic(70-72). We use the individual virion fusion assay 
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to compare the fusion kinetics of the lab adapted strain X:31 (A/H3N2/Aichi/1968) to 
another lab adapted strain , A/H3N2/Udorn/1972, and less adapted strain from recent 
clinical isolates, A/H3N2/Brisbane/2007.  
  
 
 
2.2. Materials and Methods 
The sources of all materials and detailed methods, image processing, and data 
analysis are described in the Appendix A. Described here are the major features of the 
assay and its execution. 
2.2.1. Supported Lipid Bilayers 
The following lipids were used in these experiments: 1, 2 dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine (POPC), 
cholesterol, and total ganglioside extract (bovine, brain). Lipid vesicles were prepared 
using a molar ratio of 4:4:2:0.5 of DOPC, POPC, cholesterol and total ganglioside 
extract. For acidic flow experiments, 0.01 mol% Oregon green DHPE lipid was added 
to the bilayer formulation to signal the pH drop. A detailed procedure for making 
liposomes used to form the supported bilayers and characterization can be found in the 
Appendix A. 
 
2.2.2. Virus Labeling 
Influenza X:31 (H3N2) with a hemagglutinin (HA) concentration of 2 mg/ml (as 
determined by Charles River Labs) was used in all experiments. Virus membranes 
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were labeled with lipophilic fluorophores, octadecylrhodamine B chloride (R18), a 
red-emitting fluorophore, or Rhodamine 110 octadecyl ester (R110C18), a green-
emitting fluorophore, at sufficient concentrations to (semi-) quench fluorescence, 
following slight modifications to standard procedures(50, 73) as described in the 
Appendix A. Virus internal contents were labeled with Sulforhodamine B (SRB), a 
red-emitting fluorophore, as described in the Appendix A. 
 
 
2.2.3. C dot pH Sensor Synthesis and Characterization 
 Fluorescent core-shell silica nanoparticles (Cornell or C dots) sensors were 
synthesized via a modified Stöber synthesis(74, 75). In contrast to earlier ratiometric 
two-color sensor particles(76, 77), here only single-color C dot sensors were required 
as pH sensing was performed in environments homogeneous on the length scale of the 
optical microscope resolution. To that end, first, Oregon green maleimide was 
conjugated with MPTMS at a molar ratio of 1:50 (dye: MPTMS) in dimethyl 
sulfoxide under nitrogen for 12 hours. The dye conjugate solution was then added to 
an ethanolic solution of 0.02 M ammonia and 4.275 M deionized water at a final 
concentration of 1.7 × 10-5 M dye conjugate. To this, a pure silica precursor, 
tetraethylorthosilicate, TEOS, was added at a concentration of 0.05 M. After reacting 
for 12 hours the cores were coated with a shell of additional TEOS (0.140 M) added in 
31 equal aliquots at 10 min intervals. The C dots were allowed to react for 12 hours 
after the shell addition, and were then dialyzed to deionized water. The particles in 
water were then densified by heating at 120 °C in a tightly sealed reaction vial for 48 
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hours. This post-synthesis densification step provided improved UV stability of the 
encapsulated dye (data not shown). The final size of the single-color C dots sensor was 
determined by dynamic light scattering using a Malvern Zetasizer Nano, indicating an 
average diameter of 28 nm. 
2.2.4. TIRF Microscope Configuration 
Fusion assays were carried out using total internal reflection fluorescence 
microscopy using an inverted Zeiss Axio Observer.Z1 with a α Plan-Apochromat 
100x oil objective with a numerical aperture (NA) of 1.46. Index-matching liquid 
(Carl Zeiss, Inc.) was used to couple the glass coverslip of the flow cell device to the 
objective. In this setup, two lasers can be used simultaneously to excite different color 
fluorophores; we used 561 nm and 488 nm excitation wavelengths from solid-state 
lasers. These were coupled into the optical pathway of the microscope using a Laser 
TIRF 3 slider (Carl Zeiss, Inc.), which controlled the angles of incidence.  Exceeding 
the critical angle (~ 62o) ensured total internal reflection of the lasers and created 
evanescent waves about 100 nm thick.  The evanescent waves excited fluorescently-
labeled virus bound to sialic acid groups of the ganglioside lipids comprising the lipid 
bilayers, which was positioned within several nanometers of the glass-water interface. 
The excitation laser light was band-pass filtered through a Semrock 74 HE GFP/mRFP 
filter cube, and then combined with a dichroic mirror before being focused on the 
outer edge of the back aperture of the objective. The fluorescence emission signal was 
filtered through a 525/31 and 616/57nm dual band-pass emission filter and then sent to 
an electron multiplying CCD camera (Hamamatsu ImageEM C9100-13, Bridgewater, 
NJ). For acid flow and dual labeling experiments, the emission was passed through a 
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splitter (Photometrics DV2) to divide and focus green and red channels onto separate 
regions of the EMCCD camera.  
 Supported lipid bilayers were formed in the flow cell via vesicle fusion(78-80) by 
drawing a 10% dilution of liposomes into each channel at a flow rate of 100 µl/min for 
one minute using a syringe pump (PHD 2000 Infuse/Withdraw, Harvard apparatus, 
Holliston, MA).  After one minute, the flow rate was reduced to 10 µl/min for 10 more 
minutes and then stopped to allow the channel to incubate for an additional 10 
minutes.  After this incubation, a fresh solution of liposomes was drawn into the 
channels and incubated for an additional five minutes to ensure a defect-free bilayer 
and complete coverage of the channel walls. The channels were then rinsed with 
buffer A (150 mM NaCl, 1.5 mM MES, 5 mM citric acid) for two minutes at 100 
µl/min to remove unfused liposomes. Labeled virus was then pumped into the 
channels at 30 µl/min and allowed to incubate for 20 minutes. After the first 
incubation, additional virus was pumped into the channels, incubated for 10 minutes, 
and repeated until the desired surface density was reached. After the final incubation, 
o-NBA solution (buffer B - see Appendix A for preparations) was drawn into the 
channels at 100 µl/min for three minutes. We note that no fusion was observed during 
the flow steps in any assay at any condition we used. The o-NBA solution was then 
incubated in the channel for 20 minutes to reduce any residual convection in the 
channel after pumping ceased.   
The pH drop was initiated by irradiating a 100 µm diameter section of the channel 
with a 4 mW UV laser for 200 ms. The beam diameter was measured to be 
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approximately 100 µm, thus when the beam was centered in the field of view of the 
microscope, it actually covered an area greater than the field of view. We ensured that 
the uncaging was uniform by mapping out the fusion events across the field of view in 
time, as shown in Figure A1 in Appendix A. The alignment of the laser is critical to 
ensuring that the uncaging is not biased; this can be achieved using a fluorescently-
labeled bilayer in an extra channel to map out the precise alignment prior to uncaging 
in virus-filled channels. Using this method, the time of the pH drop is known 
precisely, as the cleavage of protons from the o-NBA molecules occurs on the order of 
microseconds(66). The lag between the closing of the UV shutter and the opening of 
the camera shutter was 200 ms. The UV flash time was 200 ms. Because of the 
accurate time control of this technique, it removed the requirement for a pH sensitive 
fluorescent probe to be present in the lipid bilayers to mark when the change in pH 
occurred. These probes can potentially interfere with the fusion and increase 
background noise in the images. Hemifusion lag times are defined as the time elapsed 
between acidification of the field-of-view and fluorescence dequenching for individual 
virus particles. Pore formation lag times are defined as the time between the start of 
the hemifusion step and the start of the release of the internal viral fluorophore. 
The de-protonation of o-NBA resulted in a pH decrease from 7.0 to 5.4, 4.9, 4.6, 
depending on the amount of o-NBA added to the buffer (see Appendix A for exact 
formulations of the buffers). Fluorescence images of the viral fusion events were 
collected at 50 ms intervals for two minutes. In a few cases, images were taken for 
longer times to ensure all fusion events were captured within the typical two minute 
acquisition time.  
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2.2.6. Execution of the Acidic Buffer Flow Exchange Assay 
 In this experiment, the formation of bilayers, virus binding, and rinsing steps were 
conducted as described above.  Here, instead of initiating hemifusion using the proton 
uncaging method, hemifusion was initiated by flowing buffer A (150 mM NaCl, 1.5 
mM MES, 5 mM citric acid) pre-calibrated over a range of low pH values into the 
flow-cell at a flow rate of 100 µl/min for two minutes. The time at which acidification 
of the flow cell occurred was marked by a marked decrease in fluorescence of Oregon 
green DHPE present in the supported bilayer for this purpose. Images were collected 
at an interval of 100 ms for three or four minutes. 
 
 
2.3. Results and Discussion 
2.3.1 The Individual Virion Fusion Assay 
We monitored individual influenza X:31 (H3N2) virus fusion events occurring inside 
a microfluidic device that had its walls coated with supported lipid bilayers to mimic 
the endosomal membrane. Supported lipid bilayers have served as excellent cell 
membrane mimics in numerous applications since their introduction in the 1980s(78) 
because they are chemically tunable and preserve the two-dimensional fluidity of 
constituents. This fluidity is key, as influenza is capable of multivalent binding to 
sialic acid receptors present in the bilayer. In this application, we employed a bilayer 
containing a mix of sialic receptors for virus binding. Once the bilayer formed in the 
device, fluorescently-labeled virus was introduced into the channel and bound to the 
supported bilayer as described in Materials and Methods.  
 45 
The microfluidic device was coupled to a total internal reflection fluorescence 
microscope, as illustrated in Figure 1, A, and used to image the individual virus fusion 
events. After fusion initiation by acidification, fluorescence dequenching of a green 
fluorophore in the viral membrane signals the onset of the merging of the opposing 
leaflets of the virus and the supported bilayer, called “hemifusion.” The fluorescent 
“spike” and “cloud” features are easily monitored with TIRF(20, 21) because TIRF is 
a surface-specific technique that effectively eliminates any fluorescent signal from the 
bulk that might obscure single fusion events. Pore formation is marked by radial 
diffusion of a red fluorophore originating from inside the virus, co-localized with the 
green fluorophore. A sequence of images showing these features is given in Figure 2, 
A and is described in more detail in the Appendix A.. 
 
Figure 1.(A) An illustration of the microfluidic device coupled to a TIRF microscope for imaging individual 
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virion fusion events. The purple arrow entering the top of the device represents a UV laser that is aligned 
directly with the microscope objective beneath the device. Note that the dimensions of this drawing are not 
to scale. The actual channel is about 1 mm wide by 70 µm high and the diameter of the UV laser beam is 
about 100 µm. (B) An inset of the region within the field of view of the camera, drawn as the black rectangle 
in (A), prior to UV irradiation at a neutral pH. This illustration shows that the glass surface comprising the 
fourth wall of the microchannel is coated with a solid supported lipid bilayer (gray). Virus labeled with a 
quenching concentration of fluorophore is colored light green with a red interior. The dark pink boxes 
represent proton cages (o-NBA) that release protons when illuminated with 355 nm light. Note that this 
drawing is also not to scale; influenza virus is typically 100 nm in diameter and the bilayer is ~ 4 nm thick. 
(C) Immediately following UV irradiation the caged protons are released (denoted as free H+ in the 
diagram), acidifying the surrounding solution.  Fusing viruses are now colored bright green to denote the 
dequenching of green fluorophores and the escape of the internal red dye upon pore formation. (D) The 
photochemistry of uncaging: the conversion of o-nitrobenzaldehyde to o-nitrosobenzoic acid and a proton 
upon irradiation with UV light.  
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Figure 2. (A) Virus fusion initiated by acidic buffer flow exchange. Green and red fluorescence images of a 
single fusing virus, marked by the arrows. After acidification, the green channel shows the hemifusion of the 
membranes; the spike in fluorescence is observed in the plot to the right. The red channel shows the radial 
diffusion of the internal red fluorophore after pore formation.  The drop in red signal can be observed in the 
plot to the right; here it takes ~ 20 seconds between hemifusion and pore formation. (B) Virus fusion 
initiated by proton uncaging. Here it takes ~ 15 seconds between hemifusion and pore formation.  
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The fusion process is hypothesized to occur in several steps(54, 57, 58, 81, 82). 
First, the viral fusion protein, HA, undergoes a conformational change from a 
prefusion folded state to an extended state, exposing hydrophobic fusion peptides, 
which insert into the host membrane. This intermediate undergoes an additional 
conformational change, which brings the two distal leaflets of each membrane close to 
each other, causing them to merge. Merging of the outer leaflets results in the creation 
of a hemifusion stalk, aided by the concerted action of several HA trimer units. We 
will hereafter refer to this coordinated unit as a “fusogenic complex.” Eventually this 
structure transforms into a fusion pore through which the viral RNA escapes the 
endosome and enters the cytosol of the cell.  Each step and conformational 
intermediate has a characteristic lifetime; here, we focus on measuring the kinetic rate 
constant leading up to the hemifusion step and the lag time for pore formation 
following hemifusion. In this work, we compare the fusion of fluorescently-labeled 
influenza virus to solid-supported lipid bilayers inside microfluidic channels initiated 
by the traditional acidification method (acidic buffer exchange by flow) and the proton 
uncaging method (Figure 1). 
As both a validation of our assay setup and a control case, we initiated virus fusion by 
acidic buffer exchange, i.e., by flowing an acidic buffer through the microfluidic 
channel, not by uncaging.  Initially, virus was introduced into the microfluidic device 
at pH 7.0 and allowed to bind. Unbound virus was gently rinsed from the channel with 
buffer at pH 7.0. Subsequently, citric acid buffer at various pHs was sent through the 
channels at a rate of 100 µl/min. We chose this specific flow rate for several reasons.  
First, we wanted to match conditions as closely as possible with previously published 
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reports(21). Second, we selected this moderate flow rate as a compromise between fast 
flow (for rapid delivery of protons) and slow flow (to minimize shear rates). The rate 
of buffer exchange must be low enough to minimize tearing viruses off the receptors 
and/or stretching of the protein conformations, which could cause non-native fusion 
protein-proton interactions and impact kinetics. Balancing these constraints, the 100 
µl/min flow rate leads to acidification times for the field of view at 100x magnification 
of several seconds, as measured by the drop in fluorescence of a pH-sensitive 
fluorophore (Oregon green DHPE) doped into the supported bilayer. Images of the 
field of view were acquired just before and during acidification at 100 ms intervals. 
All fusion events within the field of view were recorded and cataloged by the time 
point at which the dequenching spike occurred immediately following acidification. A 
representative set of data for the frequency of events as a function of time after 
acidification using acid buffer exchange is shown in Figure 3, A (open black circles).  
These data were fit with a cumulative gamma distribution as described in the Appendix 
A.  Hemifusion kinetic parameters were determined from the best fits of the data for 
various initiating pHs, as shown in Figure 4 (black circles). The good agreement with 
previously reported values(21) using the same experimental conditions, validates our 
assay and provides a point of comparison for the uncaging acidification strategy 
examined later. 
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Figure 3. (A) Frequency of hemifusion events plotted as a function of time for initiation pH 4.5 obtained 
either by acidic buffer exchange (open black circles) or proton uncaging using 14 mM o-NBA (open green 
diamonds). The lines are the best fits to gamma function equation shown in the inset, and described in detail 
in the Appendix A. The rate of hemifusion, kH, was 0.20 ±  0.01 s-1 and 0.17 ±  0.01 s-1 for acidic buffer 
exchange and proton uncaging, respectively. N values for acid exchange and uncaging are 3.2 ±  0.1 s-1 and 
1.51 ±  0.05 s-1, respectively. B) Histograms of lag times between the onset of hemifusion and the onset of pore 
formation. (Top) acidic buffer exchange; (Bottom) proton uncaging. The rate of transition from hemifusion 
to pore formation (kH P) using the acid flow and uncaging methods was found to be 0.08 ± 0.02s-1 and 0.09 ± 
0.05s-1 respectively. N was less than 1 in both cases (0.7 ± 0.1 for acid flow and 0.5 ± 0.1 for uncaging), which 
agrees with previous findings that there is a single step transition between hemifusion and pore formation. 
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Figure 4. (A) Hemifusion rate constants, kH, and (B) N parameters for a range of fusion initiation pH values.  
 
 
The lag time between the hemifusion step and pore formation was also 
monitored. Previous work under similar experimental conditions has shown that pore 
formation lags hemifusion on the order of tens of seconds(21) and that this step is 
independent of pH(21, 58). A histogram for the pore formation lag time for one set of 
data taken at pH 4.5 is shown in Figure 4 B (top) and agrees with previous work. We 
note that in our case; however, a polymer cushion was not used to support the bilayer 
as employed in previous work(21).  Despite this, our results are quite similar 
indicating that the polymer cushion may not be necessary for this assay. Eliminating 
this cushion preparation step can reduce the assay preparation time greatly. 
To compare these results to the proton uncaging acidification strategy, it is 
imperative to know the pH following the uncaging event. But to our knowledge, there 
is no published characterization of the post-irradiated pH following uncaging, most 
likely because no reporter probe existed that could withstand the high energy 
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irradiation of UV without significant photobleaching. Therefore, we first report results 
obtained from a simple pH-sensing probe we developed to calibrate the pH in 
nanoliter volumes that can withstand the UV irradiation conditions in our experiment. 
pH-sensing single-color C dots are composed of Oregon green fluorophore 
encapsulated in a silica core and surrounded by a pure silica shell. As described in the 
Materials and Methods section these C dots sensors were densified in a post-synthesis 
heating step. Our rational for this dye-encapsulation approach was based on the fact 
that (i) silica is known to absorb (and therefore shield from) UV radiation, and (ii) the 
C dot architecture is known to improve photobleaching behavior of organic 
chromophores through its rigid silica matrix(83). Such particles may also find uses as 
pH sensors in small volumes in other microfluidic or in vivo applications (e.g., 
endosomal pH monitoring) or as novel UV sensors beyond the application presented 
in this work. 
2.3.3. Comparison of pH-Sensing Sensitivity Between Free Oregon Green and 
Silica-Encapsulated Oregon Green after UV irradiation 
Release of protons from o-NBA occurs within microseconds(66) when illuminated 
with 355 nm wavelength light. A pulsed diode pumped solid state laser by Teem 
Photonics (Model # SNV-04P-000, Lafayette, CO) was used to initiate proton 
uncaging in the microfluidic device. Uniformity of laser illumination was confirmed 
by mapping virus fusion event location in the field of view and noting that the events 
were random (Appendix A). The pH in the microfluidic channel after the 200 ms UV 
pulse was measured using the pH sensitive C dot sensors encapsulating Oregon green. 
We note here that free Oregon green (devoid of a silica shell) suffered significant 
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photobleaching from the UV pulse and thus could not be used as a pH sensor in this 
application. Other pH-sensitive fluorophores we tried also failed due to significant 
photobleaching. Figure 5A compares the level of photobleaching of free Oregon green 
and the silica-encapsulated Oregon green. This figure clearly shows that the silica 
capsule protects the Oregon green from photobleaching and that the level of 
photobleaching is not dependent on the pH of the solution.  
 
 
Figure 5.(A) Comparison of photobleaching between Oregon green C dots sensor and free Oregon green 
after exposure to UV light for 200 ms. Note that the error bars in the free OG case are within the data point. 
All values are normalized to the intensity value before the 200 ms UV bleach to obtain a fractional 
photostability at each pH. (B) Calibration curve for Oregon green C dot sensor fluorescence intensity at 
various pH values. All data were normalized to the pH 7.0 value so that intensities post UV irradiation could 
be compared directly. Note that these data were taken after irradiating the samples with UV light to account 
for photobleaching in the uncaging runs. (Inset) Structure of the Oregon green C dot.  
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2.3.4. Calibration of the Final pH after Irradiation of o-Nitrobenzaldehyde 
Buffer with UV Light Using C dots 
Solutions of single-color C-dot sensors were prepared in buffer C (1.25 mM MES, 
ranging from pH 3 to 7). These solutions were loaded into microfluidic channels and 
imaged under quiescent conditions. Each channel containing a different pH solution 
was exposed to a 200 ms UV pulse and images were acquired at an exposure time of 
100 ms for one minute. A calibration curve matching fluorescence intensity to pH 
(Figure 5, B) was generated by normalizing the post UV bleach intensity value of each 
solution to the post UV bleach intensity at pH 7 according to the following equation:  
background
pH
bleach
background
pHX
bleach
ncalibratio II
II
I
−
−
= 7 , where pHX is the pH of the calibration solution or the 
10, 12 , or 14 mM solution of o-NBA in buffer C. The pH post UV pulse was then 
determined by matching the normalized intensity for each o-NBA concentration to the 
corresponding pH on the calibration curve.  Note that this calibration curve matches 
well to the published Oregon green pH response curve(84) and indicates that as 
expected the presence of the silica shell does not impede the pH sensing ability of the 
Oregon green molecule.  
 
Table 1. Post-UV pH Calibration Table for Various Cage Solutions 
Concentration of o-NBA in buffer 10 mM 12 mM 14 mM 
Intensity value 0.83 ± 0.12 0.69 ± 0.06 0.63 ± 0.01 
pH from calibration curve 5.4 ± 0.5 4.9 ± 0.2 4.6 ± 0.1 
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It should be noted that the pH reported in Table 1 is the pH approximately 200-300 
ms after the UV pulse, as there is a lag time between the laser shutter closing and the 
detector turning on. This delay may contribute to the variation in the measurements, as 
it is possible that the exact pH in the irradiated zone just after the laser hits is slightly 
lower than what we report here due to the diffusion of any unbound protons along the 
length of the channel. Because the entire channel is not irradiated with the UV light, 
the pH in the irradiated zone will recover (see Appendix A for details on recovery 
characteristics in this device). Previous work has shown, however, that the steps 
following the initial conformational change of the protein induced by low pH do not 
require a low pH environment themselves(54, 58), therefore, recovery post fusion 
initiation should not impact the kinetics obtained. Our work corroborates this previous 
work, as will be discussed later. All experiments were conducted at ambient 
temperature (~ 23oC). 
2.3.5. Single Particle Fusion Assay Using Proton Uncaging to Initiate Virus 
Fusion 
In this set of experiments, acidification was achieved by proton uncaging. The 
chemical reaction upon UV excitation of o-NBA is shown in Figure 1,D: o-NBA 
undergoes an intramolecular proton transfer reaction and is converted to a nitronate 
ion and a proton. The nitronate ion is then converted to an o-nitrosobenzoic anion(33).  
In these experiments, virus was introduced into the microfluidic device at pH 7.0 and 
allowed to bind, as previously described. Buffer at pH 7.0 containing a pre-calibrated 
amount of o-NBA was used to rinse out the unbound virus. Next, a small region of the 
channel, pre-aligned with and encompassing the field of view of the microscope 
 56 
objective, was irradiated for 200 ms with 355 nm light from a solid state UV laser to 
“uncage” the proton of the o-NBA, as shown in Figure 1 A, B. Immediately preceding 
and following irradiation, images were recorded at 50 ms intervals. Fusion events 
were detected and cataloged using the same procedure described previously for the 
acidic buffer exchange. A typical set of images of virus fusion initiated by proton 
uncaging acidification is shown in Figure 2, B. Values for kH and N obtained from best 
fits of the data at various initiating pH’s for buffer exchange (flow) acidification and 
uncaging are reported in Figure 4. 
Comparing the results from the two experiments, there are important similarities 
and differences depending on the acidification method used (Figure 4). Interestingly, 
kH stays about the same, regardless of the acidification method; however, N is reduced.  
N is often interpreted to be the number of protein trimers that must act concertedly to 
initiate fusion(21, 85). Several previous studies report a value of around three for 
hemifusion to occur(12, 53, 81), although prior literature includes the possibility that it 
could be as low as one(13) or as high as six(14, 86).  
There are several possibilities that could impact fusion kinetics and explain the 
lowering of N in the uncaging experiment relative to the acidic buffer exchange 
method. These include: 1) changes in the virus fusion machinery caused by UV 
irradiation, 2) interactions of the o-NBA or the reaction product, o-NSA-, with the 
fusion protein, 3) a significant change (drop) in the overall number of particles fusing 
per experiment (extent of fusion) that affects kinetic analysis, and 4) changes in the 
delivery rate of protons to the fusion proteins (leading to better coordination of 
initiation of events, more certainty of when the pH dropped, and elimination of shear 
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effects). To identify the cause of the change, we ran a series of control experiments. A 
brief summary of the results are presented here only; the details and results of these 
control experiments are provided in the Appendix A.  
1) Impact of UV irradiation on kinetics. To ensure that UV irradiation itself does 
not trigger hemifusion or enhance fusion kinetics, a flow cell was prepared under the 
same experimental conditions as described previously for the proton uncaging 
experiment, except that it did not contain o-NBA. The flow cell was irradiated with 
the UV laser for 200 ms and then images were acquired at a rate of 200 ms post UV 
irradiation. No fusion events were detected. Following this data acquisition, fusion 
was induced by flowing acidic buffer at pH 5.1 into the channel. In this part of the 
experiment, hemifusion occurred as previously reported in the acidic buffer exchange 
experiments, indicating that prior exposure to long wave UV radiation did not affect 
the ability of the pre-bound viruses to fuse, in accordance with prior literature(87). kH 
obtained for these conditions was 0.07 ± 0.003 s-1 with N value of 2.2 ± 0.10. 
2) Impact of o-NBA or o-NSA- on fusion kinetics. To ensure that the presence of o-
NBA or o-NSA- did not alter the fusion kinetics, we conducted fusion experiments in 
exactly the same way as described previously for acidic flow experiments, except the 
virus was incubated with either o-NBA or o-NSA- (both at pH 7.0) for 30 minutes 
prior to acidic buffer flow exchange. Upon acidification by acidic buffer exchange, the 
kinetic parameters obtained were nearly the same as in the absence of these 
compounds. The respective values of kH and N obtained for each case were: 0.17 ± 
0.006 and 2.1 ± 0.07; and 0.21 ± 0.01 and 2.9 ± 0.14. Thus, we confirmed that the 
presence of o-NBA, or o-NSA- did not lead to significant changes in kinetic 
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parameters compared to the acidic flow case devoid of these compounds and that only 
during uncaging were differences in N observed.  
3) Assessment of changes in the extent of fusion. To ensure that there was no 
artifact in the kinetic analysis resulting from a reduction in extent of fusion by the 
proton uncaging method, we compared the extents of fusion between the acidic buffer 
exchange experiments and the uncaging method.  We found that the overall number of 
virions fusing in a given experiment at a given pH were similar (Table 2). This result 
shows that the uncaging process has enough power to initiate the fusion of any virus 
present in the UV beam during the short pulse duration. We corroborated this result by 
irradiating the same area with a second UV pulse and found that no more fusion was 
initiated within a given region. Even though the UV pulse is short-lived, we obtain the 
same extent of fusion and hemifusion rate constants with uncaging as we obtain with 
the buffer exchange method; only N differs. Previous studies of influenza X:31 fusion 
after neutralization immediately following acidification show that once the fusion 
protein is “activated,” the rest of the process does not necessarily require a low pH 
environment(54, 58). Therefore, the similarity of the fusion extents and hemifusion 
rate constants we obtain by these different acidification methods also corroborates 
these reports in the literature that the intermediate fusion steps are not strongly pH 
dependent.   
Table 2. Extent of Virus Fusion Obtained with Various Fusion Initiation Methods 
Fusion Initiation Method Extent of Fusion (%) 
14 mM o-NBA uncaging 27 ± 5 
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pH 4.5 acid flow exchange 17 ± 6 
pH 4.7 acid flow exchange 25 ±7 
 
4) Impact of the method and rate of proton delivery to the fusion proteins on 
kinetics. The final possibility that could explain the lower value of N is the immediate 
availability of protons to fusion proteins upon uncaging compared to the acidic flow 
experiments. As N is in the exponent of the gamma fitting equation, it will be quite 
sensitive to initiation time. In the case of uncaging, the acidification to the target pH is 
rapid: the drop is complete after the 200 ms UV pulse. In contrast, the time to drop the 
pH by the acidic buffer flow exchange is significantly longer (order of seconds) due to 
the no slip boundary condition at the bilayer surface. The impact of faster proton 
delivery on kinetics could be manifested in several ways. First, immediate availability 
of protons at the fusion protein ensures the coordination of initiation of fusion events 
at a specific pH value; second, faster acidification means better precision in knowing 
the time when acidification actually occurred (time = 0) for more certainty in 
determining lag times used in kinetic analysis.  
To speed up the delivery of protons by acidic buffer exchange to better coordinate 
events, we carried out experiments at higher flow rates (500 µl/min) to ascertain the 
difference in the data and fits, as shown in Figure 6. With faster flow rate, we do 
observe a shift in the data toward the uncaging trend and a decrease in N; however, the 
effect is small with only a 5-fold change in flow rate. We are precluded from 
increasing the flow rate much more in an attempt to match the uncaging value because 
the increased hydrodynamic shear on the bound virions starts to disrupt their 
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attachment to the bilayer and significant shear may also lead to changes in kinetics as 
the HA may stretch and alter the binding pocket for the proton.  
 
 
Figure 6. Fusion data at an initiation pH of 4.7. As the flow rate increases, the data trends shift closer to the 
uncaging data. 
 
2.3.6. Investigating the effect of influenza laboratory adaptations on fusion 
kinetics 
While the uncaging method of fusion initiation described above has many advantages, 
in order to complete a comprehensive comparison of X:31, Udorn and Brisbane, we 
chose to use the buffer exchange method in the following experiments so that we 
could probe the behavior of each strain below pH 4.5, which is unavailable in the 
current iteration of the uncaging method. The Udorn strain of influenza has a similar 
trend as a function of pH to X:31. Both strains exhibit a near linear increase in fusion 
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rate until plateauing at an optimal pH for fusion where the fusion rate reaches it’s 
maximum. However, the optimal pH for fusion is approximately 5.1, which is  0.4 pH 
units higher than the optimal pH for X:31fusion (figure 6). This indicates that after 
endosomal uptake, Udorn can fuse with the endosomal membrane and release its 
genome earlier in the pathway than X:31. Interestingly, the least lab adapted strain, 
Brisbane has a markedly different dependence on pH.  The rate of Brisbane 
hemifusion is almost an order of magnitude slower than X:31 and Udorn at the 
former’s optimal fusion pHs. At higher, more physiological pHs, hemifusion kinetics 
for Brisbane are almost independent of pH. There are several possibilities for these 
differences. The source of sialic acid in the supported lipid bilayers to which all 
viruses bound and fused is total ganglioside extract. The main component of total 
ganglioside extract is GM1, which contains α (2-3) sialic acid linkages. Brisbane is the 
most clinical strain and has been passaged through eggs far less than X:31 and Udorn. 
It is possible that the affinity of Brisbane for α(2-3) sialic acid is not as strong as 
Udorn or X:31 and this could slow the rate of hemifusion. Egg adaptation of influenza 
can also cause morphological changes. Dynamic light scattering was used to measure 
the average diameter of X:31, Udorn and Brisbane (see figure A3). Both X:31 and 
Udorn had monodisperse populations with an average hydrodynamic diameter of 
140nm and 155nm respectively. However, Brisbane was found to be more 
polydisperse, with two populations arising at 145nm and 760nm. The second larger 
population may be small filaments or viral aggregates. It is very difficult to distinguish 
the fusing spherical virions from aggregates or filaments due to quenching of the 
membrane dye. It is therefore possible that a second, slower population of fusing 
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viruses are captured in the cumulative distribution function for Brisbane hemifusion 
and this results in slower fusion kinetics.  
 
Figure 7. A) Hemifusion rate constant as a function of pH for X:31 (open black circles), A/Udorn/1972 (open 
red circles) and A/Brisbane/2007 (open red circles). Dashed lines are a guide to the eye and not linear fits to 
sections of the data . B) Number of HA trimers as a function of pH for X:31 (open black circles), 
A/Udorn/1972 (open red circles) and A/Brisbane/2007 (open red circles). C) Probability distribution of 
hemifusion decay of X:31 (grey bars), A/Udorn/1972 (red bars) and A/Brisbane/2007 (blue bars).  
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literature stating that the transition from hemifusion to pore formation is a one step 
process(21). We also found that the in all cases SRB was not released before R110C18 
dequenched eliminating the possibility of leaky pore formation.  
 
2.4 Conclusion   
The dynamics of the HA protein conformational changes measured by 
variations in intrinsic tryptophan fluorescence are known to be on the millisecond 
timescale near pH 5.0(27). While at the “optimal” pH (4.9), the protein conformational 
change is not thought to be the rate-limiting step in the fusion process; at “suboptimal” 
pHs (5.1 and above), a slower transition to the fusogenic conformational form of HA 
could explain slower fusion kinetics(27). To eliminate proton transport effects on the 
measurement of the fusion kinetic parameters at “suboptimal” fusion pHs greater than 
5.0, we used a proton uncaging strategy. The immediate availability of protons not 
only reduces or eliminates proton transport limitations, but also synchronizes 
individual initiation times, increasing the resolution of the measurements obtained 
from analysis of the hemifusion data. Our data are consistent with the prevailing 
mechanism for influenza fusion mediated by HA, and the main finding here is that the 
number of trimers required for fusion is closer to two rather than three. 
The commercially available o-NBA compound employed in this work is limited 
by its solubility in aqueous solutions to yielding a maximum change in pH from 7.0 to 
~ 4.5, thus we did not examine fusion below pH 4.5. We note that under physiological 
conditions, influenza fusion occurs within this pH range in the endosome.  However, 
other more soluble proton caged- compounds can be synthesized(88, 89) and used to 
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study fusion at lower pH values using the uncaging method, which may be 
advantageous for studying other virus strains. Additionally, this approach is adaptable 
to studies of other membrane fusion processes (e.g., SNARE-mediated fusion) by 
changing the effector molecule to calcium(90, 91), for example. 
The impact of this work from a practical standpoint is that obtaining higher 
temporal resolution measurements of kinetic parameters between different virus 
strains aids in characterizing mutations that lead to enhanced fusion and viral 
infection. Furthermore, the fusion step, and in particular the HA protein, has become a 
target for anti-viral drug development. Anti-fusogenic drugs, such as tert-butyl 
hydroquinone have been shown to strongly interact with the HA binding pocket to 
stabilize the neutral pH structure, which then presumably inhibits the conformational 
changes required for membrane fusion(49); and more recently, antibodies have been 
developed that target the stem region of the HA and are expected to disrupt fusion 
activity(92, 93).  With the method described here, the inhibition of viral fusion using 
these compounds could be tested directly and at a level of detail not available to date. 
This information will further refine anti-viral drug design and characterization 
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CHAPTER 3 
 
SINGLE PARTICLE ASSAY OF CORONAVIRUS MEMBRANE FUSION WITH 
PROTEINACEOUS RECEPTOR-EMBEDDED SUPPORTED BILAYERS 
 
3.1. Introduction 
 
Coronaviruses are membrane-enveloped viruses that show a high degree of 
adaptability for infecting a wide range of host cells and different species. It is not well-
understood how these viruses adapt to new hosts, yet they are an increasing concern as 
a source of emerging viruses for the human population, including SARS-CoV and the 
newly emerging MERS-CoV(39, 94, 95). Both SARS-CoV and MERS-CoV produce 
fatal disease in the majority of people who contract the infection. Quantitative studies 
of the entry process of the virus are therefore necessary for understanding the cues that 
mitigate host adaptation and for developing strategies to prevent infection. But 
accurately establishing the impact of various triggers on membrane fusion requires 
experimental techniques capable of quantifying fusion kinetics to characterize the 
fusion intermediates, the kinetic rate constants for transitional steps, and the fusion 
pathway.  
A relatively new approach for quantitatively studying viral entry kinetics is single 
particle imaging using total internal reflection fluorescence microscopy (TIRFM)(64). 
TIRFM requires that a supported lipid bilayer (SLB) containing viral receptors is 
located within 100 nm of an evanescent wave produced by total internal reflection at 
the interface between two dissimilar materials. This requirement is easily achieved by 
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coating the walls of a glass microfluidic channel with an SLB. SLBs preserve many 
properties of the cell membrane, like chemical tunability, lipid diversity, and mobility 
of its constituents in a planar geometry, but without the experimental complications 
imposed by live cells. However, a significant limitation of this platform has been 
capturing the complexity of cell membranes, especially the incorporation of membrane 
proteins. This limitation has precluded studies of viruses that use proteinaceous 
receptors (like coronaviruses) to date. As such, these platforms have been limited to 
the study of a few viruses, such as influenza virus(21, 22, 96), Sindbis virus(20), and 
vesicular stomatitis virus (VSV)(97), because these viruses have either known 
glycolipid receptors or are known to interact with specific lipids that are easily 
incorporated into SLBs. Herein we describe a method to integrate the proteinaceous 
receptor for feline alphacoronavirus WSU 79-1683 (referred to here as FCoV) into a 
supported bilayer and measure membrane fusion kinetics using single particle 
tracking. Importantly, this new method of forming proteinaceous supported bilayers 
for virus fusion studies opens single particle fusion assays to any enveloped virus that 
binds to proteinaceous receptors. 
To initiate infection, coronaviruses typically engage specific proteinaceous 
receptors on the surface of host cells. The specificity of receptor binding is believed to 
be one of the key factors in the host range of a given coronavirus(95). One of the best-
characterized receptors is aminopeptidase N (APN), which is utilized by the majority 
of coronaviruses in the alphacoronavirus genus(98-100). Baby hamster kidney (BHK) 
cells are transfected with the feline aminopeptidase N (fAPN) and encapsulated into 
vesicles using a cell blebbing technique(43-46, 101). These vesicles are then used to 
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form proteinaceous supported bilayers to which coronavirus can fuse and be observed 
at the single particle level using TIRF microscopy. This method for creating 
proteoliposomes is in contrast to the usual approach to incorporate membrane proteins 
into vesicles, where proteins are reconstituted into proteoliposomes using detergent. 
Detergents solubilize the proteins out of the cell membrane and can result in loss of 
native conformation of the proteins. For pathogenesis, the conformation of proteins in 
the membrane and its glycosylation are critical to controlling the host-pathogen 
interaction. We show here that fAPN in the supported bilayer made from blebs is 
enzymatically active, oriented properly, and competent to bind FCoV prior to 
membrane fusion.  
Feline coronavirus was chosen for this work because it has a well-characterized 
receptor (APN), grows readily in cell culture, and is not infectious in humans. FCoV, 
therefore, serves as a safe and effective model virus to demonstrate the use of the 
single particle approach to characterize membrane fusion of a virus requiring a 
proteinaceous receptor.  
 
3.1.1. Membrane-enveloped virus entry via class I fusion proteins 
Like influenza virus, many coronaviruses can use the endocytic pathway to enter 
cells(102). Once inside the endosome, the challenge for viruses is delivering their 
genetic material across the membrane and into the cytosol for viral replication. All 
enveloped viruses have membrane proteins that facilitate the fusion of their lipid 
envelope with the host cell membrane(103). Coronavirus particles possess at their 
surface the spike (S) envelope glycoprotein, which is a class I fusion protein(16). 
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Whereas the structure and function of the prototypical class I fusion protein, influenza 
virus hemagglutinin (HA), is well understood, structure-function relationships for 
coronavirus S proteins are not well characterized. For coronaviruses, the S protein 
mediates virus entry and determines cell tropism and pathogenesis(15). Like influenza 
virus HA, the coronavirus S protein has two primary functions: 1) it controls the 
binding of the virus to a cell membrane receptor, and 2) it mediates membrane fusion 
between the viral and host membranes(103). In general, receptor binding is controlled 
by the S1 domain of the protein, while membrane fusion is mediated by the S2 
domain. A conformational change in the S2 domain is believed to drive the viral 
membrane to fuse with the host membrane. For most coronaviruses, this 
conformational change is triggered by the acidification of the endosome, although pH-
independent fusion can also be observed.  
It is generally believed that all class I fusion proteins follow a common fusion 
pathway that has been well-established in the prototypical class I influenza virus. 
Class I fusion proteins go through a multi-step process to achieve a fusion pore that 
begins with a fusion protein conformational change triggered by low pH. During the 
conformational change the fusion protein unfolds and thrusts the fusion peptide into 
the hydrophobic region of the host membrane. Next, the protein folds back, bringing 
the anchored membrane in close contact with the viral membrane until a stalk-like 
structure is formed. The stalk structure results from the mixing of the outer leaflet of 
the host membrane with the viral membrane, referred to as hemifusion. After a short 
lag time, the stalk is converted into a fusion pore through which the viral contents can 
exit. It may be necessary for multiple fusion proteins to work in concert to bend the 
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membrane to induce fusion.  
Analogous to influenza HA, it is believed that the coronavirus S protein, 
undergoes proteolytic cleavage prior to fusion activation(15). Proteolytic cleavage is 
believed to expose specific regions of the S protein, including the fusion peptide(104). 
Because proteolytic cleavage dictates fusion competency, the availability of proteases 
in the extracellular milieu is another key factor in tropism of coronavirus. A dramatic 
example of this is human SARS-CoV. The bound virus is able to fuse at the cell 
surface in absence of acidic pH, when exposed to exogenous proteases(105). This 
route of entry may even be 2 to 3 orders of magnitude more efficient that the 
endosomal pathway(105). In this case, proteolytic cleavage changed the fusion 
pathway. By combining single particle fusion with proteinaceous supported bilayers 
and microfluidics, the sequence of triggers can be controlled and the associated fusion 
pathway and kinetics quantitatively measured. 
 
3.2. Materials and Methods 
3.2.1. Cells, plasmids, and viruses 
Baby hamster kidney-21 (BHK-21) cells, obtained from the American Type Culture 
Collection (ATCC, Manassas, VA), were grown and maintained in Dulbecco’s 
modified Eagle medium (DMEM, CellGro) supplemented with 10% fetal bovine 
serum (Gibco), 100 U/ml penicillin and 10 µg/ml streptomycin (CellGro), 1% HEPES 
buffer (CellGro) in a 37°C, 5% CO2 incubator. The pcDNA-fAPN and pCI-neo-hAPN 
plasmids were used for transfections of BHK-21 cells. They encode the feline 
aminopeptidase N (fAPN) and human aminopeptidase N (hAPN), respectively, and 
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are generous donations from Kathryn Holmes of the University of Colorado. 
pCAGGS-FCoV-1683S plasmid encodes the S protein of FCoV-1683(106). The 
pCAGGS vector was used as an empty vector control. 
Feline Coronavirus (FCoV) strain WSU 79-1683, also referred to FCoV-1683, was 
obtained from the Cornell Animal Health Diagnostic Center (Cornell University, 
Ithaca, NY). The virus was grown in canine A-72 cells provided by Dr. Colin Parish 
(Baker Institute of Animal Health, Cornell University, Ithaca, NY). 
 
3.2.2. Preparation of cell blebs 
The formation of cell blebs was established in the mid-1970’s(101). An excellent 
review of cell blebbing protocols is available by Sezgin et al (43). Here, we use a 
blebbing procedure published previously by our group (46). For transfections, 1.5 × 
106 cells were seeded in 10 cm culture dishes, and incubated for 24 hours. 
Transfections were performed using TurboFect transfection reagent 
(ThermoScientific) according to manufacturer’s instructions and using 6 µg of plasmid 
DNA for each plate. Twenty-four hours after transfection, cells were washed twice 
with buffer A (2 mM CaCl2, 10 mM HEPES, 150 mM NaCl at pH 7.4). 3 ml of buffer 
B (2 mM CaCl2, 10 mM HEPES, 25 mM formaldehyde, 2 mM dithiotreitol (DTT) and 
150 mM NaCl at pH 7.4) was added to each dish to induce cell blebbing. The dishes 
were then incubated for 1 hr at 37oC with gentle rocking. After incubation, the cell 
supernatant, containing detached cell blebs, was decanted into a 15 ml falcon tube and 
placed on ice for 20 minutes to allow any detached cells to settle out. The supernatant 
was transferred to new test tube. Blebs were then dialyzed using cellulose dialysis 
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tubing (Fischer Scientific), in two 100 ml volumes of buffer A for 24 hours. The size 
of cell blebs was determined by dynamic light scattering using a Malvern Zetasizer 
Nano (Worcestershire, UK). The sample registered 3 peaks at approximately 38 nm, 
106 nm, and 530 nm.   
 
3.2.3. Preparation of liposomes 
The following lipids/materials were used in the experiments: 1-oleoyl-2-palmitoyl-sn-
glycero-3-phosphocholine (POPC), 1-oleoyl-2-palmitoyl-sn-glycero-3-
phosphoethanolamine (POPE), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
cholesterol, and sphingomyelin. These materials were all purchased from Avanti Polar 
Lipids (Alabaster, AL). Oregon green DHPE purchased from Molecular Probes 
(Eugene, OR) was used to label supported bilayers and as a pH sensor to mark 
acidification of the bilayer during membrane fusion experiments. Octadecyl 
Rhodamine (R18), a red-emitting, lipophilic fluorophore, was used to label cell bleb 
membranes and was purchased from Molecular Probes. We also synthesized in house 
a green-emitting, lipophilic fluorophore, Rhodamine 110 Octadecyl ester (R110C18), 
from Rhodamine 110 Chloride and 1-octadecanol purchased from Sigma Aldrich. The 
synthesis procedure has been published previously(22). R110C18 was used to label 
viral membranes during dual-labeling virus fusion experiments. Sulforhodamine B 
(SRB), a red-emitting, water-soluble fluorophore purchased from Molecular Probes 
was used to label virus interiors. 
The liposome formulation used in these studies (BHK-liposome) contained POPC, 
POPE, sphingomyelin and cholesterol in the ratio 37.3:34.2:5.7:22.8. This 
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composition was formulated to match the native lipid content of BHK cells as closely 
as possible(107) and primarily used in the formation of bleb-derived supported 
bilayers.  
To form liposomes, appropriate amounts of each component were mixed in 
biotechnology grade chloroform in a scintillation vial. For formulations containing 
sphingomyelin, this component was first dissolved in a 4:1 mixture of chloroform: 
methanol then added to the mixture. The bulk solvent was removed from the vial 
under a stream of high purity nitrogen gas and then placed in a desiccator under 
vacuum overnight to ensure complete evaporation of all solvent. Phosphate-buffered 
saline at pH 7.4 was added to the dried lipid film and gently re-suspended in a 
sonication bath (Model # BD2500A-DTH; VWR) for twenty minutes on the lowest 
setting. The final lipid concentration was approximately 2 mg/ml. Liposomes were 
then extruded twice through a polycarbonate filter (Whatman Nucleopore) with pore 
size 100 nm, and five times through a filter with a pore size of 50 nm. The average 
liposome diameter for all formulations ranged between 90 and 100 nm as determined 
by dynamic light scattering. 
 
3.2.4. Fluorescent labeling of cell blebs or viruses 
To visualize both the formation of the fAPN-bleb supported bilayer formation and 
viral membrane fusion, blebs and viruses were fluorescently labeled. To visualize 
fusion using a fluorescence dequenching technique, viral membranes must be labeled 
with a semi-quenched amount of fluorophores following standard procedures(50, 73). 
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In these experiments, FCoV was labeled with R110C18 according to the following 
general procedure.  
3.2.4.1. General membrane labeling procedure (single color) 
To fluorescently label the bleb membranes for the visualization of bilayer formation 
and photobleaching experiments (FRAP), blebs were incubated with 1µl 0.18 mM 
R18, dissolved in ethanol, for 15 minutes in a sonicating bath (VWR) on the lowest 
setting.  
To fluorescently label FCoV membranes for fusion experiments, R110C18, 
dissolved in ethanol, was used. 5 µl of virus solution was diluted with 250 µl of buffer 
A and mixed with 3 µl of 2 mM R110C18 for 1 hour in a sonicating bath. In this case, 
it is desired to label membranes with a quenched amount of R110C18 to trigger 
dequenching during membrane fusion. Free R110C18, which did not insert into the 
membranes, was removed from the solution by centrifuging (Eppendorf, Centrifuge 
5451C, Hauppauge, NY) through a G-25 spin column for two minutes at rate of 
3x1000 min-1. The supernatant containing the purified virus was diluted with 0.8 ml of 
buffer A and gently vortexed to mix. 
3.2.4.2. General virus interior labeling procedure 
For pore formation experiments, 5 µl of virus solution was mixed with 10 µl of 20 mM 
Sulforhodamine B (SRB) solution and incubated overnight. Excess SRB, which did 
not partition into the virus interior, was removed from the solution by centrifuging 
through a using a G-25 spin column for two minutes at rate of 3x1000 min-1. The 
supernatant was diluted in 0.8 ml of buffer A prior to use. 
3.2.4.3. Feline coronavirus dual-color labeling 
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For FCoV hemifusion experiments, it was necessary to label the membrane with a 
green fluorophore to distinguish it from the red internal fluorophore label. For these 
experiments, virus that had been labeled with SRB as described in the previous 
section, was labeled with 3µl of R110C18 (2 mM).  The mixture was sonicated gently 
for 1 hour and excess dye was removed as previously described using at G-25 spin 
column.  
3.2.5. Preparation of microfluidic devices and PDMS wells 
3.2.5.1. Preparation of glass surfaces for supported bilayers 
Glass microscope coverslips (25 mm x 25 mm; No. 1.5) from VWR were cleaned in 
piranha solution consisting of 70% sulfuric acid and 30% hydrogen peroxide. Slides 
were immersed in 150 ml of piranha solution for 10 minutes then rinsed for 30 
minutes with copious amounts of deionized water with a minimum resistance of 18.2 
MΩ⋅cm obtained from a Siemens Purelab Ultra water purification system. Clean slides 
were stored under deionized water and dried with a stream of ultra-pure nitrogen gas 
prior to use. For bilayer formation, glass surfaces were used either with PDMS wells 
or microfluidic devices.  
3.2.5.2. Fabrication of Polydimethylsiloxane (PDMS) wells 
To form the PDMS wells, a thin sheet of PDMS was made in a Petri dish using 10:1 
elastomer/crosslinker mixture of Sylgard 184 (Robert McKeown Company; 
Branchburg, NJ). The PDMS was baked for 3 hours at 80oC, cut into small squares 
approximately the same size as a coverslip, and a hole punched through each square to 
form the wells. PDMS squares were then attached to a clean glass coverslips, which 
formed the bottom of the wells. The approximate volume of a well was 100 µl. 
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3.2.5.3. Fabrication of microfluidic devices 
Microfluidic devices for the fusion experiments were fabricated using soft lithography. 
The microchannel pattern was designed using the CAD software program L-Edit 
(Tanner EDA) and a master of the flow pattern was made on a silicon wafer at Cornell 
Nanoscale Science and Technology Facility (CNF). Each microfluidic device 
contained six channels. The dimensions of each channel are 1 mm wide by 70 µm 
deep with a total length of the channel of 1.5 cm.  The spacing between the centers of 
each channel is 1 mm. The silicon wafer was coated with P-20 primer in a spin coater, 
followed by SPR220 (Megaposit) photo-resist. The wafer was baked for 90 seconds at 
115oC and then exposed to UV light for 7.5 seconds in an ABM contact aligner to 
pattern the wafer with the flow cell design. Following this step, the wafer was baked 
again for 90 seconds at 115oC and then developed for 60 seconds in a Hamatech-Steag 
Wafer Processor. The pattern was then etched into the wafer using a Unaxis 770 Deep 
Si Etcher. The depth of the channel was determined using a Tencor P10 Profilometer.  
Microfluidic devices were formed using PDMS in a molding process. To facilitate 
the release of the cured PDMS after molding on the etched silicon master, the master 
slide was first coated with Sigmacote (Sigma). A 10:1 (elastomer/crosslinker) mixture 
of Sylgard 184 was mixed and then degassed before pouring on the silicon master 
slide etched with the flow cell pattern. The PDMS was then baked for 3 hours at 80oC. 
After baking, PDMS microfluidic devices were peeled off of the wafer, and inlet and 
exit ports were punched in each channel of the device.  Both the clean glass coverslip 
and PDMS mold were treated with oxygen plasma using a Harrick Plasma Cleaner 
(Model # PDC-32G; Ithaca, NY) at a pressure of 750 µm on the high setting for 25 
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seconds.  Gently pressing the surfaces together resulted in a tight bond between the 
glass and PDMS and formed the four walls of the microfluidic channel. 
 
3.2.6. Creating supported bilayers in microfluidic channel 
A solution containing a 1:4 dilution fAPN-blebs in buffer A was drawn into the 
microchannel at a flow rate of 30 µl/min for 1 minute and incubated on the glass 
surface for 20 minutes. The microchannel was then rinsed with buffer A at 100 µl/min 
for 2 minutes. A solution of BHK-liposomes (0.5 mg/ml) was drawn into the 
microchannel at 100 µl/min for 1 minute and incubated for 10 minutes.  To heal any 
defects in the membrane, more vesicle solution was drawn into the microchannel at 10 
µl/min for 5 minutes. Finally, the microchannel was rinsed with buffer A at 100 µl/min 
for 2 minutes to remove any excess liposomes. 
 
3.2.7. Diffusion measurements in supported bilayers 
Integrity of bilayers and diffusion of the lipids within it was examined by fluorescence 
recovery after photobleaching (FRAP). Bilayers were formed following the above 
procedures inside PDMS wells. R18 was used to label the bilayer and carry out the 
photobleaching experiments. Once formed, bilayers were gently scratched with a 
dissection tool to remove a thin section to aid in focusing on the plane of the bilayer 
on the microscope. Following this step, the bilayer was rinsed again for one minute 
with buffer A to wash out any lipids removed by scratching. A 20 µm diameter spot in 
the supported lipid bilayer was bleached with a 4.7 mW 488 nm krypton/argon laser 
for 200 ms. The recovery of the intensity of the photobleached spot was recorded for 
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15 minutes at regular intervals. The fluorescence intensity of the bleached spot was 
determined after background subtraction and normalization for each image. The 
recovery data was fit using a Bessel function following the method of 
Soumpasis(108). The diffusion coefficient is then calculated using the following 
equation: 
€ 
D = w
2
4t1/ 2
, where w is the full width at half-maximum of the Gaussian 
profile of the focused beam.  
 For protein mobility, single particle tracking at 100x magnification was 
conducted.  Fluorescently labeled fAPN-specific antibodies (see next section for 
antibody and labeling details) were bound to fAPN in the bilayer and monitored for at 
least 40 minutes to determine if any proteins diffused during that time. Figure S3 
summarizes the protein mobility results. 
 
3.2.8. Antibody binding to confirm presence and orientation of APN in the 
supported bilayer 
To confirm that fAPN proteins were incorporated into the supported bilayer and the 
active, extracellular end was oriented facing the bulk solution (i.e., not inverted 
towards the glass support), the bilayer was incubated with an fAPN-specific antibody, 
RG4(109) (generously donated by Tsutomu Hohdatsu), which recognizes an epitope 
(residues 251-582)(99) located in the C-terminal ectodomain (extracellular-facing 
domain) of the protein. The bilayer was incubated with 1 µg/ml of a primary antibody 
anti-fAPN mouse monoclonal antibody (RG4) for 20 minutes. The unbound primary 
antibody was rinsed and 1 µg/ml of Alexa Fluor 488 conjugated-goat anti-mouse IgG 
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secondary antibody was added and incubated for 20 minutes. Excess secondary 
antibody was rinsed and the sample was imaged on an inverted fluorescence 
microscope with appropriate filter set, described below.  
 
3.2.9. Functionality of APN in cell blebs and supported bilayers (APN enzyme 
activity assay) 
Many cells and species express aminopeptidase N. APN is a membrane-bound enzyme 
that cleaves the N-terminal amino acids from bioactive proteins, leading to their 
inactivation or degradation(110). This function is believed to be integral to several 
biological processes including antigen processing and presentation, cell adhesion, 
tumor cell metastasis, neurotransmitter degradation. APN also serves as a well-
characterized receptor for certain coronaviruses(111), including FCoV-1683(99) used 
in these experiments.  
To ensure the APN proteins maintain their native enzymatic functionality in the 
supported bilayers, we performed an enzymatic activity assay. In this assay, the 
substrate for APN is non-fluorescent until the enzyme cleaves it. Therefore, 
functionality of APN in blebs or supported bilayers can be verified by detecting 
fluorescence after introducing the substrate into a cuvette of bleb solution or into a 
microfluidic device containing supported bilayers. For these experiments, human APN 
(hAPN), instead of feline APN, was expressed in BHK cells and tested for activity. 
This change was necessary because there is no activity assay specific for the feline 
APN. The control cases are the empty vector blebs or empty vector-SB.  
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3.2.9.1. Blebs in Solution 
Blebs containing human APN (hAPN) were formed as previously described for fAPN-
blebs.  The activity of hAPN and empty vector cell blebs in solution was tested using 
bulk fluorescence measurements in fluorimeter (Photon Technologies International 
Inc) at an excitation/emission of 380/460nm. The substrate for hAPN, H-Ala-AMC, 
was purchased from Bachem. A 50:50 mixture of blebs and H-Ala-AMC substrate at 
270 µM in a 50 mM Tris buffer at pH 7.4 were mixed in a quartz cuvette and intensity 
of the mixture was monitored for 30 minutes.  
3.2.9.2. Supported lipid bilayer 
Bleb-derived supported bilayers containing hAPN were formed in microfluidic 
channels as previously described for fAPN-SBs.  The substrate, at concentration of 
270 µM in 50 mM Tris buffer at pH 7.4, was drawn into the channel at a flow rate of 
100 µl/min for 2 minutes. The fluorescence intensity of the channel was observed at 
10x magnification at an excitation/emission of 380/455nm.  A control channel 
containing an empty vector bleb-derived supported bilayer devoid of exogenous APN 
proteins was subjected to the same conditions as described above.   
Figure S5 summarizes the enzyme activity assay results. In Fig. S5a, blebs with 
and without hAPN were loaded into cuvettes and the fluorescence monitored 
temporally using a fluorimeter after the substrate was added. The empty vector blebs 
show no appreciable fluorescence, while the hAPN blebs continue to increase in signal 
as increasing amount of substrate is cleaved during the course of the experiment. In 
Fig. S5b, supported bilayers with and without hAPN are loaded into a microfluidic 
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channels with substrate. The microfluidic device is monitored at specific time points 
and the two channels are compared in the inset.  In the control case, no fluorescence is 
detected above the background, but the hAPN-SB shows significant intensity after 
several hours.  
 
3.2.10. Cleavage of FCoV spike protein by trypsin protease (Western blot) 
In order for class I fusion proteins to become fusion-competent, they must first be 
activated by proteolytic cleavage, a modification performed by cellular proteases. 
There are numerous enzymes capable of proteolytically cleaving the coronavirus spike 
protein. These proteases can be found in either the intra- or extra- cellular 
environment. For example, cathepsin proteases found in the endosomal compartment 
are naturally used to breakdown proteins taken up into the lysosome(112). Once a 
virus gets endocytosed, cathepsins can also cleave the coronavirus spike protein(102, 
106, 113, 114)Trypsin is a common extracellular protease found in the digestive tract 
of many vertebrates(115) to break down proteins during digestion(115). We show here 
that trypsin is also capable of cleaving the spike protein of coronaviruses. 
Cleavage likely occurs at two distinct sites for coronavirus S: at the junction of the 
S1/S2 domains, as well as within the S2 domain (S2’)(18). Proteolytic cleavage is 
believed to expose specific regions of the S protein, including the fusion peptide(104). 
For some coronaviruses, cleavage at S1/S2 is necessary to allow subsequent cleavage 
at S2’, and allow the S2 domain to respond a low pH trigger that initiates the 
conformational change required for fusion(18). In other coronaviruses, in particular 
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alphacoronaviruses, like FCoV-1683, the S1/S2 site does not need to be cleaved. In 
these cases, activation is likely mediated solely through the S2’ cleavage site. 
We used trypsin as a means to activate FCoV-1683 S. To confirm that trypsin can 
proteolytically cleave FCoV-1683 S in an appropriate manner, FCoV-1683 viral 
suspensions were ultracentrifuged at 42,000 rpm in a TLA 55 rotor using a Optima 
Max-E ultracentrifuge (Beckman Coulter) for 2 hours at 4°C. The viral pellets were 
resuspended in 50 µL of PBS (non treated sample), or PBS containing 3 µg/mL of L -
1-Tosylamide-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin 
(ThermoScientific) (trypsin treatment), or MES buffer pH 5.0 supplemented with 2.5 
mM EDTA and 2 mM DTT and containing 0.5 µM Cathepsin B (Calbiochem). The 
samples were incubated at 37°C for one hour, except the cathepsin-treated sample 
which was incubated for 15 min at 37°C. All samples were then subjected to treatment 
with the deglycosylating enzyme PNGase F (New England Biolabs), using 2500 units 
and supplied buffer at 37°C for 16 hours. This was done to avoid having differentially 
glycosylated species of S protein. LDS loading buffer (Invitrogen) with DTT (50 mM 
final) was added to samples, and were subjected to 5 min 95°C incubation for 
denaturation. The samples were then analyzed by Western blot using FCoV-S-specific 
mouse mAb 22G6.4, provided by Dr. Ed Dubovi (Animal Health Diagnostic Center, 
New York State College of Veterinary Medicine, Cornell University) followed by 
incubation with HRP-conjugated goat anti-mouse IgG (AbCam).  
As shown in Fig. S6, cathepsin B and trypsin treatment yield major cleavage 
products at approximately 100 kDa, while in the non-treated sample, the majority of S 
protein migrated as a single band around 200 kDa, indicating little cleavage event 
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occurred without protease treatment. These results show that trypsin cleaves FCoV 
1683 S in a similar way as does cathepsin B, and are consistent with published results 
for this virus cleaved with cathepsin B(106).  
 
3.2.11. TIRF microscope configuration 
Membrane fusion assays were conducted with total internal reflection fluorescence 
(TIRF) microscopy using an inverted Zeiss Axio Observer.Z1 with a α Plan-
Apochromat 100x oil objective with a numerical aperture (NA) of 1.46. Index-
matching liquid (Carl Zeiss, Inc.) was used to couple the glass coverslip of the 
microfluidic device to the objective. In this setup, two lasers can be used 
simultaneously to excite different color fluorophores; we used 561 nm and 488 nm 
excitation wavelengths from solid-state lasers. These were coupled into the optical 
pathway of the microscope using a Laser TIRF 3 slider (Carl Zeiss, Inc.), which 
controlled the angles of incidence.  Exceeding the critical angle for glass/water 
interface (~ 62o) ensured total internal reflection of the lasers and created evanescent 
waves about 100 nm thick. At this thickness, the evanescent waves excited 
fluorophores positioned within the supported bilayer, or virions labeled R18. The 
excitation laser light was band-pass filtered through a Semrock 74 HE GFP/mRFP 
filter cube, and then combined with a dichroic mirror before being focused on the 
outer edge of the back aperture of the objective. The fluorescence emission signal was 
filtered through a 525/31 and 616/57 nm dual band-pass emission filter and then sent 
to an electron multiplying CCD camera (Hamamatsu ImageEM C9100-13, 
Bridgewater, NJ). 
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3.2.12. Data Analysis 
3.2.12.1. Image Processing 
The images acquired during the membrane fusion assays were analyzed using both 
ImageJ (NIH) and MATLAB (Mathworks). Fusing particles were manually selected in 
ImageJ and the fluorescence intensity in a 4x4 pixel region around each particle was 
collected as a function of time. In videos where background noise was high due to a 
large amount of fusion events, a rolling ball background subtraction algorithm was 
applied to all of the images to remove excess background noise as the fluorophores 
diffused into the membrane after hemifusion. The rolling ball algorithm determines 
the local background for every pixel by averaging over a large circular region around 
the pixel. This background value is then subtracted from the original image. The 
fluorescence trajectories for the particles were then imported to MATLAB 
(Mathworks) for further analysis. A code written in MATLAB determined the onset 
time of the dequenching ‘spike’ for each particle by finding the time of the maximum 
intensity in each particle trajectory.  
The accuracy with which N and kH can be determined depends on both the number of 
experimental observations and the number of steps in the process(116). To accurately 
estimate N from a gamma distribution a minimum number of a fusion events must 
occur for statistical significance. For example, to distinguish a 2-step process from a 3-
step process i.e. N = 2 from N = 3, a minimum of 50 fusion events must be 
observed(116). The number of fusion events that occurred during each experiment 
reported here varied from 70 to 120.  
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3.3. Results and Discussion 
 
3.3.1. Proteinaceous supported bilayer formation from cell blebs expressing APN 
protein  
Pure liposome solutions, prepared as described in the Methods section, self-assemble 
on glass to form supported bilayers via vesicle fusion(78, 80). Proteoliposomes, on the 
other hand, generally do not readily form supported bilayers on their own. We 
discovered that proteoliposomes derived from cell blebs could be induced to form 
supported bilayers with the addition of pure liposomes(46). We describe this self-
assembly process here in the context of forming fAPN-supported bilayers (fAPN-SB) 
as substrates for FCoV fusion studies. The process is illustrated in Fig. 1 (top) and 
begins with the formation of cell blebs containing fAPN. The detailed procedure for 
forming cell blebs containing fAPN from BHK cells can be found in the Methods 
section. fAPN blebs are then used to form proteinaceous supported bilayers, as will be 
described in detail next. Once the proteinaceous supported bilayer is formed, FCoV 
binds to fAPN, localizing the virus within the evanescent wave and enabling single 
particle fusion experiments that will be described in a later section.  
To visualize the formation of the supported bilayer from fAPN-blebs derived from 
BHK cells, the bleb membranes were labeled with a lipophilic fluorophore, Octadecyl 
Rhodamine (R18) (see Methods section). A small aliquot of the labeled bleb solution 
was added to a PDMS well and incubated for 10 minutes at room temperature. During 
this time, blebs contact and adsorb to the glass surface. Excess blebs that did not 
adsorb to the glass surface were removed by gently rinsing the well with buffer A (2 
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mM CaCl2, 10 mM HEPES, 150 mM NaCl at pH 7.4). At this stage, the adsorbed 
intact blebs stick to the glass surface as intact proteoliposomes, as seen in Fig. 1, t = 0 
image, as punctuate spots.  
 
To 
induce 
the  
Figure 1 (Top) Illustration of the formation of a fAPN-bleb supported bilayer from cell blebs derived from BHK 
cells. (Bottom) Fluorescence images of fAPN-SB formation, corresponding to the above cartoon. (Left, t = 0) 
fAPN-blebs containing R18 adsorbed to glass substrate. Note that some larger blebs dominate the signal, but many 
smaller blebs are adsorbed as well. (Middle images) ~ 100 seconds after the addition of BHK-liposome solution to 
adsorbed blebs. Note that the BHK-liposome solution is devoid of fluorescent label, thus all signal comes from 
release of R18 initially confined to the bleb vesicle before rupture. (Right, t = 300 s) Continuous supported bilayer 
observed 300 seconds after the addition of liposomes. These images are all taken under 40x magnification. The 
dark lines in each image are scratches intentionally made with a dissection tool that is used to find the focal plane 
of the bilayer. The continuous focus of this line throughout the rupture process indicates that the focal plane not 
change and that the uniform distribution of fluorescence at t = 300 s is due to mobility of fluorophores redistributed 
throughout the newly-formed planar bilayer.  
Cell expressing 
fAPN protein 
+ = fAPN blebs 
Supported 
fAPN bilayer 
cell 
fAPN 
blebbing 
solution 
+ BHK liposomes Adsorbed 
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formation of a supported bilayer from the adsorbed blebs, we formulated 
liposomes to match closely the BHK endosomal membrane composition(107) 
(referred to as BHK-liposome) and added this solution to the PDMS well containing 
the adsorbed blebs. In this experiment, the BHK-liposomes are devoid of fluorophore 
labels. This labeling scheme assists in observing the formation of the supported bilayer 
as the initially punctuate blebs rupture and the R18 disperses throughout the newly-
formed planar bilayer (Fig. 1, bottom image series). Note that as the R18 spreads in 
the bilayer and gets diluted with the unlabeled BHK lipids, the fluorescence signal 
increases due to fluorophore dequenching.  
Bilayer formation is verified by fluorescence recovery after photobleaching 
(FRAP). In this technique, a laser beam is used to photobleach a 20 µm diameter spot 
in the newly-formed fluorescently-labeled (R18) supported bilayer. The recovery of 
the fluorescence in this photobleached area is used to determine the 2D mobility of 
R18 embedded in the planar supported bilayer, which in turn, verifies that the R18 is 
no longer confined to discrete bleb vesicles adsorbed to the glass surface, but freely 
moving throughout a 2D bilayer plane. FRAP interrogates a macro scale area (~ 
microns) and thus is useful for characterizing how well the bilayer has formed over 
this length scale. Note that the largest population of blebs is on the order of 500 nm in 
diameter (Fig. S1), so if the blebs have not ruptured into a contiguous planar bilayer, 
then the fluorescence will not be able to recover after the sample is photobleached. 
This lack of recovery was confirmed by preparing samples containing only adsorbed 
cell blebs (no addition of BHK-liposomes). Photobleached spots did not recover on 
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these samples.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2 fAPN supported bilayer characterization and mobility. (a) R18 fluorescence recovery after 
photobleaching in a fAPN supported bilayer (similar to t = 300 s in Fig. 1). The images correspond to the times for 
each color-coded arrow on the plot. The data are fit to curve (black line) to obtain the diffusion coefficient. At t = 0, 
the bilayer was bleached with a 561 nm laser beam. The diameter of the bleached area is ~ 20 mm. The reported 
diffusion coefficient on the plots is averaged from several experiments.  
 
For mobile samples, we obtain two quantitative measurements from these 
experiments: the mobile fraction and the 2D diffusion coefficient. Samples were 
prepared on glass surfaces in PDMS wells, as described above. Figure 2 is a typical 
fluorescence recovery of R18 in a fAPN-SBs. From this plot, the recovery is nearly 
restored to 100%, indicating that the mobile fraction of R18 in the fAPN-SB is quite 
high. The reported diffusion coefficient, averaged over several, similarly-prepared 
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samples, is 0.35 ± 0.005 µm2/s. Mobile fraction and diffusion coefficient values 
compare well with a control bilayer made of only R18-labeled BHK-liposomes (see 
Appendix C for data, Fig. C2).  
Note that the recovery curve is smooth and fits well to the 2D diffusion model 
(black line). Irregular recovery could indicate either disconnected, isolated, bilayer 
patches that did not heal to form a contiguous film over this length scale, or the 
presence of lipid microdomain formation. This data indicates that the bilayer has a 
relatively uniform distribution and is contiguous. Other possibilities for the structure 
of the bilayer include partial bleb rupture (such as only the outer leaflet fusing to the 
BHK-liposomes). However, because the diffusion coefficients and mobile fractions in 
the pure BHK-liposome SLB and fAPN-SB bilayers are comparable, this structure can 
be ruled out by the following argument. If the blebs were only partially fused, then the 
R18 trapped in the inner leaflet could not readily exchange with the surrounding lipids 
after being photobleached. This behavior would manifest as a slower recovery and 
reduced mobile fraction, relative to the pure BHK-liposome case, over the same 
timescale of recovery experiment. 
Once the bilayer was formed, we verified that the fAPN proteins were incorporated 
into the supported bilayer and the active, extracellular end was oriented facing the 
bulk solution (i.e., not inverted towards the glass support) by labeling with a fAPN-
specific antibody against the extracellular portion of the protein. Details of these 
experiments and controls are provided in the Methods section (Fig. S4) and confirm 
that fAPN is in the bilayer and oriented properly. Next, we tested APN activity in the 
blebs and support bilayers using an enzyme activity assay (see Methods section). Fig. 
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S5 summarizes the enzyme activity assay, and the results show that APN is 
enzymatically active in the supported bilayer derived from cell blebs.  
Taken together, the antibody binding assay and the enzymatic assay results 
corroborate that APN protein is functional and maintains its native activity and 
orientation in the supported bilayer. We note that while the R18 and lipids are mobile 
in the fAPN-SB (Fig. 2), the proteins do not appear to be mobile to the same extent 
(Fig. S3). Because APN is the binding receptor for the virus, immobility will reduce 
the strength of binding (avidity) of the virus to the supported bilayer. However, as 
long as one receptor bond in able to hold the virus in close proximity to the supported 
bilayer (and within the evanescent field) prior to fusion initiation, we can still track 
individual virus fusion events using TIRFM, as will be shown in the next section.  
We coated microfluidic channels with supported bilayers devoid of, or containing, 
fAPN. To make the bilayers, either empty-vector blebs or fAPN blebs were used, 
following the procedure described above for PDMS wells, but modified slightly to be 
compatible with a microfluidic device. A description of this procedure is in the 
Methods section.  
We prepared two suspensions of FCoV virus. The first was treated with the 
protease, trypsin, (2.5 µg/ml) for 15 minutes at 37oC prior to fluorescence labeling, 
and the second suspension was left untreated. Fig. S6 demonstrates, by Western blot 
analysis, that trypsin treatment of FCoV-1683 virions results in proper cleavage 
activation of the S protein. This cleavage step is necessary to prime the S protein for 
the fusion assay that will be carried out following virus binding. 
Next, suspensions of fluorescently-labeled, trypsin-treated FCoV were sent through 
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the channels and incubated for 20 minutes. During this time, virus bound to the fAPN 
in the supported bilayer, but virus introduced to the channels containing empty-vector-
SBs showed no visible binding (Fig. 3). Comparing these results emphasizes the 
requirement that the supported bilayer contain fAPN to localize the virus at the bilayer 
surface.  
 
Figure 3 A comparison of FCoV binding to (top) empty vector-SB and (bottom) fAPN-SB. The fAPN-SB exhibits 
specific binding of the virus. Note that due to the random intercalation of R18 in the viral membranes, fluorescence 
quenching varies among the virions, so some viruses are dimmer than others in this image. 
 
3.3.3. pH-triggered fusion 
To monitor and distinguish the intermediate steps in the fusion pathway from each 
other in the single particle fusion assay, we use a dual-color labeling scheme (Fig. 4), 
as described in the Methods section. Here, the viral membrane is labeled with a green-
emitting, lipophilic fluorophore (R110C18), and the internal contents are labeled with 
a red-emitting fluorophore (SRB). With this scheme, hemifusion of the outer leaflets is 
marked by fluorescence dequenching of R110C18 when the outer leaflets mix. Pore 
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formation is marked by a drop in SRB fluorescence at the fusion site, indicating 
release of the internal contents. These colors are co-localized in one particle by 
simultaneous monitoring of both emission wavelengths using TIRFM. In this way, 
three important time intervals can be obtained for each individual particle: 1) the time 
for the onset of hemifusion; 2) the lag time between hemifusion and pore formation; 
and 3) the time when the internal contents are released. 
 
In our  
 
Figure 4 Dual-labeling scheme of coronavirus for single particle fusion experiments that facilitate the capture of 
intermediate states. The viral membrane is labeled with a green-emitting, lipophilic fluorophore. The viral contents 
are labeled with a red-emitting fluorophore. The two leaflets of the membranes are distinguished by the thin white 
line. (top) Spike proteins bind to fAPN (purple) present in the supported bilayer (gray). (middle) A drop in pH 
triggers hemifusion between the viral membrane and supported bilayer, leading to the mixing of the outer leaflets 
of each and the formation of a stalk. (bottom) Collapse of the stalk into a fusion pore, which results in the release of 
viral contents. 
assay, membrane fusion between bound trypsin-treated FCoV and supported 
bilayers is primarily initiated with acidic buffer, although on occasion, some cleaved 
viruses spontaneously fuse prior to acidification. To test the influence of triggering pH 
on fusion kinetics, buffer solutions (150 mM NaCl, 1.5 mM MES, 5 mM citric acid) 
pre-calibrated over a range of acidic pH values (up to pH 7.0) were used. Each 
solution was sent through a microfluidic channel at a flow rate of 100 µl/min for 2 
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minutes to acidify the system. The time at which acidification of the flow cell occurred 
was marked by an obvious decrease in fluorescence of the pH-sensitive fluorophore, 
Oregon green DHPE, present in the supported bilayers for this purpose. TIRFM 
images were collected at an interval of 100 ms for three or four minutes. A series of 
images of a single virion undergoing hemifusion triggered at pH 5.3 is provided in 
Fig. 5a. The dequenching spike is traced in the plot beneath the images. The time at  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Coronavirus hemifusion kinetics after pretreatment with trypsin. (a) Images of a single coronavirus 
hemifusion dequenching event. The system was acidified at t = 0 to pH 5.3. The color-coded frames correspond to 
the time points in the curve marked with arrows. The trace plots the fluorescence in a small 4 x 4 mm region 
around the virus. The spike in intensity is when the hemifusion event begins. The lag time leading up to this point 
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is the hemifusion lag time between acidification and hemifusion. (b) Many events like those in (a) are cataloged 
and plotted as a cumulative distribution function and fit with equation 2 for several pH values. (c) Hemifusion rate 
constants over a range of pH. (d) The corresponding number of spike proteins, N, determined from the statistical 
analysis of data. 
which the onset of hemifusion occurs (following acidification at t = 0) is declared 
as the start of the dequenching spike for each individual virus fusion event in the field 
of view.  
A cumulative distribution curve for each triggering pH was generated by plotting 
the frequency of hemifusion events as a function of the times of the onset of each 
hemifusion event. For a given triggering pH, a curve (like in Fig. 5b) is then fit with a 
cumulative gamma distribution (equation 1) to estimate the kinetic parameters:
  
   
   
              
     (1)
 
where kH is the hemifusion rate constant, t is time, and N is an additional fit parameter, 
often correlated to the number of steps or the number of fusion proteins that act 
together to initiate fusion(21).  
A gamma distribution is commonly used to fit single particle kinetics of 
membrane-enveloped viral fusion because individual fusion events occur 
independently of each other. The gamma distribution describes a multistep reaction 
scheme, where each step is a stochastic Poisson process with a rate constant k. This 
model has been used to analyze the kinetics of single particle influenza fusion(21, 22), 
and because of the similarity between the class I fusion proteins of HA and S, this 
model is used to analyze coronavirus fusion here. The probability distribution was fit 
to our data using a non-linear least squares fitting algorithm. 
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Figure 5c-d summarizes the hemifusion kinetic parameters obtained for trypsin-
treated FCoV over a range of triggering pH: 4.0 to 6.0. We note that at pHs above 6.0, 
the number of fusing particles was too low to obtain statistically significant kinetic 
parameters. The data presented here (pH 4.0 – 6.0) corresponds to experiments where 
at least 50 fusion events occurred. What is clear from this data is that FCoV-1683 S 
cleaved with trypsin requires at least a mildly an acidic environment to fuse, but the 
rate dependence on pH is negligible. This may indicate that there is a mildly acidic pH 
threshold at which FCoV-1683 S becomes fusogenically active. As such, we show 
here that acidic pH may be considered as a subtle trigger for fusion, along with the 
better characterized triggers of receptor binding and proteolytic processing of S.  
A second finding from these experiments is that trypsin can substitute for 
cathepsins in activating membrane fusion. In the absence of trypsin treatment, the total 
number of fusion events is less than 10% of the number of events that occur with 
treatment, post acidification (data not shown).  
A third finding is that protease activation can occur before the virus binds the APN 
receptor, in contrast to the situation with SARS-CoV where the virus must first be 
bound to the receptor before cleavage. It is interesting to note that FCoV-1683 is one 
of the coronaviruses that does not need to be cleaved at the S1/S2 junction, and so this 
result highlights that there may be differences in receptor priming of fusion, depending 
on how individual coronaviruses are proteolytically activated.  
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3.3.4. Fusion pore formation 
The lag time between the onset of hemifusion and pore formation can be determined 
from the relative time stamps of the onset of hemifusion dequenching and the onset of 
the release of fluorophores initially inside the virion. In Fig. 6, a series of images of a 
Figure 6 (a) A single, dual-labeled coronavirus fusion event at pH 4.5. Green and red channel images of this virion 
undergoing hemifusion (green) and then pore formation (red). The arrows denote the virion being analyzed, which 
has both labels co-localized in one particle. In the red channel, a second particle is visible; however, during this 
span of time, it does not fuse. (b) The corresponding fluorescence intensity traces of the virion in (a). The lag time 
between hemifusion and pore formation for this virion is denoted by the black double-ended arrow. (c) Pore 
formation statistics at pH 4.5 taken from single particle fusion events, like those in (b).  
dual-labeled, trypsin-treated FCoV fusing to the supported bilayer is shown in Fig. 6a, 
with the intensity quantified in Fig. 6b. The initiating pH in this experiment was 4.5. 
In Fig. 6b it is straightforward to determine the lag time as a difference between the 
dequenching spike of the green label and the drop in fluorescence of the red label. Lag 
times for the virions in this sample are cataloged and plotted in the bar graph in Fig. 
6c. Fitting this histogram with an exponential decay, we determine that the rate 
constant for the formation of the pore is 0.07 ± 0.01 s-1. Pore formation was also 
conducted with an initiating pH of 5.0. Here the rate constant for the formation of the 
97 
 
pore is ~0.09 s-1. For both initiating pH’s, the transition to pore formation histogram fit 
best to a one-step process. 
These experiments reveal that FCoV exhibits a distinct hemifusion event before 
the release of internal label, which supports that coronavirus, like influenza, proceeds 
to pore formation via a stalk intermediate. No release of internal red label was 
observed prior to hemifusion of dual-labeled virions. 
 
3.3.5. Comparison between class I fusion proteins, HA and S 
 
With our results, it is now also possible to compare the fusion kinetics obtained for 
CoV S with the prototypical protein of this class, influenza HA. In our previous single 
particle kinetics studies of influenza X-31 HA membrane fusion(22), we found 
hemifusion and pore formation rate constants at pH 4.5 of kH ~ 0.2 s-1 and kpore ~ 0.08 
s-1, respectively. Here, for FCoV S at the same pH, we obtain kH ~ 0.05 s-1 and kpore ~ 
0.07 s-1, respectively. One main difference we observe between HA and S is the pH-
dependence of the hemifusion rate constant. FCoV-1683 S apparently requires an 
acidic environment to fuse, but the rate dependence on pH is negligible. Influenza, on 
the other hand, exhibits pH-dependent kH(21, 22). However, the pore formation 
kinetics for both viruses are approximately the same. This result is not surprising 
because the pore formation step is not believed to be pH dependent(54, 58), but 
controlled to some extent by the physico-chemical properties (e.g., lipid composition, 
protein content, cholesterol quantity, etc.) of the membranes involved in fusion. Since 
cell blebs can be made from various cell types, the method presented here for forming 
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supported bilayers from blebs also provides a new way to interrogate the impact of 
cell membrane type on viral fusion kinetics. 
A second difference between influenza HA and FCoV S is the value of N obtained 
from the kinetic analysis. N represents the number of steps in a multi-step scheme 
convoluted into a gamma distribution. In the case of influenza, N has been interpreted 
as the number of HA proteins that work in parallel to induce hemifusion(21, 22). For 
influenza, N varies depending on the pH, but within the range of pH 4.0 to 6.0 is ~ 3 
using the same experimental acidification conditions employed in these studies. In the 
case of FCoV S, if this interpretation were used, our data indicates that on average 1-2 
S proteins are required to induce hemifusion across the same pH range.  For this 
interpretation, a single S protein appears to have more energy stored within it to 
induce fusion compared to HA. An alternative interpretation is that N in this case 
simply means that ~ 1 step is dominating the kinetics, and that step apparently does 
not vary much with pH. Future experiments are required to shed more light on the 
mechanism of FCoV fusion and provide a conclusive interpretation of this parameter. 
Such studies are now ongoing in our laboratory. 
 
3.3.6. Implications of this work 
The formation of proteinaceous supported bilayers using the cell blebbing technique 
opens the possibility for quantitative characterization of membrane fusion kinetics of 
any enveloped virus that binds to membrane proteins in the host membrane (beyond 
coronaviruses) and also enables studies of unknown viral receptors in the cell 
membrane. Because supported bilayers can be made from many cell types(43, 101), 
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this method can be used to obtain kinetics of virus fusion as it depends on the kind of 
cell membrane host. In particular, for the many viruses that engage multiple receptors 
or co-receptors, this method allows the role of individual receptors to be defined in the 
context of the fusion event. Through biochemical means, proteins can be expressed or 
suppressed in the plasma cell membrane. Thus, supported bilayers can be tailor-made 
for fundamental studies of specific host-pathogen interactions that mitigate infection. 
In addition, by the incorporation of pseudoparticles(97), the method may be expanded 
to study viruses of high biomedical importance that require enhanced biosafety 
procedures (BSL-3 and BSL-4). 
3.4. Conclusions 
  
In this work, we obtain the membrane fusion kinetics of a less-studied, but 
clinically important, class I fusion protein: coronavirus S. Overall, the fusion results 
here recapitulate what is observed in vivo, that coronavirus entry requires binding to 
specific receptors and that membrane fusion is both receptor- and protease-dependent. 
These results indicate that the in vitro method described here is a suitable substitute 
for studying fusion in vivo, but our method of creating and combining proteinaceous 
bilayers with single particle tracking, now provides a convenient way to obtain 
quantitative kinetic rate parameters for intermediate steps in the coronavirus fusion 
pathway, which to our knowledge have not been obtained before. The single particle 
approach combined with microfluidics offers versatile control over the sequence of 
triggers of binding, protease exposure, and acidification. Control of the sequence of 
these triggers is important, as the order may define the fusion pathway, tissue tropism, 
and pathogenicity of coronaviruses. Systematically varying these complex triggers 
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using this platform provides a new way to study this virus’s ability to rapidly adapt to 
other hosts. Versatile platforms are of critical importance to providing data that can be 
leveraged to limit the infection of the human population, especially in light of the 
recently-emerging strain of MERS-CoV.  
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        CHAPTER 4 
 
MEMBRANE FUSION-COMPETENT VIRUS-LIKE PROTEOLIPOSOMES AND 
PROTEINACEOUS SUPPORTED BILAYERS MADE DIRECTLY FROM CELL 
PLASMA MEMBRANES 
 
4.1 Introduction  
 
Mammalian cell membranes are composed of a mixture of phospholipids, 
cholesterol and proteins. Membranes are coated with a carbohydrate layer composed 
of glycosylated proteins and glycolipids that are collectively referred to as the 
glycocalyx. The properties of the glycocalyx dictate host-pathogen interactions, and 
these interactions play a key role in the pathogenesis of infectious viruses such as 
influenza.  
Influenza is a membrane-enveloped virus that causes seasonal outbreaks and 
occasionally pandemic illnesses in humans. Outbreaks occur because continuous viral 
evolution produces mutants capable of optimal interactions with the glycocalyx of 
target cells while also being able to successfully evade the immune system. 
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Continuous viral evolution, therefore, requires scientists to be vigilant in determining 
both the host and viral factors that facilitate infection. Researchers must have tools 
available to quickly and safely assess virus-host interactions to: 1) monitor virus 
evolution necessary for future vaccine development, 2) screen new antiviral drugs, and 
3) study fundamental membrane fusion processes.  
A relatively new approach for quantitatively studying virus-cell interactions and 
viral entry kinetics is single particle imaging using total internal reflection 
fluorescence microscopy (TIRFM) (64). A key ingredient in this platform is a 
supported lipid bilayer (SLB) that coats the walls of microfluidic channels and acts as 
a host membrane mimic (78, 117). This biomimetic material preserves lipid mobility 
in the bilayer plane and the planar geometry removes many experimental 
complications imposed by live cells. These features facilitate the study of virus-cell 
interactions and the membrane fusion processes required for viral infection, but in a 
convenient platform for imaging and quantitative data collection. These platforms 
have provided useful information about seasonal influenza (21, 22, 96), Sindbis (20), 
and other low pathogenic viruses. However, to study fusion processes of highly 
pathogenic membrane-enveloped viruses, like pandemic strains of influenza, Ebola 
virus, or Severe Acute Respiratory Syndrome (SARS) coronavirus, one must have 
laboratory biosaftey level of 3 or more. Fewer facilities have this classification, which 
effectively limits the number of researchers that study these pathogens.  
One strategy to safely study highly pathogenic viruses uses pseudovirus particles.  
One of the most common constructs for pseudovirus particles is the Vesicular 
Stomatitis Virus (VSV) (118, 119). In the VSV pseudoparticle approach, a cell is 
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transfected with a viral fusion protein of interest so that this protein is expressed at the 
cell surface. The transfected cell is then infected with a modified, laboratory strain of 
VSV (designated VSVΔG*-G) that has the gene for the fusion protein (G) deleted. 
The infected cells replicate the VSV following its usual infection pathway via 
endocytosis: endosomal escape, genome replication in the nucleus, viral protein 
production, and repackaging at the membrane surface. At the conclusion of this 
process, nascent viral particles bud from the cell plasma membrane surface. During 
the budding process, the emerging virions membrane acquires the fusion protein that 
was expressed in the plasma cell membrane of the infected cell. It is important to note 
that the pseudovirus does not contain the gene for the fusion protein of either VSV-G 
or the fusion protein coded in the plasmid that was used to transfect the cells prior to 
its infection with the VSVΔG*-G strain. Thus, the emerging pseudovirus cannot 
propagate further infection, making it a safe strategy to study the activity of fusion 
proteins of virulent viruses.  
Combining these virus-like particles with analytical techniques that can 
quantitatively assess virus-host interactions, such as single particle imaging, gives 
researchers powerful tools to study viral entry. However, the production of the 
pseudovirus particles is complex, requiring trained technicians and several days of 
culture, growth, and infection, which limits its wider use beyond research laboratories. 
Our goal was to create a simpler method to produce virus-like proteoliposome 
particles that can be used for fundamental virus entry studies, as probes to assess 
virus-host interactions, or as packages for therapeutics where the viral fusion 
machinery ensures the delivery of cargo to cytosol of a target cell.  
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Herein we describe a simple method to create virus-like proteoliposomes from cell 
plasma membranes that express a viral membrane protein of interest using a cell 
blebbing technique. Cell blebs are chemically-induced membrane vesicles that bud 
from the cell plasma membrane. These chemically-induced vesicles were first 
generated in the 1970s(101, 120). Since then, blebs have been used to make giant 
plasma membrane vesicles (GPMV) to study lipid raft and domain formation (44, 45), 
to test membrane permeability for drug delivery applications (121, 122), and to 
elucidate membrane protein behavior (43), but not as a means to produce virus-like 
particles, to our knowledge. We show here that influenza virus-like proteoliposomes 
(VLPs) produced from cell blebs contain fusion proteins that maintain full fusion 
functionality, like native virions. Membrane fusion of these VLPs is assessed using 
single particle imaging and demonstrates their utility as non-infectious virus 
surrogates for studies of pathogen-host interactions and virus fusion mechanisms. We 
also found that we can also use cell bleb proteoliposomes to create virus-like 
supported bilayers (VLSB) that contain viral fusion proteins. These VLSBs are also 
capable of carrying out membrane fusion with lipid vesicles containing the viral 
receptor.  
In this paper, we create cell blebs from baby hamster kidney (BHK) cells, 
transfected with the transmembrane influenza fusion protein, hemagglutinin (HA). 
Pure blebs have difficulty self-assembling into supported bilayers presumably because 
of high protein and cholesterol content. Our strategy for inducing the SLB formation 
of the cell blebs is adapted from Dodd et al (123), where liposomes are added to blebs 
adsorbed onto a glass substrate. The rupturing of the liposomes in spaces in-between 
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the adsorbed blebs induces bleb rupture.  To closely mimic the native BHK cell 
membrane, we use a liposome composition to match that reported by Sobo et al (107) 
for BHK endosomes.  
One key advantage of making supported bilayers using cell bleb proteoliposomes, 
compared to traditional methods to produce proteoliposomes (124), is that proteins can 
be incorporated directly into supported bilayers without the requirement of detergent 
membrane solubilization, protein purification steps, and reconstitution into liposomes. 
These steps can result in loss of native conformation of the membrane protein and 
disruption of the local lipid-protein interactions that may be necessary for regulating 
protein activity (125). Thus, a virus-like supported bilayer produced from cell blebs 
with fully-functional proteins, combined with a microfluidic platform, could facilitate 
high throughput screening of antiviral drugs and host cell-pathogen interactions. 
  
4.2 Materials and Methods 
4.2.1. Cells and plasmids 
 
Baby hamster kidney-21 (BHK-21) cells, a generous gift from Michael Whitt, 
were grown and maintained in Dulbecco’s modified Eagle medium (DMEM, CellGro) 
supplemented with 10% fetal bovine serum (Gibco), 100 U/ml penicillin and 10 μg/ml 
streptomycin (CellGro), 1% HEPES buffer (CellGro) in a 37°C, 5% CO2 incubator.  
The following plasmids were used: pCAGGS-H3/X31, encoding the influenza 
hemagglutinin HA X-31, a generous gift from David Steinhauer. The pCAGGS vector 
was used as an empty vector control. 
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4.2.2. Preparation of cell blebs 
 
For transfections, 1.5 × 106 cells were seeded in 10-cm culture dishes, and 
incubated for 24 hours. Transfections were performed using TurboFect transfection 
reagent (ThermoScientific) according to manufacturer’s instructions and using 12 μg 
of plasmid DNA for each plate. Buffer used in cell culture will be referred to as buffer 
A (2 mM CaCl2, 10 mM HEPES, 150 mM NaCl at pH 7.4) and to induce cell 
blebbing, as buffer B (2 mM CaCl2, 10 mM HEPES, 25 mM formaldehyde, 2 mM 
dithiotreitol (DTT) and 150 mM NaCl at pH 7.4). Cell blebs were dialyzed using 
cellulose dialysis tubing (Fischer Scientific) in two 100 ml volumes of buffer A for 24 
hours to remove the blebbing buffer. The size distribution of cell blebs was 
determined by dynamic light scattering using a Malvern Zetasizer Nano 
(Worcestershire, UK). A plot of the size distributions is provided in the Appendix A.  
4.2.3. Preparation of liposomes 
The following lipids were used in the experiments: 1-oleoyl-2-palmitoyl-sn-
glycero-3-phosphocholine (POPC), 1-oleoyl-2-palmitoyl-sn-glycero-3-
phosphoethanolamine (POPE), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
cholesterol, sphingomyelin and total ganglioside extract. These materials were all 
purchased from Avanti Polar Lipids (Alabaster, AL). Fluorescent lipids and lipophilic 
labels used to label membranes include, Oregon green DHPE and Octadecyl 
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Rhodamine (R18), all purchased from Molecular Probes, Eugene, OR. The water-
soluble fluorophore, Sulforhodamine B (SRB), was purchased from Molecular Probes, 
and used to label interiors of liposomes and virus.  
Two formulations of liposomes were used in these studies. The first preparation, 
referred to as BHK-liposome, contained POPC, POPE, sphingomyelin and cholesterol 
in the ratio 37.3:34.2:5.7:22.8. This composition was formulated to match the native 
lipid content of BHK cells as closely as possible (107) and primarily used in the 
formation of bleb supported bilayers. The second preparation, referred to as SA-
liposome (SA = sialic acid), was composed of DOPC, POPC, cholesterol and total 
ganglioside extract (which contain sialic acid) in the ratio 4:4:2:0.5. SA-liposomes 
were used both to form supported lipid bilayers containing SA and as liposomes to 
verify HA functionality in cell bleb-derived HA-supported bilayers. Standard 
procedures were used to form the liposome solutions (117).  Our detailed procedure is 
described in the Appendix A. 
4.2.4. Formation of supported lipid bilayers from pure liposome solutions 
Liposome solutions were added to either a polydimethylsiloxane (PDMS) well or 
drawn into a microfluidic device and incubated for at least 5 minutes before rinsing 
with buffer A. fabrication procedures for PDMS wells and microfluidic devices is 
provided in the Appendix A. Supported lipid bilayers self-assemble on clean glass 
during vesicle fusion (78-80) of these liposome formulations. In some experiments, 
liposome membranes were fluorescently-labeled with Oregon green DHPE or with 
R18 prior to bilayer formation. Fluorescent labels enabled visualization of the 
supported lipid bilayer; were indicators of bilayer acidification in fusion experiments; 
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and were probes for mobility measurements. 
 
 
4.2.5. Fluorescent labeling of blebs, liposomes, or native virus 
Influenza X-31 (H3N2) with a hemagglutinin (HA) concentration of 2 mg/ml (as 
determined by Charles River Labs) was used in virus membrane fusion experiments.  
To visualize membrane fusion using a fluorescence dequenching technique, 
membranes must be labeled with a semi-quenched amount of fluorophores following 
standard procedures(50) (73, 80). In these experiments, HA-bleb membranes, SA-
liposome membranes, and virus membranes of influenza X-31 virus were labeled with 
R18 according to the general procedure outlined in the Appendix A.  
4.2.6. Antibody binding experiments 
To label HA proteins in cell bleb-derived support bilayers, the bilayer was 
incubated with Alexa Fluor 488-conjugated mouse monoclonal IgG1 anti-
hemagglutinin antibody (16B12) (Invitrogen) at a concentration of 1 µg/ml for 20 
minutes. Following incubation, bilayers were rinsed extensively with buffer A to 
remove unbound antibodies and visualized using an inverted fluorescence microscope 
with appropriate filter set.  
4.2.7. Single particle membrane fusion to supported bilayers: TIRF microscope 
configuration 
Membrane fusion assays were conducted using total internal reflection 
fluorescence (TIRF) microscopy using an inverted Zeiss Axio Observer.Z1 with a α 
Plan-Apochromat 100x oil objective with a numerical aperture (NA) of 1.46. Index-
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matching liquid (Carl Zeiss, Inc.) was used to couple the glass coverslip of the 
microfluidic device to the objective. In this setup, two lasers can be used 
simultaneously to excite different color fluorophores; we used 561 nm and 488 nm 
excitation wavelengths from solid-state lasers. These were coupled into the optical 
pathway of the microscope using a Laser TIRF 3 slider (Carl Zeiss, Inc.), which 
controlled the angles of incidence.  Exceeding the critical angle for water-glass system 
(~ 62o) ensured total internal reflection of the lasers and created evanescent waves 
about 100 nm thick. At this thickness, the evanescent waves excited fluorophores 
positioned within the supported bilayer, within fluorescently-labeled liposomes bound 
to hemagglutinin proteins embedded in the supported bilayer, or within fluorescently-
labeled virions bound to SA-containing lipid bilayers. The excitation laser light was 
band-pass filtered through a Semrock 74 HE GFP/mRFP filter cube, and then 
combined with a dichroic mirror before being focused on the outer edge of the back 
aperture of the objective. The fluorescence emission signal was filtered through a 
525/31 and 616/57 nm dual band-pass emission filter and then sent to an electron 
multiplying CCD camera (Hamamatsu ImageEM C9100-13, Bridgewater, NJ). 
4.2.8. pH-triggered membrane fusion assay 
Membrane fusion between bound virions (or liposomes) and supported bilayers 
was initiated by flowing buffer (150 mM NaCl, 1.5 mM MES, 5 mM citric acid) pre-
calibrated to the optimal acidic triggering pH for X-31, pH = 4.5 (27). This acidic 
buffer was sent into the microfluidic device at a flow rate of 100 µl/min for 2 minutes. 
The time at which acidification of the flow cell occurred was marked by an obvious 
decrease in fluorescence of the pH-sensitive fluorophore, Oregon green DHPE, 
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present in the supported bilayer for this purpose. TIRFM was used to monitor fusion 
and images were collected at an interval of 100 ms for 3 to 4 minutes.  
 
4.2.9. Image processing 
The images acquired during the membrane fusion assays were analyzed using both 
ImageJ (NIH) and MATLAB (Mathworks). Fusing particles were manually selected in 
ImageJ and the fluorescence intensity in a 4x4 pixel region around each particle was 
collected as a function of time. In videos where background noise was high due to a 
large amount of fusion events, a rolling ball background subtraction algorithm was 
applied to all of the images to remove excess background noise as the fluorophores 
diffused into the membrane after hemifusion. The rolling ball algorithm determines 
the local background for every pixel by averaging over a large circular region around 
the pixel. This background value is then subtracted from the original image. The 
fluorescence trajectories for the particles were then imported to MATLAB 
(Mathworks) for further analysis. A code written in MATLAB determined the onset 
time of the dequenching ‘spike’ for each particle by finding the time of the maximum 
intensity in each particle trajectory.  
 
 
4.3. Results and discussion 
4.3.1. Formation of cell blebs and size characterization 
Cell blebs are produced from baby hamster kidney (BHK) cells, transfected with 
the transmembrane influenza fusion protein hemagglutinin (HA). Twenty-four hours 
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after transfection of BHK cells with the desired plasmid, cells were washed twice with 
buffer A. 3 ml of buffer B, which contains the chemical that induce the formation of 
bleb vesicles from the cell plasma membrane, was added to each culture dish. The 
dishes were then incubated for 1 hr at 37oC with gentle rocking. After incubation, the 
cell supernatant, containing detached cell blebs, was decanted into a 15 ml falcon tube 
and placed on ice for 20 minutes to allow any detached cells to settle out. The 
supernatant was then transferred to new test tube. Buffer B was removed from the 
supernatant by dialysis with buffer A for 24 hours. An excellent recent review of 
protocols for cell bleb production is given in Sezgin et al (43). 
The size and distribution of cell blebs in the supernatant was determined by 
dynamic light scattering. The bleb supernatant showed three populations typically, 
with three main peaks at 40 nm, 100 nm, and 600 nm. A plot of the size distribution is 
provided in the Appendix A (Fig. S1). The size of BHK-liposomes and SA-liposomes 
were relatively monodisperse with diameters ranging between 90 – 100 nm. Aliquots 
of these solutions were used to carry out single particle membrane fusion experiments, 
as will be described later. 
4.3.2. Formation of proteinaceous supported bilayers from cell blebs 
To visualize the formation of supported bilayers derived from BHK cell blebs, the 
membranes of HA-blebs were first labeled with a lipophilic fluorophore, R18. A small 
aliquot of the labeled bleb solution was added to a PDMS well and incubated for 10 
minutes at room temperature. During this time, blebs contact and adsorb to the glass 
surface. Excess blebs that were not adsorbed to the glass surface were removed by 
gently rinsing the well with buffer A. Observation of samples under 40x and 100x 
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magnification show that the blebs are not ruptured at this stage, but are adsorbed to the 
glass surface intact, as seen in Fig. 1(A) as punctuate bright spots. Although the 
absolute concentration of the bleb solution is unknown, the solution was observed to 
be sufficiently concentrated to absorb blebs over the entire glass surface.  
 
Fig. 1. Formation of HA-bleb VLSB containing hemagglutinin from influenza X-31. 
(A) Intact HA-blebs containing R18 adsorbed to glass substrate. (B) 15 seconds after 
the addition of BHK-liposome solution to (A). Note that the BHK-liposome solution is 
devoid of fluorescent label. (C) Continuous supported bilayer observed 2 minutes after 
the addition of BHK-liposomes. The images are all taken under 40x magnification. 
The dark line in the right corner of the images is a scratch intentionally made with a 
dissection tool to aid in finding the focal plane of the bilayer. The continuous focus of 
this line throughout the rupture process indicates that the focal plane does not change 
during this series of experiments and that the uniform distribution of fluorescence in 
(C) is due to mobility of fluorophores redistributed throughout the newly-formed 
planar bilayer.  
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To induce the formation of a supported bilayer from the adsorbed blebs, we 
adapted a procedure Dodd et al (123) used to form supported bilayers from the inner 
membrane vesicles of E. coli. In our case there are two distinct procedural differences 
from Dodd et al. First, the liposomes used to rupture the BHK cell blebs were 
formulated to closely match the BHK endosomal composition (107) (referred to as 
BHK-liposome) so that the resulting bilayer would most closely resemble the native 
cell membrane lipid content. Second, we adsorb cell blebs to the substrate first, rather 
than mix in solution with BHK-liposomes prior to adding to the well. This latter step 
ensures that the liposomes do not outcompete the cell blebs for glass adsorption.  
In this experiment, the BHK-liposomes do not contain any fluorophore labels. The 
rupturing of the liposomes in the spaces in-between the adsorbed blebs rapidly 
induced the rupture of the blebs, as indicated by the dispersion of the bright, punctuate 
spots (Fig. 1B - C). This observed dispersion in fluorescence is due to the spread of 
R18 that originated in the membranes of the adsorbed blebs, diffusing within the 
newly-formed bilayer plane after rupture. Photobleaching a small section of this 
newly-formed bilayer and monitoring the temporal recovery also confirms that the 
blebs have ruptured to form a planar film. Photobleaching experiments are used to 
determine diffusion coefficients in the supported bilayers and will be described in a 
later section.  
The newly-formed supported bilayer was monitored for 12 hours after formation. 
During this time it remained visually stable and uniform (e.g., no domain formation 
was observed or growth of defects). 
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4.3.3. Supported bilayer quality, planarity, and thickness characterization   
 AFM and ellipsometry were used to confirm the formation of supported 
bilayers from cell blebs, visually assess their uniformity, and to characterize the film 
thicknesses. Three different samples were characterized by each method: A) a 
supported lipid bilayer formed from protein-free, BHK-liposome solution only, B) a 
supported bilayer formed from HA-blebs+BHK-liposomes (VLSB), and C) non-
ruptured, adsorbed HA-blebs (VLPs) on glass, prior to BHK-liposome addition.  
4.3.3.1 AFM 
Samples for AFM were prepared in PDMS wells as described in the Methods 
section. Details of the AFM setup and images (Fig. S2) are provided in the Appendix 
A. Contact mode under water was used to image and measure the thickness/height of 
the bilayer. For a point of comparison, we first characterized a standard bilayer made 
from BHK-liposome solution only (Sample A). Typical supported bilayers formed by 
vesicle fusion to glass are ~ 4 nm thick and have about a 1 nm water layer between the 
bottom leaflet and glass support. An AFM image in Fig. 2SA in the Appendix A 
shows that the BHK-liposome bilayer is a relatively uniform film of thickness ~ 4 - 6 
nm, as determined by scanning across the depth of a thin line intentionally scratched 
on the bilayer.  This thickness is in good agreement with literature values for similar 
supported lipid bilayers (126-128).  
In the next experiment, we imaged the VLSB (Sample B). From the AFM image 
(Fig. 2SB, Appendix A) we see in general that the bilayer is uniform, but there are 
some defects present in the film. The thickness of the VLSB was determined by 
measuring the depth of a defect. The measured depths of several defects were 
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consistently between 3 and 4 nm, which are consistent with the thickness measured for 
the standard BHK-liposome bilayer. However, to be sure we were not measuring 
thicknesses based on areas primarily consisting of BHK-liposome bilayer; we also 
measured film thicknesses of these samples over and extended area (0.5 cm x 0.5 cm) 
using ellipsometry. 
We also attempted to image adsorbed cell blebs prior to supported bilayer 
formation (Sample C), but found that images were very irregular and difficult to 
interpret as is consistent with irregularly adsorbed material and incomplete film 
formation.  
4.3.3.2. Ellipsometry  
To corroborate that the addition of lipid vesicles to adsorbed cell blebs induced the 
formation of a supported bilayer film, ellipsometry was also performed on the same 
three kinds of samples used in AFM imaging. For these measurements, it was 
necessary to prepare samples on silicon wafers instead of glass coverslips, but the 
procedure was otherwise the same as described in the Methods section. Additional 
experimental details are provided in the Supplementary Information Appendix A. The 
thickness of the oxide layer of the silicon wafer used for these experiments was 
determined to be approximately 4.1 nm. This value was into account when modeling 
the supported lipid bilayer data to determine the film thickness, as described in the 
Appendix A. A water layer of ~ 1 nm exists between the oxide support and a 
supported lipid bilayer film typically. We did not determine the thickness of protein 
layer protruding from the supported cell-bleb bilayer. The total amount of expressed 
HA protein is not dense enough to create a contiguous film, as inferred by results of 
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antibody binding experiments presented in the next section.  
The film thicknesses are summarized in Table S1 in the Appendix A and match 
reasonably well to the thicknesses measured using AFM. No film thickness could be 
determined from the sample of adsorbed cell blebs prior to BHK-liposome addition, 
presumably because of the irregularity of the adsorbed bleb surface density.  
4.3.4. Antibody binding to confirm presence of proteins derived from cell blebs in 
the supported bilayer   
To confirm that the hemagglutinin proteins expressed in the cells used to produce 
blebs were both incorporated into the supported bilayer and oriented facing the bulk 
(i.e., not inverted towards the glass support), the bilayer was incubated with anti-HA 
antibodies specific for X-31 HA protein. Anti-HA labeled with Alexa Fluor 488 
conjugate was incubated with HA-bleb supported bilayers for 20 minutes. The bilayer 
was then rinsed extensively with buffer A to remove unbound antibodies.  Control 
experiments were performed where the anti-HA antibodies were incubated for 20 
minutes on an HA-free bilayer (derived from empty vector blebs). Binding was 
assessed by imaging samples with an inverted fluorescence microscope. The images 
for the antibody binding experiments are provided in the Appendix A (Fig. S3) and 
show that a significant amount of specific anti-HA binding occurs on the VLSB, while 
minimal non-specific binding occurs for the HA-free bilayer. This specific binding not 
only indicates that HA was present in the bilayer, but also that a significant amount of 
protein was in the correct orientation facing the bulk solution, and not towards the 
glass support.  
4.3.5. Mobility in supported bilayers  
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4.3.5.1. Lipid mobility 
Fluorescence recovery after photobleaching (FRAP) was employed to determine 
the fluidity of the cell bleb bilayers. Details for the experiment and data analysis are 
provided in the Appendix A. Samples were prepared on glass surfaces as described in 
the Methods section. Fig. 2(A-C) shows the typical bleaching and recovery of R18 
probes in various supported bilayers after bleaching with a 561 nm circular laser 
beam. Sample A is the BHK-liposome supported lipid bilayer, sample B is a glass 
surface coated with adsorbed VLPs (HA-blebs) prior to BHK-liposome solution 
addition, and sample C is a VLSB derived from HA-blebs after BHK-liposome 
addition. The diffusion coefficients of R18 in samples A and C were found to be 
around 0.25 µm/s2 with mobile fractions near 1. For the samples containing only 
absorbed cell blebs (sample B), photobleached spots did not recover, as expected if 
lipids and R18 fluorophores were confined to the adsorbed proteoliposomes and 
unable to exchange with surrounding unbleached adsorbed blebs.  
 
To determine if the binding of an anti-HA antibody to HA in the VLSB reduces 
the mobility of R18 in the supported bilayer, the mobility of R18 was tested before 
and after antibody binding. It was found that antibody binding did not hinder the 
diffusion of R18 or cause the bilayer to lose mobility (Fig. 2D). This result indicates 
that the VLSB is not near a phase transition (129) and should remain in the fluid state 
after receptor binding.  This is a key point as binding-induced phase transition could 
impact the ability of membrane fusion to occur, or at minimum, slow down the 
membrane fusion kinetics 
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Fig. 2. Fluorescence images of intensity recovery with time after photobleaching. Data from these images if used to 
determine diffusion coefficients and mobile fractions in various supported bilayers. (A) R18 in BHK-liposome 
supported lipid bilayer: protein-free, control case. (B) Adsorbed R18-labeled VLPs. (C) R18-labeled VLSB. (D) 
R18-labeled VLSB after anti-HA antibody binding. The top bar graph summarizes the diffusion coefficients for 
each sample. The bottom bar graph summarizes the mobile fraction for each sample.  
 
4.3.5.2. Protein mobility 
The mobility of HA protein in the supported bilayers was assessed by two 
methods. First, the position of bound, fluorescently-labeled antibodies to HA were 
tracked at 100x magnification for an extended period of time. Second, fluorescence 
recovery after photobleaching was monitored as described for the lipid diffusion 
measurements. In both methods, limited protein mobility was observed.  
There are two possibilities to explain immobilization of the protein. First, the thin 
water layer beneath the supported bilayer is may not be thick enough to keep the 
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extended portions of the HA from coming into contact with the underlying support and 
non-specifically adsorb to it. Second, because the fluorescent antibody used to label 
the HA can bind multiple proteins, it is possible that cross-linking due to antibody 
binding can cause a reduction in mobility as well.   
There are a number of cushioning strategies that can be used to improve protein 
mobility, from tethered polymer layers (130-132) to dextran cushions (133, 134). 
None of these cushioning strategies were integrated here because, as we will describe 
next, protein immobility did not seem to block hemagglutinin’s ability to bind sialic 
acid or carry out its function of inducing the fusion of membranes. We elected not to 
use cushions to keep the system simple for this study. 
4.3.6. Membrane fusion functionality of HA protein in cell blebs and in bleb-
derived supported bilayers 
The function of hemagglutinin (HA) in influenza entry virus is to mediate the 
fusion between viral and host endosomal membranes. HA protein undergoes a 
conformational change at pH values less than 5.5 to trigger the fusion of the viral and 
endosomal membrane during virus infection (48). Antibody binding experiments 
verified that HA was present in the supported bilayer in the correct orientation. 
However, the blebbing buffer, which contains a small amount of DTT and 
formaldehyde, can induce the cleavage of disulphide bonds and the cross-linking of 
HA proteins before dialysis takes place to remove these chemicals from the blebs. 
Thus, the fusion function of the proteins must be tested to ensure the blebbing buffer 
did not destroy the function of the protein. To test the functionality of HA proteins 
expressed in cell blebs and in bleb-derived bilayers, we performed the following series 
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of experiments.   
4.3.6.1. Membrane hemifusion 
Membrane hemifusion is the merging of the two outer-most leaflets of the viral 
and host membranes. At this stage, the complete fusion pore has not opened, but a 
stalk-like structure connects the viral and host membrane. When this stalk forms, 
fluorescent labels can mix with lipids from the host cell and radially diffuse away 
from the hemifusion site. By labeling one membrane with a quenched amount of 
fluorophore, and the other membrane with nothing, hemifusion can be marked by a 
“dequenching” event when the stalk is formed (5, 50). These dequenching events are 
easy to observe using TIRFM at the individual virion level.  
In the first experiment, we tested the ability of HA expressed in cell blebs (VLPs) 
to hemifuse to sialic acid-containing supported lipid bilayers. SA-liposomes were 
drawn into a microfluidic device at a flow rate of 100 μL /min for 1 minute and 
incubated in the channel for 20 minutes. The channel was rinsed with buffer A at 100 
μL /min for 2 minutes to form a supported lipid bilayer containing sialic acid receptor. 
HA-blebs labeled with R18 were drawn into the channel at a flow rate of 30 μL/min 
for 5 minutes and bound to SA in the supported bilayer during 20 minute incubation. 
Unbound HA-blebs were removed from the channel by rinsing with buffer A at 100 
μL/min for 2 minutes. HA-mediated fusion of the blebs to the supported lipid bilayer 
was initiated by flowing pH 4.5 buffer into the channel at 100 μL/min for 2 minutes. 
Hemifusion was marked by dequenching of the R18 that originated in the HA-bleb, 
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Fig. 3. Single particle hemifusion and lipid mixing experiments compare HA fusion functionality in the HA-bleb 
VLP, the HA-VLSB, and in a native influenza virus. HA = hemagglutinin; NA = neuraminidase; SA = sialic acid. 
(A) VLP labeled with R18 fusing to sialic acid-containing supported lipid bilayer. (B) Sialic acid-containing vesicle 
labeled with R18 fusing to VLSB. (C) Influenza X-31 virion labeled with R18 fusing to sialic acid-containing 
supported lipid bilayer. The plots to the right trace the fluorescence intensity around each particle and show the 
dequenching event and the 2D diffusion of the R18 fluorophores away from the fusion site until background levels 
are reached. The black dashed lines are fits to equation 2 of the decay portion of the curve to obtain diffusion 
coefficients, as described in the text. 
 
and its subsequent radial diffusion among the lipids in the supported SA-bilayer 
(Fig. 3A).  
In a second set of experiments, we tested the functionality of HA in supported 
bilayers derived from HA-blebs. HA-VLSB were formed at neutral pH in microfluidic 
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channels, following the general procedure outlined above. First, HA-bleb solution was 
drawn into the microchannel at a flow rate of 30 µl/min for 1 minute and incubated for 
20 minutes to allow the blebs to adsorb to the channel walls. The channel was 
subsequently rinsed with buffer A at 100 μl/min for 2 minutes to remove excess blebs. 
Second, BHK-liposome solution was drawn into the microchannel at 100 μl/min for 2 
minutes and incubated to induce the rupture of adsorbed blebs. After 10 minutes 
elapsed, more BHK-liposome solution was drawn into the channel at 10 μl/min for 5 
minutes to heal defects in the membrane. Third, the channel was rinsed with buffer A 
at 100 μl/min for 2 minutes to rinse out the excess liposomes. Following the formation 
of the VLSB, SA-liposomes labeled with R18 were then added to the channel and 
incubated for 20 minutes. During this time, the SA-liposomes bound to the HA 
proteins in the supported bilayer. Excess vesicles were rinsed from the channel. To 
activate the HA protein to induce hemifusion, buffer A at pH 4.5 was drawn into the 
channel. Hemifusion of the SA-liposome to the VLSB was indicated by R18 
dequenching and radial diffusion through the bleb membrane away from the point of 
fusion (Fig. 3B).  
The third experiment was a control case of an R18-labeled X-31 influenza virion 
fusing to SA-containing supported lipid bilayer.  The SA-bilayer was formed as 
described above in the first experiment of this series, and fusion initiated in the same 
manner. The hemifusion results for this control case are presented in Fig. 3C. A 
qualitative comparison of the HA-bleb VLP and HA-VLSB results to the native virion 
shows that hemifusion proceeds without much variation among these geometries. 
For a more quantitative comparison among the hemifusion events, the fluorescence 
123 
 
intensity curves plotted to the right of Fig. 3 can be fit with a two-dimensional 
diffusion equation to determine the diffusion coefficient of the R18 fluorophores as 
they move radially away from the fusion site. The equation used to fit the decay in the 
fluorescence intensity data is: 
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where I(t) is the intensity at time, t; I(0) is the intensity value at maximum 
dequenching (the peak intensity in each plot); r is the initial size of the radial spot 
containing the fluorophores (here taken to be 0.85 µm to match the area monitored for 
intensity); and D is the diffusion coefficient. In fitting these data, we chose only the 
portion from the highest part of the dequenching peak to the decay to the background 
level. At the highest intensity of the peak, the curve reflects a transition from 
fluorescence dequenching to the relaxation of fluorescence (decay of fluorescence 
signal) due to only the radial diffusion of the fluorophores away from the fusion site.  
The intensity data was fit with equation 1. D was determined as the value that 
minimized the sum of the square of the error between the data and fit. The results for 
each kind of sample are summarized in Table A2 in the Appendix A. These values are 
averages of the diffusion coefficients obtained from several (at least 4) single particle 
fusion events for each sample type and fall within the range of values obtained from 
the FRAP experiments. This good match confirms that the lipids remain mobile during 
the fusion process and that the VLP and VLSB exhibit similar characteristics during 
hemifusion as the native virion. 
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4.3.6.2. Pore formation 
Membrane hemifusion is directly followed by the formation of a fusion pore, 
where in the native virus, the viral RNA is released into the cytosol of the host cell. To 
show that HA maintained full functionality to induce pore formation after membrane 
hemifusion, the single vesicle fusion experiments carried out for hemifusion were 
repeated here. In this case, the interior compartment was fluorescently labeled instead 
of the membrane. Release of the interior contents and subsequent loss of fluorescence 
indicates pore formation. 
 
Fig. 4. Pore formation between: (A) SRB-labeled HA-bleb VLP and SA-containing supported lipid bilayer; (B) 
SRB-labeled SA-liposome and HA-VLSB, and (C) SRB-labeled native X-31 influenza virus and SA-containing 
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supported lipid bilayer. The initial images are the particles (indicated with the arrow) just before the internal 
fluorophores are release; the second images show the same location after the release of SRB.  The plots to the right 
track the intensity in the local region around the particle during the release. 
 
HA-blebs, sialic acid liposomes, and native virus were labeled with SRB, a water-
soluble dye that intercalates through lipid membranes and partitions into the aqueous 
interiors of liposomes and virions. When the fusion pore opens the SRB is released 
and diffuses away from the fusion site, so a drop in fluorescence indicates when the 
pore formation event occurred. Both the HA-blebs and SA-liposomes dropped in 
fluorescence, indicating pore formation occurred in both these cases (Fig. 4, A-B). For 
comparison, we also ran the control case of the native virion forming a pore with a 
SA-containing supported lipid bilayer, shown in Fig. 4 C.   
The hemifusion and pore formation experiments taken together show that HA 
membrane proteins, in either cell bleb proteoliposomes or embedded in supported 
bilayers, remain fully fusion-competent. There are two important outcomes of these 
results. First, these results illustrate that virus-like particles can be created using a 
straightforward cell blebbing technique. This simple approach to creating virus-like 
particles has several advantages over a prominent strategy that employs VSV virus to 
create pseudovirus particles. Both approaches require that a cell express the viral 
fusion protein of interest in its plasma membrane. In the blebbing approach, the bleb-
inducing buffer is added to the culture and induces proteoliposomes “bud” from the 
cell resulting in virus-like proteoliposomes containing the fusion protein of the virus. 
In the pseudovirus approach, several more intricate infection steps with VSV and 
pseudovirus are required; these steps take about 3 - 4 additional days. Depending on 
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the application, the cell bleb approach may be advantageous for producing virus-like 
particles because of its much simpler procedure. Additionally, it should be possible to 
co-express additional viral coat proteins into the cell bleb to incorporate components 
of the virus as desired (in the case of influenza this might be neuraminidase or the M2 
ion channel). By doing so, a useful research tool emerges that can decouple or isolate 
specific proteins or protein pairs for fundamental fusion studies. An exciting and 
related application for this technique is incorporating other desired proteins in cell 
blebs, in addition to the virus fusion machinery, as an avenue to reconstitute virus-like 
particles with designer functions such as therapeutic protein delivery. These 
applications are currently being undertaken in our laboratory. 
The second important outcome these data illustrate is that functional, virus-like 
planar surfaces can be created from the cell blebs. This geometry may be useful for 
biosensing applications or for high throughput assays designed to quantify pathogen-
host or pathogen-antiviral drug interactions. Additionally, if one can express a 
membrane protein of interest (not necessarily a viral protein) in a cell bleb, this 
technique can be used to incorporate that protein into supported bilayers without 
having to detergent-solubilize the membrane, purify, and reconstitute extracted 
proteins into liposomes. This is a significant advantage for reducing the possibility of: 
1) denaturing proteins and suffering a consequent loss of function, and 2) disrupting 
critical protein-lipid interactions necessary to maintain proper protein activity. This 
method also affords the possibility to create support bilayers that capture much more 
of the complexity of the cell membrane, i.e. the glycocalyx, into a planar format. A 
planar version of the complex plasma membrane architecture can offer new features 
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for many in vitro biological assays and biosensing applications that already use 
standard supported lipid bilayers and biophysical-biochemical analytical techniques 
compatible with these materials.    
 
4.4.  Conclusion 
In this work, membrane fusion-competent virus-like proteoliposomes and 
proteinaceous supported bilayers were made directly from cell plasma membranes 
using a cell blebbing technique. It was demonstrated in both geometries that 
hemagglutinin from X-31 influenza maintained both the ability to bind and fuse to 
sialic acid containing membranes. Analysis of the decay dynamics of the fluorescent 
probe during membrane hemifusion showed that fusion dynamics in the HA-
proteoliposome and HA-supported bilayer are in line with the native virus fusing to 
chemically-similar host membrane mimics. Both the virus-like proteoliposomes and 
proteinaceous supported bilayers could also proceed to full pore formation, illustrating 
that fusion function of the HA is not disrupted by the blebbing technique. The 
spherical or planar geometry of the virus-like membrane has many possible 
applications from fundamental fusion studies and therapeutic delivery to high 
throughput screening of host-pathogen interactions and antiviral drugs.  
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CHAPTER 5 
CHARACTERIZATION OF VIRAL FUSION CHARACTERISTICS USING VSV AND MLV 
PSEUDOTYPES 
 
5.1 Introduction 
Worldwide influenza epidemics, known as pandemics, occur when novel subtypes 
of influenza mutate and infect a population that has no preexisting immunity. 
Pandemics can result in global devastation and millions of deaths worldwide(135). 
Influenza A viruses are subtyped according to the antigenic properties of the 
hemagglutinin (HA) and neuraminidase (NA) glycoproteins. As discussed in previous 
chapters, HA plays a crucial role in determining host tropism, by controlling the 
binding and fusion of the virus to the host cell. NA plays a key role in egress, by 
cleaving the sialic acid-HA linkages that bind newly made viral progenies to the cell 
membrane. HA also contains a cleavage site that must be activated by host cell 
proteases before membrane fusion can take place. There are currently sixteen HA 
subtypes and nine NA subtypes circulating in wild birds and two subtypes circulating 
in humans: H3N2 and H1N1(136). Only three strains are known to have caused 
pandemics in humans, H3N2, H1N1 and H2N2(137, 138) (this strain is not currently 
circulating in humans but caused epidemics between 1957 and 1968).  
   In recent years, highly pathogenic avian influenza (HPAI) has emerged as a 
new global pandemic threat. The first case of HPAI H5N1 was reported in humans in 
1997(120) and since then 562 human cases have been confirmed in 15 countries, with 
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a fatality rate of 59%(139). The biosafety hazard associated with such a highly 
pathogenic virus means that studying the native H5N1 virus is restricted to biosafety 
level 3 facilities, which can limit the type of experiments performed and speed at 
which data can be collected. However, certain aspects of H5N1’s pathogenicity may 
be attributed to the HA protein. It is hypothesized that HPAI H5N1 viruses arose from 
mutations in the HA cleavage site, when a low-pathogenic avian virus jumped from 
wild birds into domestic birds(140). Another important aspect of HPAI H5N1 
infection is host cell receptor type. H5N1 preferentially binds to α-2-3 linked sialic 
acid, which is predominantly found in birds(141, 142). Human sialic acid moieties 
typically have an α-2-6 linked sialic acid. These binding properties make it difficult 
for H5N1 to spread rapidly among humans, like H1N1 did. However, it has been 
shown that α-2-3 linked sialic acids are present in the lower respiratory tract of 
humans and there is a constant threat of mutations in H5N1, which could confer 
preferential binding to α-2-6, linked sialic acids. Thus by studying the envelope 
glycoproteins of highly pathogenic influenza in isolation from the native virus more 
insight into how pandemic strains arise could be gained in safe manner. One, well-
established way of studying viral envelope glycoproteins is to use utilize viral 
pseudotyping.  
 Pseudotyped viruses contain the backbone and genome of one type of virus, 
which propagates readily in cell culture and is safe to work with, and the envelope 
protein of a different virus(143). Vesicular stomatitis virus (VSV) is commonly used 
as the viral backbone as it readily forms pseudotypes with envelope proteins from 
many different viruses(144-146). In 1997, Takada et al(118) developed a VSV- 
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pseudotyping system to study the Ebola Reston virus glycoprotein (ResGP). Using 
techniques developed by Lawson et al(147) and Whelan et al(148) they generated 
recombinant VSV that contained the green fluorescent protein gene (GFP), instead of 
the VSV G protein, which was designated VSVΔG*-GFP. The recombinant viruses 
are non-infectious unless the viral proteins required for binding and fusion are 
supplied by transfection. GFP was used as a fluorescent readout to measure the 
transduction efficiency of VSVΔG*-GFP in cells that were transfected with Ebola 
Reston GP. Upon egress from the transduced cell line, VSVΔG*-GFP budded through 
the plasma membrane, which coated the VSV nucleocapsid with Ebola Reston GP and 
the resultant pseudotyped viruses were designated VSVΔG*-ResGP. By infecting 
Vero cells, Takada et al, demonstrated that Ebola virus GP is sufficient for attachment 
and entry into cells.  
 Gammaretroviruses like murine leukemia virus, MLV, has also been used for 
influenza pseudotyping(149-151). Construction of MLV pseudotypes is achieved by 
introducing a foreign envelope gene, retroviral gag-pol construct and a transfer gene 
into producer cells, typically human embryo kidney (HEK) 293T cells (152). The gag-
pol construct contains two genes that encode the matrix nucleocapsid p7 from gag and 
reverse transcriptase, protease and integrase expressed from pol. The transfer gene 
usually contains GFP or luciferase to measure transduction. MLV-HA pseudotypes 
have been used to develop in cell-based antiviral assays to screen for anti HA and NA 
drug resistance(149). Wang et al constructed retroviral particles pseudotyped with 
high pathogenicity H5 from A/Vietnam/1194/04, with a luciferase reporter gene. 
These pseudoviruses were used in a high-throughput assay to screen for HA inhibitors. 
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Entry of H5 pseudotypes into human lung carcinoma A549 was blocked by α-
2,3SialGal oligosaccharides and also by a newly discovered synthetic peptide 
P7B3(149) 
However there are some drawbacks to using pseudotyped systems to study 
viral entry.  Some viruses acquire a lipid membrane at the endoplasmic reticulum e.g. 
flaviviruses(153) and produce low titers when their envelope proteins are expressed in 
pseudotype producer cells. A second important difference between native viruses and 
their pseudotyped analogues is the density of glycoproteins on the viral surface. The 
density of envelope glycoproteins on the pseudotype surface is difficult to control and 
predict(152). If the protein density is significantly lower, antibodies may more readily 
neutralize the pseudovirus compared to the native virus(152). Finally for VSV based 
pseudotyping, morphology may also impact entry dynamics when compared to the 
live virus. VSV is bullet shaped and there is some evidence that fusion usually occurs 
between the flat end of the virus and the viral membrane (154). In the case of HA-
VSV pseudotypes this could significantly change the energetics associated with 
fusion, since native HA-mediated membrane fusion typically takes between a 
spherical of pleomorphic particle and the endosomal membrane. It is therefore 
important to evaluate entry kinetics of pseudoviruses with a resolution technique, like 
the single virion fusion assay(23, 97). In this chapter we compare the fusion kinetics 
of native influenza X:31 to VSV-H3/X31 and observe that the presence of 
neuraminidase in the viral envelope could impact fusion kinetics. We also evaluate the 
binding and fusion behavior of influenza H2/Japan/57 in pseudotyped form, a strain 
that unfortunately cannot be compared to the native virus. By doing so, new insight 
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into the relationship between receptor binding and fusion of H2 viruses is shown.  
Finally, we show that the MLV pseudotyping system can be used to learn new 
information regarding the cellular entry process of the newly emerged Middle Easter 
respiratory virus (MERS)(155, 156).  
 
  
5.2 Materials and Methods 
5.2.1 Materials 
The following lipids were used in these experiments: 1, 2 dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine (POPC), 
cholesterol, total ganglioside extract (bovine, brain) and total liver extract. These were 
obtained from Avanti Polar Lipids (Alabaster, AL). The fluorescently labeled lipid, 
Oregon green 488 DHPE (Molecular Probes, Eugene, OR), was used to conduct 
fluorescence recovery after photobleaching experiments and to detect the pH drop in 
acidic flow experiments. Biotechnology grade chloroform and methanol for 
preparation of vesicles were purchased from Sigma-Aldrich. Polycarbonate filters 
(Whatman Nucleopore) with pore diameters of 100 nm and 50 nm were used in the 
preparation of vesicles.  Glass coverslips (25 mm x 25 mm; No. 1.5) from VWR were 
used as supports for the bilayers. Sulfuric acid and hydrogen peroxide used to clean 
the glass coverslips were purchased from VWR. Polydimethylsiloxane (PDMS; 
Sylgard 184) used to fabricate microfluidic flow cell devices was purchased from 
Robert McKeown Company (Branchburg, NJ). Sodium chloride salt (NaCl) and (2-
(N-Morpholino) ethanesulfonic acid sodium salt (MES) used to make buffers were 
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purchased from VWR. Influenza X:31 (H3N2) was purchased from Charles River 
Labs (Wilmington, MA). Octadecyl Rhodamine B chloride (R18) and Sulforhodamine 
B (SRB) used to label the virus were purchased from Molecular Probes (Eugene, OR).  
G-25 spin columns used in virus labeling and purification were purchased from GE 
Healthcare. Triton-X (J.T. Baker) detergent used in virus labeling optimization was 
purchased from VWR. 
Rhodamine 110 chloride and 1-octadecanol were purchased from Sigma Aldrich 
for the synthesis of the Rhodamine 110 octadecyl ester (R110C18). The concentrated 
sulfuric acid used to start the synthesis reaction was purchased from VWR and the 
triethylamine used to stop the reaction was purchased from Acros Organics. Silica Gel 
60 (63-200 µm particle diameter) was purchased from EMD and Neutral Alumina (50-
200 µm particle diameter) was purchased from Dynamic Adsorbents, Inc.) in order to 
purify the dye product using column chromatography. Isopropanol, chloroform, and 
methanol were all purchased from VWR to make the elution solvents.  
 
5.2.2 Surface Preparation  
Glass microscope coverslips (25 mm x 25 mm; No. 1.5) were cleaned in piranha 
solution (70% sulfuric acid, 30% hydrogen peroxide). Slides were immersed in 150 ml 
of piranha solution for ten minutes. The slides were subsequently rinsed for 30 
minutes with copious amounts of deionized water with a minimum resistance of 18.2 
MΩ⋅cm obtained from a Siemens Purelab Ultra water purification system. Clean slides 
were stored under deionized water, then dried with a stream of ultra pure nitrogen gas 
prior to use.  
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5.2.3 Microfluidic Device Fabrication 
Microfluidic devices for the fusion experiments were fabricated as described in 
previous chapters.  
 
5.2.4 Synthesis of R110C18 
For experiments examining just the hemifusion step, R110C18, a green-emitting 
fluorophore, was used. R110C18 was synthesized following the procedure in Floyd et 
al(21, 157).  
 
5.2.5 Cells and plasmids 
Baby hamster kidney-21 (BHK-21) and madine darby canine kidney (MDCK) cells, 
obtained from the American Type Culture Collection (ATCC, Manassas, VA), were 
grown and maintained in Dulbecco’s modified Eagle medium (DMEM, CellGro) 
supplemented with 10% fetal bovine serum (Gibco), 100 U/ml penicillin and 
streptomycin and 10% HEPES.  
The following plasmids were used: pCAGGS-H3/X31, pCDNA3-H2/Japan/1957, 
pCAGGS-VSVG, pCAGGS-N2/MS96 encoding the influenza hemagglutinin HA X-
31, influenza hemagglutinin H2/Japan/1962, vesicular stomatitis virus G protein and 
influenza neuraminidase MS96 respectively. pCAGGS-H3/X31 was a generous gift 
from David Steinhauer. The pCAGGS vector was used as an empty vector control. 
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5.2.6 Preparation of VSV pseudoparticles  
BHK-21 cells were transfected with pCAGGS-H3/X31, pCAGGS-H2/Japan/1962, 
pCAGGS-VSVG or pCAGGS by using TurboFect (Invitrogen). 24 hours after 
transfection cells were infected with VSVDG*-G. Cells were incubated with rocking 
at 37oC, 5% CO2 for 2 hours to facilitate virus adsorption and entry. Cell were washed 
three times with DPBS and incubated in DMEM for 24 hours at 37oC, 5%CO2. 
Transduction of BHK-21 cells with VSVDG*-G was confirmed by the observation of 
GFP expression using a Zeiss inverted microscope. Cell supernatant was collected and 
cell debris was cleared by centrifugation at 3000RPM for 10 minutes at 4oC. Virus 
stock was then stored at -80oC.  
 
5.2.7 Infection of MDCK cells with influenza VSV pseudoviruses 
MDCK cells were grown seeded at a density of 6 x 104 cells/ml in 24 well plates. 
VSV pseudoviruses containing hemagglutinin were treated with TPCK-treated trypsin 
at 2µg/ml and incubated at 37oC for 15 minutes. Trypsin inhibitor was then incubated 
with the virus for at least 5 minutes.  
 
5.2.8 Lipid Vesicle Preparation 
The following lipids were used in these experiments: 1, 2 dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine (POPC), 
cholesterol, and total ganglioside extract (bovine, brain). Lipid vesicles were prepared 
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using a molar ratio of 4:4:2:0.5.01 of DOPC, POPC, cholesterol, total ganglioside 
extract and Oregon green DHPE. Liposomes were prepared using the same techniques 
described in previous chapters  
 
5.2.9 Virus Membrane Labeling and Purification 
 To fluorescently label the viral pseudotype membranes, 20 µL of virus and 3.5 µL of 
R110C18 were added to 250µL of buffer A. The mixture was sonicated gently in a 
water bath for one hour. Free R110C8, which did not insert into the viral membrane, 
was removed from labeled virus using a G-25 spin column for two minutes in a 
centrifuge (Eppendorf, Centrifuge 5451C, Hauppauge, NY) at rate of 3x1000 min-1. 
The supernatant containing the purified virus was diluted with 600µL of buffer A and 
gently vortexed to mix the virus and buffer.  
 
5.2.10 Marking the Onset of Hemifusion by Fluorescence Dequenching 
 In this assay, membrane hemifusion events are detected by the dequenching of a 
fluorescent membrane probe R110C18 located in the viral membrane. In this example, 
VSV-H3N2 was incubated with R110C18, until enough R110C18 partitioned into the 
viral membrane so that neighboring fluorophores quench each other, as described in 
the virus labeling procedure above. During fusion, when the outer monolayers of the 
viral and supported membranes mix, the fluorophore gets diluted and a sharp increase 
(spike) in fluorescence (dequenching) is observed as shown in Figure S2. Following 
the ‘spike’ in fluorescence, the fluorescent probe diffuses away from the hemifusion 
site, thus indicating that these are true fusion events and the fluorescence increase, 
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which marks the onset of hemifusion, and is not a result of a viral particle changing its 
position in the evanescent field.  
 
5.3 Results & Discussion 
5.3.1 Production of H3 and H2 VSV-pseudotypes  
VSV pseudotypes were produced according to procedures designed in the Whittaker 
lab. In this study we investigated the effect of producing HA-VSV pseudotypes with 
and without endogenous neuraminidase (NA). We produced 6 different types of HA-
VSV pseudotypes, VSV-H3/X31, VSV-H2/Japan, VSV-H3X31/N2MS96, VSV-
H3X31/N1ACal09, VSV-H2Japan/N2MS96 and VSV-H2Japan/N1ACal09, which 
shall be hereafter referred to as VSV-H3, VSV-H2, VSV-H3N2, VSV-H3N1, VSV-
H2N2 and VSV-H2N1 respectively. To produce pseudotyped viruses, BHKmw cells 
were transfected with the appropriate DNA plasmids for the membrane protein to be 
expressed or co-expressed in the BHKmw plasma membrane. Transfected cells were 
then transduced with a recombinant VSV supplied by the Whittaker lab, 
VSVΔG/GFP-G*. The recombinant virus contains the gene for GFP instead of the 
VSV G fusion protein and GFP expression is used as a fluorescent readout for 
successful cell infection with recombinant virus. VSVΔG/GFP is replicated within the 
cells and upon egress through the plasma membrane, pseudotyped viruses are formed 
because the viral membrane envelope contains the heterologous membrane proteins 
HA and NA (figure 1). MDCK cells, which contain receptors for influenza, are 
infected with pseudotyped viruses and GFP expression indicates successful infection 
as shown in figure 2. The highest levels of fluorescence were obtained in cells infected 
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with H3N2 and H2N2. VSV-G and VSV-Δenv pseudotypes were produced as positive 
and negative controls (figure 2). Cells infected with VSV-Δenv exhibited almost no 
fluorescence, while VSV-G showed high levels of infection, which is typical for VSV 
infection in MDCK cells.   
 
 
 
Figure 1. Schematic representation of vesicular stomatitis virus (VSV) pseudotyping. BHKmw cells are 
transfected with heterologous HA and NA proteins and infected with the recombinant VSV virus, VSVΔG*-
GFP. Successful transducion of BHKmw cells results in expression of GFP gene encoded in the VSV genome. 
HA/NA proteins are acquired by VSV as it buds from the BHKmw cells to prodcue VSV-HA/NA. MDCK 
cells are infected with VSV-HA/NA and GFP expression indicates successful pseudotyping with HA protein. 
 
5.3.2 Single particle kinetic measurements of pseudotype VSV-H3N2 fusion to 
supported lipid bilayers 
 Influenza HA binds to sialic acid residues on the plasma membrane and 
triggers the uptake of the virus into the cell via clathrin-mediated endocytosis. Inside 
the endosome, the HA undergoes a conformational change at acidic pH’s and induces 
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fusion of the viral and endosomal membranes and viral RNA is released. Fusion is a 
multistep process involving hemifusion (merging of the outer lipid monolayers of the 
viral and endosomal membrane) and pore formation (the formation of pore in the 
merged membranes that facilitates the release of RNA).  We used total internal 
reflection microscopy (TIRFM) to visualize the binding, hemifusion individual 
pseudotyped virions to supported lipid bilayers in microfluidic channels. To visualize 
hemifusion, virions were incubated with a quenched concentration of the lipophilic 
dye, R110C18, which inserts into the viral membrane. Excess dye that did not insert 
into the membrane was removed in a size exclusion column. Prior to labeling with 
R110C18, pseudoviruses were treated with TPCK-trypsin for 15 minutes in order to 
cleave the precursor HA0 into HA1 and HA2, which is essential for membrane fusion. 
The virus solution is then drawn into a microfluidic channel coated with a supported 
lipid bilayer containing a mixture of DOPC, POPC, cholesterol and 5 mol% total 
ganglioside extract, which contains the sialic acid receptor.  Fusion is triggered by 
buffer exchange with low pH buffer in the channel and the time at which acidification 
is indicated by a drop in fluorescence of a pH sensitive fluorophores (Oregon green 
DHPE) in the bilayer. Hemifusion is marked by a sharp increase in fluorescence as the 
dye from the viral membrane mixes with the supported bilayer and diffuses radially 
away from the site of hemifusion. The hemifusion lag time (t) is defined as the time 
elapsed between acidification and the 
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 Figure 2. Infection of MDCK cells with VSV-pseudotypes. The level of GFP expression in MDCK cells is 
indicative of successful infection. Panel A) shows postive and negative control experiments, N.I. cells were 
not infected, Δenv particles contain no heterologous membrane protein and VSV-G shows high expression of 
GFP due to recombinant of the pseudotype virus with G protein. Dynamic light scattering (DLS) results 
show the size distributions of particles obtained from each supernatant. Panel B) depicts infection with 3 
pseudotypes of H2/Japan/1952 either treated with exogenous neuraminidase (NA) or co-transfected with 
plasmids for N1/ACal/09 or N2/MS96 and the respective DLS results. Panel C) is the same as panel B except 
the H2/Japan/1957 plasmid has been switched for H3/X31 
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peak of the hemifusion traces shown in figure 3. This lag time is collected for each 
fusing virus in the field of view and plotted as a cumulative distribution (figure 3D) as 
a function of time.  This distribution is described by the gamma distribution: 
       (1) 
where kH is the hemifusion rate constant and N is the number of HA proteins required 
for hemifusion (figure 3). The gamma distribution is used as fusion events occur 
stochastically and independent of each other. Each fusion event is a multistep process, 
with each step in the process being described by a Poisson distribution. The gamma  
distribution is thus a convolution of a multistep Poisson process. Fusion experiments 
were monitored for 3-4 minutes at rate of 10 frames per second.  
 The kinetic parameters kH and N, were determined for VSV-H3N2 fusion for 
pH values ranging from 5.1 to 4 (figure 3). As shown in figure 3, the rate of fusion of 
VSV-H3N2 is significantly slower than native X:31 ( data from chapter 2) at each pH 
€ 
pH =
kHN tN −1
Γ(N) e
−kH tdt
0
t
∫
0.01 
0.10 
1.00 
3.5 4.0 4.5 5.0 5.5 
VSV-H3N2 
X:31 (H3N2)  
0.00 
1.00 
2.00 
3.00 
4.00 
3.5 4.0 4.5 5.0 5.5 
VSV-H3N2 
X:31 (H3N2)  
H
em
ifu
si
on
 ra
te
 c
on
st
an
t (
k H
) (
s-
1 )
 
N
um
be
r o
f H
A 
Tr
im
er
s 
pH pH 
Figure 4 compares the hemifusion rate constants and number of HA trimers, determined from the gamma 
distribution, as a function of pH for native X:31 (black open circles) and pseudotypes VSV-H3N2 (green open 
cirlces). 	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value. At pH 4.7, the maximum kH value for X:31, VSV-H3N2 is an order of 
magnitude slower than H3N2/X:31. As previously discussed in chapter 2, the 
hemifusion kinetics of X:31 are strongly dependent on pH. The rate of hemifusion 
increases almost linearly at from pH 5.3 to 4.7 and plateaus at the ‘optimal’ fusion pH. 
It is not evident from the data shown in figure 3 that VSV-H3N2 exhibits the same 
dependence on pH. While the maximum rate of fusion of VSV-H3N2 also occurs at 
pH 4.7, the error associated with the parameter falls within the rate constants values 
associated with the adjacent pHs, thus it can be concluded that the fusion of VSV-
H3N2 is independent of pH.  
 The number of HA trimers (N) required for VSV-H3N2 fusion was also 
calculated and compared to native X:31 (figure 3). At high, physiological pH values, 
N for X:31 is found to be approximately 3. Our fusion data shows that for VSV-
H3N2, N is consistently close to unity as a function of pH. This suggests that only one 
HA trimer is required for fusion in this VSV pseudotyped system. However, since 
hemifusion is a multi-step process, an N value equal to 1 could indicate that one step 
in hemifusion process e.g. the conformational change of HA, may occur so slowly that 
kinetics are dominated by this single steps, thus resulting in a gamma distribution 
where N=1.  
There are several possibilities for the reduction fusion rates of VSV-H3N2.  It 
is possible the bullet shaped morphology of VSV is responsible for the reduction in kH 
and N for VSV-H3N2. It has been suggested that VSV fuses to membranes at the flat 
end of the ‘bullet’(158). Native X:31 is spherical to pleiomorphic in shape. Thus the 
energy required to mediate fusion between two almost planar membranes may be 
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markedly higher than for VSV pseudotypes than the native virus. Hemifusion could 
therefore be limited by the timescale for a sufficient number of HA trimers to undergo 
conformational changes and induce fusion. A second possibility is that the density of 
HA trimers on the surface of VSV-H3N2 is markedly reduced compared to native 
influenza viruses and this may have a profound effect on the hemifusion kinetics of 
influenza-VSV pseudotypes. While VSV is less selective than MLV pseudotypes 
when acquiring membrane proteins during egress, it is still very difficult to quantify 
the level of HA coverage on the VSV surface. The density of HA on native influenza 
has been shown to be vital for membrane fusion(14, 54, 159). We chose to co-transfect 
with NA to improve virus yield but it has also been suggested that NA helps in the 
trafficking of HA from the Golgi to the plasma membrane. In these experiments we 
co-expressed N2/MS96 with H3/X31. This combination of HA and NA resulted in the 
highest MDCK infection efficiency, however the mismatch between these proteins 
could play a role in the observed fusion kinetics. A more accurate VSV-pseudotype of 
X:31 requires co-expression of N2/X31 with H3/X31. This work is currently ongoing 
on in our lab.  
 
5.3.3 Fusion of VSV-H2N2 to total liver extract supported bilayers 
 In the previously described pseudotype production, we produced VSV-H2N2 
pseudoviruses. The HA protein for these pseudoviruses was originally cloned from 
influenza A/H2N2/Japan/305/57. These experiments describe the first single virion 
kinetic analysis of hemifusion mediated by the H2 protein. Influenza 
A/H3N2/Japan/305/57 is a biosafety level 3 virus, thus we cannot compare the kinetics 
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to those of the native strain. However, the kinetics of fusion mediated by H2 rather 
than H3 may be analyzed by comparing VSV-H2N2 to VSV-H3N2, which 
demonstrates the utility of viral pseudotyping systems.  Fusion experiments involving 
VSV-H2N2 were set up as described in the previous section.  As show in figure 2, 
VSV-H2N2 showed the highest level of GFP expression upon inoculation in MDCK 
cells. However, fusion of VSV-H2N2 with DOPC, POPC, cholesterol and 5 mol% 
total ganglioside extract (TGE), supported bilayers was unsuccessful. As show in 
figure 5, binding of VSV-H2N2 was observed but upon buffer exchange with low pH 
buffer almost no fusion events occurred. The predominant species in total ganglioside 
extract is monosialoganglioside (GM1), with an avian type, α (2,3) sialic acid-
galactose linkage. Previous work by Suzuki et al(160), showed that native 
A/H2N2/Japan/305/57 bound preferentially to α (2,6) sialic acid-sugar linkages.  It is 
difficult to commercially procure purified α (2,6) sialic acid ganglioside for 
incorporation into supported bilayers. In order to more closely mimic an environment 
where α (2,6) sialic acids may be present, we decided to use bovine total liver extract 
(TLE) that is commercially available from Avanti polar lipids.  
 The exact composition of TLE is unknown. The approximate composition of is 
42% phosphatidylcholine (PC), 22% phosphatidylethanolamine (PE), 8% 
phosphatidylinositide (PI), 1%Lyso PI, 7% cholesterol and 20% unknown lipids. We 
hypothesized that these unknown lipids may contain gangliosides containing α(2,6)  
and α(2,3) sialic acids. As described in previous chapters, lipid mobility on the glass 
substrate is essential for fusion to occur. We first tested the mobility of pure TLE in a  
microfluidic channel using standard fluorescence recovery after photobleaching  
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(FRAP) methods (108). Unfortunately we could not form consistently mobile and 
contiguous bilayers using pure TLE. Using the same method described in chapter 3 for 
making cell bleb bilayers, we diluted the TLE lipids and adsorbed the vesicles to the 
glass substrate. Using a similar strategy described in chapter 4(46), BHK lipids devoid 
of gangliosides were then flown into the channel and incubated for at least 4 hours to 
obtain mobile, contiguous supported lipids bilayers. The diffusion coefficient for the 
TLE/BHK mixture was determined using FRAP to be approximately 0.25µm2/s.  
 Next we performed VSV-H2N2 fusion experiments as previously described 
using TLE/BHK supported bilayers. Due to the quenched state of the virions upon 
binding, it was difficult to quantify if binding had been significantly enhanced. 
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Figure 5. Fluorescence recovery after photobleaching (FRAP)  of total ganglioside extract (TGE) and total 
liver extract supported lipid bilayers, characterized in microfluidic channels described in the methods 
section.  
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However upon the low pH trigger, VSV-H2N2 underwent the typical hemifusion 
reaction as shown in figure 4. In the same microfluidic device in different channels, it 
was found on separate days that while VSV-H2N2 could bind to bilayers containing 
TGE but could never fuse, while in the same device the virus could bind and fuse to 
TLE/BHK bilayers. Hemifusion kinetics were determined for VSV-H2N2 as previous 
described using a gamma distribution (figure 5). Despite the low mobility of TLE 
compared to TGE, hemifusion of VSV-H2N2 occurred at a rate comparable to native 
X:31 fusing to TGE lipids. However unlike native X:31 and VSV-H3N2, almost no 
hemifusion activity was observed above pH 5.  
 These results display the utility of using single virion fusion assays to examine 
viral entry. This data represents the first individual virion visualization of membrane 
fusion mediate by a H2 serotype. However, the observation that VSV-H2N2 fusion is 
dependent on the composition of the lipid bilayer is striking. VSV-H2N2 can bind to 
TGE bilayers but upon acidification the virions almost never undergo hemifusion, in 
stark contrast to experiments performed on TLE bilayers. Although LCMS must be 
carried out to determine the sialic acid composition of TLE, this data still reveals 
important information about H2N2 entry into cells. The requirement of HA-sialic acid 
binding for fusion has long been a source of debate for virologists. Work carried out 
using bulk assays to determine the effect of receptors on fusion indicated that HA-
sialic acid binding actually impeded fusion(55). However both experiments described 
in this chapter and previous work by Niles et al(62) indicate that receptor binding is 
indeed essential for genome release. This data extends this observation by showing 
that although binding can occur between H2N2 and α(2,3) sialic acids, fusion will 
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almost never occur even upon triggering with low pH, unless bound to a specific sialic 
acid or unknown ganglioside or lipid found in TLE bilayers. This highlights the 
importance of using techniques to distinguish between binding and fusion, as this data 
shows successful binding does not guarantee successful genome release.  
 
 
Figure 5 Fusion kinetics of VSV-H2N2 pseudotype viruses. A) Dequenching of R110C18 in the VSV-H2N2 in 
the lipid envelope upon lipid mixing with the target supported lipid bilayer (red line -TLE, blue trace – 
TGE). B) TIRFM images of VSV-H2N2 fusion to TLE (red) and TGE (blue) lipid bilayers. C) Hemifusion 
rate constant and number of H2 trimers required for hemifusion as  function of pH determined from the 
gamma distribution.  
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5.3.4 Preliminary MLV-Pseudotyping fusion assay 
One of key advantages of using viral pseudotypes is the ability to study the 
entry kinetics of highly pathogenic viruses with reduced risk of exposure to the 
pathogen. In the Whittaker laboratory at Cornell, pseudotyped MERS viruses were 
produced using retroviral pseudotyping. 293T cells were transfected with murine 
leukemia virus structural (gag), enzymatic (pol) genes, GFP and the spike gene (S) 
from MERS virus (figure 6). Mature retroviral particles containing MERS S protein in 
the lipid envelope were harvested from the supernatant. The receptor for MERS virus 
was recently identified to be dipeptidyl peptidase 4 (DPP4)(39). As described 
previously for coronavirus fusion(23), we utilized our cell blebbing method to 
integrate DPP4 into a  supported lipid bilayer in our microfluidic platform for 
investigating viral fusion. MLV-MERS was treated with TPCK-trypsin to cleave the S 
protein. The virus was then labeled as previously described with R110C18. MLV-
MERS did not bind or fuse to membranes devoid of DPP4. Unlike FECV-1683, MLV-
MERS did not fuse upon binding at pH 7. Fusion was only triggered upon exposure to 
low pH.   At pH 4.7, kH and N were determined to be 0.03s-1 and 0.8 respectively. This 
preliminary work highlights the importance of integrating high resolution microscopy 
techniques and viral pseudotyping to study emerging viral pandemics.   
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Figure 6 Murine leukemia virus (MLV) retroviral pseudotyping of MERS S protein. A) Schematic of MLV 
pseudotyping in HEK 293T cells. Cells are transfected with DNA coding for MLV gag and pol genes, green 
fluorescent protein (GFP) and the MERS S protein and MLV-MERS viruses are collected from the cell 
supernatant and titrated against  Vero E6 cells) Cumulative distribution function depicting hemifusion 
frequency of MLV-MERS to supported bilayers containing human DPP4 protein at pH 4.5, fit with a 
gamma distribution. kH and N were determined to be 0.03s-1 and 0.8 respectively. B) also shows TIRFM 
image series of MLV-MERS hemifusion to the aforementioned supported lipid bilayer at pH 4.5.  
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CHAPTER 6 
CONCLUSIONS & OUTLOOK 
 
This thesis has presented several advancements to methods of studying membrane-
enveloped virus host interactions. Single particle tracking techniques (SPT) offer new 
insight into the mechanisms that govern how viruses enter cells and cause local or 
systemic infection. This work provides solutions to the drawbacks associated with 
current techniques and extends their applications to study a potentially wide range of 
membrane-enveloped viruses.  
 By integrating a novel proton uncaging technique into the previously described 
fusion assays(21), we have addressed inherent difficulties associated with using acidic 
hydrodynamic buffer exchange as a method to trigger pH dependent membrane fusion 
of influenza viruses. Employing this method, we found that optimal number of HA 
trimers required for fusion could be 1 or 2, which is less than previously determined 
using experimental techniques. From a practical standpoint, this work demonstrates 
the importance of techniques with high temporal resolution when monitoring fusion 
reactions with millisecond timescales. This novel proton uncaging technique could 
thus be extended to study the fusion of other membrane-enveloped viruses and other 
protein mediated fusion processes such as snare-mediated fusion.  Another significant 
advantage of using this quiescent method of initiating membrane fusion is that now 
both virus binding and fusion can be observed for a single virus, in one combined 
assay. This option was not feasible using acid buffer exchange, as the shear force 
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generated washes many bound and unbound virions out of the field of view making 
combined binding and fusion analysis impossible.  
 One of the biggest limitations with using SPT assays to study virus fusion is 
the narrow range of viruses that can be studied. This thesis presents a method of 
extending SPT assays beyond influenza A, vesicular stomatitis virus and Sindbis virus 
(all viruses that bind glycolipids) to viruses that bind proteinaceous receptors(23).  
Using cell-blebs to create supported lipid bilayers that contain functional, 
enzymatically proteinaceous receptors, the first single virion fusion measurements of 
coronavirus were obtained. The ability to monitor binding and fusion with 
unprecedented detail revealed that the fusion of feline coronavirus (FCoV) requires a 
low pH, but unlike other class 1 fusion proteins like HA, the rate of conformational 
change of the spike protein S, is independent of proton concentration. This technique 
provides a new way to investigate and control the sequence of proteolytic cleavage of 
spike, binding and fusion, which could provide insight into how zoonotic viruses adapt 
to new hosts. In the future, the role of receptor co-factors in viral entry could also be 
investigated.  By co-expressing both the viral protein receptor and a putative 
proteinaceous co-factors in cell blebs, the effect of these co-factors on entry or host 
tropism can be investigated in-vitro. One example where this would be beneficial is in 
studying HIV entry. The HIV fusion protein, gp160, interacts with the CD4 protein on 
the cell surface and a variety chemokine receptors also expressed on the cell surface 
(typically CCR5 or CXCR4)(161, 162). By selectively deleting certain species from 
the membrane, one could assess their impact on efficiency of HIV fusion. 
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Identification of new co-factors in HIV infection could lead to the development of new 
antiviral drugs.  
 Another important result outlined in this thesis, is the development of new 
tools to study highly pathogenic viruses with minimized safety concerns. RNA free 
virus-like proteoliposomes (VLPs)(46) are a simple system for examining the fusion 
kinetics of a range of dangerous pathogens, that naturally extended from our blebbing 
procedures developed here. VLPs are also versatile because they can be used to form 
virus-like supported bilayers (VLSBs), as demonstrated with HA protein. HA was 
shown to be capable of undergoing a pH triggered even when embedded in a 
supported bilayer.  VLSBs thus have potential applications in high-throughput 
screening of small molecule antivirals or antibody therapies.  
 This research also presents the first single virion analysis of viral pseudotype 
fusion. VSV and MLVs are also useful and commonly used tools for studying the 
fusion proteins of highly pathogenic viruses. Until now, there have been no direct 
comparisons of the fusion activity of a native virus with its pseudotyped counterpart. 
This work highlights the importance of using high-resolution techniques to probe entry 
mechanisms of these proxy particles. While VSV-X31 underwent hemifusion in the 
same manner as native X:31, the kinetics were markedly different. This result calls 
into question the importance of neuraminidase in the fusion process, which has been 
previously unexplored. Future work on this project could involve co-expressing 
different combinations of HA and NA in VSV pseudotypes and comparing infection 
and fusion efficiency. Finally, by combining the method of embedding proteinaceous 
receptors in supported lipid bilayers and viral pseudotyping the first fusion events 
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mediated by MERS spike proteins were observed. This work highlights the multiple 
improvements made to SPT virus fusion assays and opens this technique to have a 
broader impact on how virus-host interactions are studied and the speed at which 
emerging pandemic strains may be characterized.   
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Appendix A 
 
 
Materials. The following lipids were used in these experiments: 1, 2 dioleoyl-sn-
glycero-3-phosphocholine (DOPC), 1-oleoyl-2-palmitoyl-sn-glycero-3-
phosphocholine (POPC), cholesterol, and total ganglioside extract (bovine, brain). 
These were obtained from Avanti Polar Lipids (Alabaster, AL). The fluorescently 
labeled lipid, Oregon green 488 DHPE (Molecular Probes, Eugene, OR), was used to 
conduct fluorescence recovery after photobleaching experiments and to detect the pH 
drop in acidic flow experiments. Biotechnology grade chloroform and methanol for 
preparation of vesicles were purchased from Sigma-Aldrich. Polycarbonate filters 
(Whatman Nucleopore) with pore diameters of 100 nm and 50 nm were used in the 
preparation of vesicles.  Glass coverslips (25 mm x 25 mm; No. 1.5) from VWR were 
used as supports for the bilayers. Sulfuric acid and hydrogen peroxide used to clean 
the glass coverslips were purchased from VWR. Polydimethylsiloxane (PDMS; 
Sylgard 184) used to fabricate microfluidic flow cell devices was purchased from 
Robert McKeown Company (Branchburg, NJ). Sodium chloride salt (NaCl) and (2-
(N-Morpholino) ethanesulfonic acid sodium salt (MES) used to make buffers were 
purchased from VWR. o-nitrobenzaldehdye (o-NBA) was purchased from Sigma 
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Aldrich. Influenza X:31 (H3N2) was purchased from Charles River Labs 
(Wilmington, MA). Octadecyl Rhodamine B chloride (R18) and Sulforhodamine B 
(SRB) used to label the virus were purchased from Molecular Probes (Eugene, OR).  
G-25 spin columns used in virus labeling and purification were purchased from GE 
Healthcare. Triton-X (J.T. Baker) detergent used in virus labeling optimization was 
purchased from VWR. 
Rhodamine 110 chloride and 1-octadecanol were purchased from Sigma Aldrich 
for the synthesis of the Rhodamine 110 octadecyl ester (R110C18). The concentrated 
sulfuric acid used to start the synthesis reaction was purchased from VWR and the 
triethylamine used to stop the reaction was purchased from Acros Organics. Silica Gel 
60 (63-200 μm particle diameter) was purchased from EMD and Neutral Alumina (50-
200 μm particle diameter) was purchased from Dynamic Adsorbents, Inc.) In order to 
purify the dye product using column chromatography. Isopropanol, chloroform, and 
methanol were all purchased from VWR to make the elution solvents.  
For the Oregon Green C dot preparation, Oregon Green 488 maleimide was 
purchased from Molecular Probes (Eugene, OR). Silane for conjugation, 3-
mercaptopropyltrimethoxy silane (MPTMS), was purchased from Gelest (Morrisville, 
PA). Tetraethyl orthosilicate (TEOS) and 2 M ammonia in ethanol were purchased 
from Sigma Aldrich. Particles were dialyzed using a 3500 molecular weight cut-off 
(MWCO) SnakeSkin Dialysis Tubing purchased from Thermo Scientific (Rockford, 
IL). The C dots were densified using a 20 mL reaction vial with a Teflon faced septa 
lid from Chemglass (Vineland, NJ). 
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Buffer Preparation. Sodium chloride salt (NaCl) and (2-(N-Morpholino) 
ethanesulfonic acid sodium salt (MES), citric acid, o-NBA, and o-nitrosobenzoic 
anion (o-NSA-) were used to make buffer solutions according to the formulations in 
Table S1. o-NSA- is the post-irradiated product of the photoisomerization reaction of 
o-NBA. The pHs of each solution are indicated within the text where appropriate. 
 
 
 
Table A1. Buffer Formulations 
 
NaCl 
(mM) 
MES 
(mM) 
Citric 
Acid 
(mM) 
o-NBA 
(mM) 
o-NSA- 
(mM) 
Buffer A 150 1.5 5 0 0 
Buffer B 150 1.25 0 10, 12, 14 0 
Buffer C 0 1.25 0 0 0 
Buffer D 150 1.25 0 0 12 
Buffer E 150 1.25 0 0 0 
 
Note that for buffer B, the concentration of o-NBA was 10, 12, or 14 mM, with all 
other components constant. Varying o-NBA concentration allowed us to control the 
post-irradiated pH, as described in the text. Various concentrations of o-NBA buffer 
could be made by dissolving the appropriate amount of o-NBA in 50 ml of Buffer B 
initially at pH 7.0. For example, to create a 12 mM solution (used here for some of the 
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proton uncaging experiments), 0.0906 g of o-NBA was required. The solution was 
heated to 98oC and then cooled gradually to room temperature. Solutions were 
prepared in a darkened room to prevent any stray light from irradiating the solution, 
partially uncaging protons, and consequently dropping the pH of the buffer solution. 
The solution was stored at room temperature in the dark and used within three days of 
preparation. The pH was checked prior to use to ensure that no degradation had taken 
place.  
Surface Preparation. Glass microscope coverslips were cleaned in piranha 
solution (70% sulfuric acid, 30% hydrogen peroxide). Slides were immersed in 150 ml 
of piranha solution for ten minutes. The slides were subsequently rinsed for 30 
minutes with copious amounts of deionized water with a minimum resistance of 18.2 
MΩ⋅cm obtained from a Siemens Purelab Ultra water purification system. Clean slides 
were stored under deionized water, then dried with a stream of ultra pure nitrogen gas 
prior to use.  
Microfluidic Device Fabrication. Microfluidic devices for the fusion experiments 
were fabricated using soft lithography. The microchannel pattern was designed using 
the CAD software program L-Edit (Tanner EDA) and a master of the flow pattern was 
made on a silicon wafer at Cornell Nanoscale Science and Technology Facility (CNF). 
Each microfluidic device contained six channels. The dimensions of each channel are 
1 mm wide by 70 µm deep with a total length of the channel of 1.5 cm.  The spacing 
between the centers of each channel is 1 mm. The silicon wafer was coated with P-20 
primer in a spin coater, followed by SPR220 (Megaposit) photo-resist. The wafer was 
baked for 90 seconds at 115oC and then exposed to UV light for 7.5 seconds in an 
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ABM contact aligner to pattern the wafer with the flow cell design. Following this 
step, the wafer was baked again for 90 seconds at 115oC and then developed for 60 
seconds in a Hamatech-Steag Wafer Processor. The pattern was then etched into the 
wafer using a Unaxis 770 Deep Si Etcher. The depth of the channel was determined 
using a Tencor P10 Profilometer.  
Microfluidic devices were formed using PDMS in a molding process. To facilitate 
the release of the cured PDMS after molding on the etched silicon master, the master 
slide was first coated with Sigmacote (Sigma). A 10:1 (elastomer/crosslinker) mixture 
of Sylgard 184 was mixed and then degassed before pouring on the silicon master 
slide etched with the flow cell pattern. The PDMS was then baked for 3 hours at 80oC. 
After baking, PDMS microfluidic devices were peeled off of the wafer, and inlet and 
exit ports were punched in each channel of the device.  Both the clean glass coverslip 
and PDMS mold were treated with oxygen plasma using a Harrick Plasma Cleaner 
(Model # PDC-32G, Ithaca, NY) at a pressure of 750 µm on the high setting for 25 
seconds.  Gently pressing the surfaces together resulted in a tight bond between the 
glass and PDMS and formed the four walls of the microfluidic channel. 
Lipid Vesicle Preparation. The following lipids were used in these experiments: 
1, 2 dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-oleoyl-2-palmitoyl-sn-glycero-
3-phosphocholine (POPC), cholesterol, and total ganglioside extract (bovine, brain). 
Lipid vesicles were prepared using a molar ratio of 4:4:2:0.5 of DOPC, POPC, 
cholesterol and total ganglioside extract. For diffusion measurements and acidic flow 
experiments, 0.01 mol% Oregon Green DHPE was also added to the bilayer 
formulation. Cholesterol was dissolved in biotechnology grade chloroform and total 
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ganglioside extract was dissolved in a 2:1 mixture of biotechnology grade 
chloroform/methanol. Lipids were thoroughly mixed in a scintillation vial and then the 
solvent was removed under a stream of high purity nitrogen gas. To ensure all solvent 
was removed, the vial was placed in a desiccator under vacuum for an additional 2.5 to 
3 hours. 6 ml of Buffer A at pH 7.0 was then added to the dried lipid film and 
resuspended gently in a sonication bath (Model # BD2500A-DTH, VWR) for twenty 
minutes on the lowest setting. The final lipid concentration was approximately 8.3 
mg/ml. Liposomes were then extruded twice through a polycarbonate filter with pore 
size 100 nm, and five times through a filter with a pore size of 50 nm.   
Lipid Vesicle Characterization: Size and Zeta Potential. The average liposome 
diameter was determined by dynamic light scattering using a Malvern Zetasizer Nano 
(Worcestershire, UK) and ranged between 90 and 100 nm in diameter. To ensure that 
the cage compounds did not interfere with the surface charge of the bilayer and 
possibly alter the electrostatic interactions between the virus and supported bilayer, we 
measured the zeta potential of the vesicles and virus under various conditions (Table 
S2). We found that there is little difference in the zeta potentials of either the virus or 
the vesicle in the presence of o-NBA or its post-irradiated analog, o-NSA-, compared 
to the base case in plain buffer conducted at the same pH. 
 
Table A2. Zeta Potential Measurements of Lipid Vesicles and Virus 
in Various Buffer Environments 
Vesicle/Environment pH Zeta Potential (mV) 
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Vesicles in buffer E 7 -10.8 ± 0.3 
Vesicle in Buffer E 5.2 -10.2 ± 0.5 
Vesicles + o-NBA (12 mM) in 
buffer B 
7.0 -12.4 ± 1.1 
Vesicles + o-NSA- (12 mM) in 
buffer D 
5.2 -11.8 ± 0.4 
Virus/Environment pH Zeta Potential (mV) 
Virus in buffer A 7.0 -11.2 ± 1.0 
Virus in buffer A 5.2 -7.2 ± 0.2 
Virus + o-NBA in buffer B 7.0 -12.8 ± 0.7 
Virus + o-NSA- in buffer D 5.2 -7.8 ± 0.5 
 
Lipid vesicles were subsequently used to form supported bilayers inside the 
microfluidic device via vesicle fusion(163-165). Lipid diffusion and bilayer quality 
was then assessed by fluorescence recovery after photobleaching. 
Supported Bilayer Characterization: Diffusion Measurements.  
Integrity of bilayers and diffusion of the lipids within it was examined by 
fluorescence recovery after photobleaching (FRAP). To measure the diffusion 
coefficient and mobile fraction of the lipid bilayer, liposomes of the same composition 
used in experiments were prepared with 0.01 mol% Oregon Green DHPE (Molecular 
Probes, Eugene, OR). A 10% dilution of liposomes in buffer A was incubated in a 
PDMS well attached to a piranha cleaned slide. Diffusion measurements were taken of 
the aforementioned liposomes under three different conditions:  
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1) In the presence of buffer A at pH 7 (control case). 
2) In the presence of 12 mM o-NBA at pH 7. 
3) In the presence of 12 mM o-NSA-, with the pH of this solution adjusted to 
pH 7 using sodium hydroxide.  
 
Liposomes were allowed to incubate for 10 minutes in each solution, before being 
rinsed with buffer A at pH 7.0 for one minute. The bilayer was scratched with a 
dissection tool to remove a thin line of bilayer to aid in focusing on the plane of the 
bilayer on the microscope. Following the scratching step, the bilayer was rinsed again 
for one minute with buffer A to wash out any lipids removed by scratching.  A 20 µm 
diameter spot in the supported lipid bilayer was bleached with a 4.7 mW 488 nm 
krypton/argon laser for 200 ms. The recovery of the intensity of the photobleached 
spot was recorded for 15 minutes. The fluorescence intensity of the bleached spot was 
determined after background subtraction and normalization for each image. The 
recovery data was fit using a Bessel function following the method of 
Soumpasis(166). The diffusion coefficient was then calculated using the following 
equation: 
€ 
D = w
2
4t1/ 2
, where w is the full width at half-maximum of the Gaussian profile 
of the focused beam. The average diffusion coefficient for the samples under the 
aforementioned buffer conditions are shown in Table S3.  Neither o-NBA nor its post-
irradiated analog, o-NSA-, affects the diffusion coefficient of the supported lipid 
bilayer. These diffusion coefficients are in line with numerous reports of lipid 
diffusion in supported bilayers and also indicate good formation and integrity of the 
supported bilayers used here. 
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Table A3. Lipid Diffusion Coefficients and Mobile Fractions in Supported Bilayers 
under Various Buffer Conditions 
Bathing Solution 
Control: Buffer A, 
pH 7.0 
With o-NBA at 
pH 7.0 
With o-NSA- at 
pH 7.0 
Diffusion 
Coefficient (µm2/s) 
1.76 ± 0.23 1.73 ± 0.46 1.95 ± 0.27 
Mobile Fraction 0.97 ± 0.11 1.03 ± 0.05 0.94 ± 0.18 
 
Virus Membrane Labeling and Purification. In these studies, two virus 
membrane labels were used. For experiments examining just the hemifusion step, R18, 
a red-emitting fluorophore, was used. In this case, 5 µL of virus and 0.1 µL of R18 
were added to 250 µL of buffer A. The mixture was sonicated gently in a water bath 
for one hour. Free R18, which did not insert into the viral membrane, was removed 
from labeled virus using a G-25 spin column for two minutes in a centrifuge 
(Eppendorf, Centrifuge 5451C, Hauppauge, NY) at rate of 3x1000 min-1. The 
supernatant containing the purified virus was diluted with 1.8 ml of buffer A and 
gently vortexed to mix the virus and buffer.  
The optimal incubation time for R18 labeling of influenza X:31 to achieve the best 
fluorescence dequenching signals was achieved by varying both the sonication time 
and R18 concentration and then quantifying the extent of dequenching in a fluorimeter 
(PTI, Birmingham, NJ). Triton-X detergent was used to solubilize the membranes, 
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thus diluting the fluorophore and leading to full fluorescence dequenching. From these 
results, labeling-to-dequenching was optimized.  
In experiments where both the membrane and internal viral contents were labeled, 
the membrane dye was switched to R110C18, a green-emitting fluorophore, so that a 
red-emitting fluorophore (SRB) could be used to label the internal contents. The same 
general labeling procedure described for R18 was used for labeling the viral 
membranes with R110C18. R110C18 was synthesized following the procedure in 
Floyd et al(81), and described here only briefly. In a reaction vial, 7.5 g of 1-
octadecanol and 30 mg of Rhodamine 110 Chloride were mixed together at 80°C.  
Once the octadecanol melted, 100 µl of concentrated sulfuric acid was added to 
catalyze the dye conjugation reaction. The reaction was run for 48 hours at 80°C and 
halted by adding 600 μl of triethylamine. The reaction mixture was cooled to room 
temperature, dissolved in 200 mL of diethyl ether, and then filtered, leaving behind a 
solid product. A chromatography column was prepared so that there was a 1 cm-high 
silica slurry at the bottom with a 10 cm-high alumina slurry above, both soaked in 
10% isopropanol in chloroform. The product was loaded on the column and eluted 
with 100 mL each of 10%, 20%, 30%, and 40% isopropanol in chloroform, in that 
order, to remove excess octadecanol. The R110C18 product was eluted using a 10% 
methanol/20% isopropanol/70% chloroform solution. Fluorescent volume fractions 
were dried under nitrogen and then vacuum desiccated, leaving behind R110C18 
powder that was subsequently used to label viruses. 
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Dual-Color Virus Labeling and Purification. For dual-color virus fusion 
experiments, influenza X:31 was labeled with SRB and R110C18. First, 10 µL of 20 
mM SRB dissolved in buffer A was added to 5 µL of influenza X:31. 250 µL of buffer 
A was added to the virus/SRB mixture and allowed to incubate for 16-20 hours. 
Excess SRB was removed from labeled virus using a G-25 spin column for two 
minutes in a centrifuge at rate of 3x1000 min-1. Free R18, which did not insert into the 
viral membrane, was removed from labeled virus using a G-25 spin column for two 
minutes in a centrifuge at rate of 3x1000 min-1. Next, 3 µL of 2 mM R110C18 was 
added to the supernatant collected from the G-25 spin column and placed in a gentle 
sonicating bath for 90 minutes. Post sonication, the mixture was filtered through 
another G-25 spin column, as described previously to remove excess dye. The 
supernatant was diluted in 1.4 ml of buffer A.  
Uniformity of Uncaging Across the Field-of-View. Uniformity of illumination 
and uncaging across the field of view (~ 100 µm2) by the laser is confirmed by the 
random mapping of the fusion events shown in Figure S1.  
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Figure A1. A map of the virus fusion events in time triggered by uncaging. Each 
image is the same t = 0 image marked with the time interval in which dequenching 
began for those viruses.  Each dequenching event during that interval is marked with a 
colored circle to map out the events across the field of view.  The events are randomly 
distributed, indicating that there is uniformity in the uncaging across the field of view. 
 
Temperature change after UV pulse. To ensure that the UV laser pulse does not 
significantly change the temperature in the ROI at the time of fusion, the temperature 
pre- and post-UV pulse was checked using a thermocouple placed on a coverslip in the 
t = 0 s 
(before uncaging)
Fusion events 
between 0 – 1 s
Fusion events 
between 1 – 2 s
Fusion events 
between 2 – 3 s
Fusion events 
between 3 – 5 s
Fusion events 
between 5 – 10 s
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path of the UV beam on the 100x microscope objective. The temperature pre-UV 
pulse was 23.4oC and immediately post-UV pulse the temperature increased slightly to 
24.5oC but almost immediately returned to ambient temperature.  
Marking the Onset of Hemifusion by Fluorescence Dequenching. In this assay, 
membrane hemifusion events are detected by the dequenching of a fluorescent 
membrane probe (R18 or R110C18) located in the viral membrane. In this example, 
influenza X:31 was incubated with R18, until enough R18 partitioned into the viral 
membrane so that neighboring fluorophores quench each other, as described in the 
virus labeling procedure above. During fusion, when the outer monolayers of the viral 
and supported membranes mix, the fluorophore gets diluted and a sharp increase 
(spike) in fluorescence (dequenching) is observed as shown in Figure S2. Following 
the ‘spike’ in fluorescence, the fluorescent probe diffuses away from the hemifusion 
site, thus indicating that these are true fusion events and the fluorescence increase, 
which marks the onset of hemifusion, and is not a result of a viral particle changing its 
position in the evanescent field.  
Figure S2 shows a series of images of a single virus particle following the 
acidification at time = 0 by acidic buffer exchange method. The initial image (t = 0), 
onset of dequenching (t = 25 s), and after diffusion of R18 away from the fusion site (t 
= 49 s) are labeled on the plot with color-coded arrows. The time of hemifusion is 
defined by the timestamp of the image where the fluorescence begins to rapidly 
increase. 
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Figure A2. Virus particle dequenching trace. (Top) Images of a virus particle 
dequenching after hemifusion with the supported bilayer.  The scale bar in image, t = 
0,  is 1 µm. (Bottom) A trace of the fluorescence level surrounding the fusion site in 
time. Images at t = 0, 25 s, and 49 s, are labeled on the plot with color-coded arrows.  
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Virus Diameter Measurements. The average virus diameter was determined by 
dynamic light scattering using a Malvern Zetasizer Nano (Worcestershire, UK). The 
average diameter of X:31 and Udorn was 140nm and 155nm respectively. Brisbane 
contained two populations with peaks at 145nm and 760nm.  
 
 
Figure A3. Dynamic light scattering measurements of influenza virion diameter 
 
Image Processing. The images acquired during the fusion assays were analyzed 
using both ImageJ (NIH) and MATLAB (Mathworks). Fusing particles were manually 
selected in ImageJ and the fluorescence intensity in a 3x3 pixel region around each 
particle was collected as a function of time. In videos where background noise was 
high due to a large amount of fusion events, a rolling ball background subtraction 
algorithm was applied to all of the images to remove excess background noise as the 
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fluorophores diffused into the membrane after hemifusion. The rolling ball algorithm 
determines the local background for every pixel by averaging over a large circular 
region around the pixel. This background value is then subtracted from the original 
image. The fluorescence trajectories for the particles were then imported to MATLAB 
(Mathworks) for further analysis. A code written in MATLAB determined the onset 
time of the dequenching ‘spike’ for each particle by finding the time of the maximum 
intensity in each particle trajectory.  
Kinetic Analysis. The lag time for each hemifusing virus was recorded and a 
cumulative distribution curve was generated by plotting the time of the onset of 
hemifusion as a function of the frequency of events. The resulting curve (like those in 
Figure 3 in the main text) is then fit with a cumulative gamma distribution (equation 
S8) to estimate the kinetic parameters:
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Where kH is the hemifusion rate constant, t is time, and N is an additional fit 
parameter, often correlated to the number of steps or the number of HA trimers that 
must act concertedly to initiate fusion(81). A gamma distribution is commonly used to 
fit kinetics of viral fusion because individual fusion events occur independently of 
each other. The gamma distribution describes a multistep reaction scheme, where each 
step is a stochastic Poisson process with a rate constant k. For N kinetic steps, the 
overall rate constant is defined as kH, the hemifusion rate constant. The sharp rise and 
decay of hemifusion events is indicative of multiple intermediate kinetic steps that 
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take place between acidification and hemifusion. An exponential decay of observed 
events would suggest that hemifusion is a single step process; however, previous work 
suggests that kinetic steps involved in influenza hemifusion occur in parallel and that 
N may represent the number of HA trimers required to initiate hemifusion(81). The 
probability distribution was fit to our data using a non-linear least squares fitting 
algorithm.  
The accuracy with which N and kH can be determined depends on both the number 
of experimental observations and the number of steps in the process(167). To 
accurately estimate N from a gamma distribution a minimum number of a fusion 
events must occur for statistical significance. For example, to distinguish a 2-step 
process from a 3-step process i.e. N = 2 from N = 3, a minimum of 50 fusion events 
must be observed in a single experiment. The number of fusion events that occurred 
during each experiment reported here varied from 159 to 228 and 129-187 for fusion 
initiated using proton uncaging and acid flow respectively. 
Control Experiments. This section summarizes control experiments conducted to 
ensure that o-NBA and o-NSA- did not have adverse effects on the fusion kinetics of 
influenza. The data are summarized in Figure A4. In this figure, the black circles are 
the acid flow data obtained by buffer exchange experiments at various pH’s (buffer A) 
as indicated on the plots. Buffer exchange rates for all control experiments were 100 
µl/min. Both the kH and N data for acidic flow exchange match remarkably well with 
the data in the literature(81).  
To first ensure that the UV laser itself did not adversely affect the virus’s ability to 
fuse, we ran a control where the virus was bound to the bilayer, then irradiated with 
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UV light for 200 ms, and then fusion initiated by acidic buffer exchange to pH 5.1 
(green square).  The data falls within the acid flow control data.  
Next, we checked if the presence of o-NBA affected fusion by incubating the virus 
in this solution at pH 7.0 for 30 minutes, followed by acidic buffer exchange to pH 4.7 
(blue square) and also find that the data falls within the acid flow controls.   
Finally, we checked if the post-irradiated product of o-NBA, o-NSA-, impacted 
virus fusion in two ways. For both of these experiments, a 12 mM solution of o-NBA 
was irradiated with UV light uniformly to maximally uncage all o-NBA and create o-
NSA- in its place. For the first experiment, a portion of this solution was brought back 
to pH 7.0 with sodium hydroxide and then incubated with the virus for 30 minutes.  
Following this incubation, acidic buffer exchange at pH 4.7 was used to initiate fusion 
(purple square). The data falls within the acidic flow controls. For the second 
experiment, the pH of the remaining solution was measured with a pH probe and 
found to be ~ 4. This acidic solution was then exchanged with the existing pH 7.0 
solution in the device to initiate fusion (pink square).  This data also falls within the 
trends of acidic flow controls. 
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Figure A4. Summary of control experiments showing that the o-NBA and o-NSA- do 
not adversely affect the fusion kinetics of the virus. 
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Appendix B 
 
1. Preparation of glass surfaces for supported bilayers 
Glass microscope coverslips (25 mm x 25 mm; No. 1.5) from VWR were cleaned 
in piranha solution consisting of 70% sulfuric acid and 30% hydrogen peroxide. Slides 
were immersed in 150 ml of piranha solution for 10 minutes then rinsed for 30 
minutes with copious amounts of deionized water with a minimum resistance of 18.2 
MΩ⋅cm obtained from a Siemens Purelab Ultra water purification system. Clean slides 
were stored under deionized water and dried with a stream of ultra-pure nitrogen gas 
prior to use. For bilayer formation, glass surfaces were used either with PDMS wells 
or microfluidic devices.  
2. Fabrication of PDMS wells 
To form the PDMS wells, a thin sheet of PDMS (~ 5 mm) was made in a Petri dish 
using 10:1 elastomer/crosslinker mixture of Sylgard 184 (Robert McKeown Company; 
Branchburg, NJ). The PDMS was baked for 3 hours at 80oC, cut into small squares 
approximately the same size as a coverslip, and a hole punched through each square to 
form the wells. PDMS squares were then attached to a clean glass coverslips, which 
formed the bottom of the wells. The approximate volume of a well was 100 µl. 
3. Fabrication of microfluidic devices 
Microfluidic devices for the fusion experiments were fabricated using soft 
lithography. The microchannel pattern was designed using the CAD software program 
L-Edit (Tanner EDA) and a master of the flow pattern was made on a silicon wafer at 
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Cornell Nanoscale Science and Technology Facility (CNF). Each microfluidic device 
contained six channels. The dimensions of each channel are 1 mm wide by 70 µm 
deep with a total length of the channel of 1.5 cm.  The spacing between the centers of 
each channel is 1 mm. The silicon wafer was coated with P-20 primer in a spin coater, 
followed by SPR220 (Megaposit) photo-resist. The wafer was baked for 90 seconds at 
115oC and then exposed to UV light for 7.5 seconds in an ABM contact aligner to 
pattern the wafer with the flow cell design. Following this step, the wafer was baked 
again for 90 seconds at 115oC and then developed for 60 seconds in a Hamatech-Steag 
Wafer Processor. The pattern was then etched into the wafer using a Unaxis 770 Deep 
Si Etcher. The depth of the channel was determined using a Tencor P10 Profilometer.  
Microfluidic devices were formed using PDMS in a molding process. To facilitate 
the release of the cured PDMS after molding on the etched silicon master, the master 
slide was first coated with Sigmacote (Sigma). A 10:1 (elastomer/crosslinker) mixture 
of Sylgard 184 was mixed and then degassed before pouring on the silicon master 
slide etched with the flow cell pattern. The PDMS was then baked for 3 hours at 80oC. 
After baking, PDMS microfluidic devices were peeled off of the wafer, and inlet and 
exit ports were punched in each channel of the device.  Both the clean glass coverslip 
and PDMS mold were treated with oxygen plasma using a Harrick Plasma Cleaner 
(Model # PDC-32G; Ithaca, NY) at a pressure of 750 µm on the high setting for 25 
seconds.  Gently pressing the surfaces together resulted in a tight bond between the 
glass and PDMS and formed the four walls of the microfluidic channel. 
4. Liposome formation procedure 
To form these liposome preparations, appropriate amounts of each component 
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were mixed in biotechnology grade chloroform in a scintillation vial. For formulations 
containing sphingomyelin, this component was first dissolved in a 4:1 mixture of 
chloroform: methanol then added to the mixture. The bulk solvent was removed from 
the vial under a stream of high purity nitrogen gas and then placed in a desiccator 
under vacuum overnight to ensure complete evaporation of all solvent. Phosphate-
buffered saline at pH 7.4 was added to the dried lipid film and gently resuspended in a 
sonication bath (Model # BD2500A-DTH; VWR) for 20 minutes on the lowest 
setting. The final lipid concentration was approximately 2 mg/ml. Liposomes were 
then extruded twice through a polycarbonate filter (Whatman Nucleopore) with pore 
size 100 nm, and five times through a filter with a pore size of 50 nm. The average 
liposome diameter for all formulations was determined by dynamic light scattering.  
5. General membrane labeling procedure 
To fluorescently label the cell bleb proteoliposome membranes for the 
visualization of bilayer formation, blebs were incubated with 0.18 mM R18 for 15 
minutes in a sonicating bath (VWR) on the lowest setting.  
To fluorescently label membranes for fusion experiments, 5 μl of SA-liposome or 
virus solution was diluted with 250 μl of buffer A and mixed with 0.1 μl of 1.8 mM 
R18 for 1 hour in a sonicating bath. For fusion experiments, it is desired to label 
membranes with a quenched amount of R18 to mark membrane hemifusion events by 
fluorescence dequenching. Free R18, which did not insert into the membranes, was 
removed from the solution by centrifuging (Eppendorf, Centrifuge 5451C, 
Hauppauge, NY) through a G-25 spin column for 2 minutes at rate of 3x1000 min-1. 
The supernatant containing the purified SA-liposomes or virus was diluted with 1.8 ml 
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of buffer A and gently vortexed to mix. 
6. General liposome or virus interior labeling procedure 
For pore formation experiments, 5 μl of SA-liposome or virus solution was mixed 
with 10 μl of 20 mM Sulforhodamine B (SRB) solution and incubated overnight. 
Excess SRB, which did not partition into the SA-liposome or virus interior, was 
removed from the solution by centrifuging through a using a G-25 spin column for 2 
minutes at rate of 3x1000 min-1. The supernatant was diluted in 800 µL of buffer A 
prior to use. 
 
Cell bleb and supported bilayer characterization 
1.    Size distribution in cell bleb supernatant 
The hydrodynamic diameter and its distribution for the cell bleb supernatant were 
measured using dynamic light scattering. A plot of the size distribution is shown in 
Fig. B1.  
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Fig. B1. Distribution of particle diameters in cell bleb samples determined by dynamic 
light scattering.  
 
2. Atomic force microscopy (AFM)  
AFM was used to image the supported bilayer samples and measure bilayer 
thicknesses. Samples for AFM were prepared as described and the surfaces were 
gently scratched so as to allow a step height measurement of the lipid bilayer. Samples 
were imaged with a PicoPlus 2500 AFM (Molecular Imaging) using DNP-S10 contact 
mode tips (Bruker). Images were taken under aqueous buffer in contact mode at 10 
µm/s, 256 lines per image, and 10x10 µm scan size.  
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Fig. B2. AFM images confirm the presence of a lipid bilayer. A) 2D and 3D AFM 
images of BHK-liposome (bleb-free) SLB with accompanying depth profile across the 
scratch (white line) in the 3D image. B) AFM image of ruptured HA-bleb bilayer 
formed with BHK-liposomes with accompanying depth profile (white line) of a defect 
in the 3D image. 
 
3. Ellipsometry  
Ellipsometry was used to confirm thickness measurements made by AFM. An EP3 
Imaging Ellipsometer (NanoFilm) with a liquid cell, filled with deionized water, was 
used for all ellipsometric experiments. Measurements of both bare silicon and bilayer 
films were taken to confirm oxide layer thickness. The area of the surface over which 
the measurements were made was 0.5 cm x 0.5 cm. Variable angle measurements of 
57- 60 degrees were taken of areas of about 0.25 mm2 at a wavelength of 531.7 nm. 
The data from the ellipsometric measurements was modeled using a Marquardt-
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Levenberg simulation in Thin Film Companion software (Semiconsoft, Inc.). The 
thickness of the oxide layer on the bare silicon wafer used for these experiments was 
determined to be approximately 4.1 nm, and this value was incorporated into the 
calculation of total supported bilayer thickness. For the supported bilayers, we used 
frequency-dependent complex refractive index parameters, n = 1.38 and k = 0, based 
on previously published results (168, 169), to model the experimental data. 
Table B1 
Average thickness of supported bilayer films measured by ellipsometry  
            Sample      Thickness (nm) 
(A) BHK-liposome SLB              3.2 
(B) HA-bleb+BHK-liposome SLB             3.9 
(C) Adsorbed HA-blebs     -- 
 
4. Antibody binding experiments 
The following figure show the antibody binding to the VLSB and control cases, with 
appropriate background reference to asses specific binding, as described in the main 
text.  
 
HA-bleb 
VLSB
Empty vector-
bleb supported 
bilayer
No Ab Anti-HA Ab
A B
C D
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Fig. B3. Antibody binding to various supported bilayers derived from cell blebs. (A) 
HA-VLSB (no fluorescent label or antibody, just background signal); (B) HA-VLSB 
with fluorescently-labeled anti-HA bound; (C) Empty vector-bleb supported bilayer 
(control case with no fluorescent label or antibody present); (D) Empty vector-bleb 
supported bilayer with fluorescently-labeled anti-HA. 
5. Diffusion measurements in supported bilayers using fluorescence recovery 
after photobleaching 
 
Integrity of bilayers and diffusion of the lipids within it was examined by 
fluorescence recovery after photobleaching (FRAP). Bilayers were formed following 
the above procedures inside PDMS wells. R18 was used to label the bilayer and carry 
out the photobleaching experiments. Once formed, bilayers were gently scratched with 
a dissection tool to remove a thin section of the supported bilayer. This line aided in 
focusing on the plane of the bilayer on the microscope. Following this step, the bilayer 
was rinsed for 1 minute with buffer A to wash out any lipids removed by scratching. A 
~20 µm diameter spot in the supported lipid bilayer was bleached with a 4.7 mW 488 
nm krypton/argon laser for 200 ms. The recovery of the fluorescence intensity of the 
photobleached spot was recorded for 15 minutes at regular intervals. The fluorescence 
intensity of the bleached spot for each image was determined after background 
subtraction and normalization. The recovery data was fit using a Bessel function 
following the method of Soumpasis (166). The diffusion coefficient was then 
calculated using the following equation:                         
    (B1) 
€ 
D = w
2
4t1/ 2
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where w is the full width at half-maximum of the Gaussian profile of the focused laser 
beam.  
 
 
 
6. Diffusion coefficients in supported bilayers determined by fluorescence 
dispersion during hemifusion  
 
Table S2 
Diffusion coefficients determined from the radial dispersion of R18 fluorophores 
during membrane hemifusion  
R18 HA-bleb to SA-SLB              0.14 ± 0.08 µm2/s  
R18 SA vesicle to HA bilayer        0.27 ± 0.11µm2/s  
R18 Virus to SA-SLB   0.22 ± 0.03 µm2/s 
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Appendix C 
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Figure C2 Lipid-only supported bilayer characterization and mobility. (a) R18 
fluorescence recovery after photobleaching in a supported bilayer made from BHK-
liposomes labeled with R18. The images correspond to the times for each color-coded 
arrow on the plot. The data are fit to curve (black line) to obtain the diffusion 
coefficient, as described in the Methods section. At t = 0, the bilayer was bleached 
with a 561 nm laser beam. The diameter of the bleached area is ~ 20 µm. The reported 
diffusion coefficient on the plots is averaged from several experiments.  
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Figure C3 Antibody binding to various supported bilayers. Row 1: (1a) fAPN-SB (no 
fluorescent label); (1b) fAPN-SB with fluorescently-labeled anti-fAPN. Row 2: (2a) 
Empty vector-SB (control case with no fluorescent label); (2b) Empty vector-SB with 
fluorescently-labeled anti-fAPN. 
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Figure C4 Enzymatic activity of APN in cell blebs and in supported bilayers. (a) 
Fluorescence intensity measured in a fluorimeter over time for hAPN blebs (red) and 
empty vector bleb control (blue). Intensity increases as substrate is cleaved by APN 
present in cell blebs. The control case is the empty vector bleb. (b) Fluorescence 
intensity measured inside microfluidic channel coated with hAPN-SB. The intensity is 
measured after 12 hours. The inset shows the microchannels for the hAPN and empty 
vector supported bilayers under the same experimental conditions.  
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Figure C5 Cleavage of FCoV-1683 by cathepsin B and trypsin. Ultracentrifuged viral 
preparations of FCoV 1683 were either non-treated, trypsin-treated, or cathepsin B-
treated. The samples were then subjected to deglycosylation by PNGase F treatment to 
avoid having differentially glysosylated species of FCoV-1683 S. Samples were then 
analyzed by Western blot with the anti-FCoV S mAb 22G6.4. 
 
 
 
 
 
 
